3,538 Matching Annotations
  1. Last 7 days
    1. PatientID: 46

      KindredID: 46

      Case: Sex Unknown, 24Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0010797, HP:0006770 (hemangioblastoma, clear cell renal cell carcinoma )

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0009711, HP:0001737, HP:0002666, HP:0000107 (retinal capillary hemangioma, pancreatic cyst, pheochromocytoma, renal cyst)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2, S3.

      Variant: p.R161* (c.481C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: CA020408 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.481C%3ET

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161*(c.481C>T)

      MultipleGeneVariants: N/A

    2. PatientID: 231

      KindredID: 231

      Case: Sex Unknown, 9Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: CNS hemangioblastoma.

      CaseNotHPOs: HP:0006770; HP:0002666; HP:0000107; HP:0001732; HP:0009711 (Clear cell renal cell carcinoma, Pheochromocytoma, Renal cyst, Abnormality of the pancreas, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 17006605

      SupplementalData: Table S1, S2 and S3

      Variant: c.-61_-51dup

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 517152, https://www.ncbi.nlm.nih.gov/clinvar/variation/517152/

      CAID: N/A

      gnomAD: 0.00009581, https://gnomad.broadinstitute.org/variant/3-10183466-C-CTCCGCCCCGCG?dataset=gnomad_r2_1

      VariantEvidence: Variant was reported as c.-65_-55dup11 which was mapped to c.-61_-51dup.

      MutationType: splice_site_variant; duplication; plus_2_frameshift_variant; 5_prime_UTR_variant

      CivicName: c.-61_-51dup11

      MultipleGeneVariants: N/A

    3. PatientID: 118

      KindredID: 118

      Case: Sex Unknown, 36Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001732; HP:0010797; HP:0009711 (Abnormality of the pancreas, Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: Retinal hemangioblastoma, CNS hemangioblastoma and pancreatic cyst and tumor.

      CaseNotHPOs: HP:0002666; HP:0006770; HP:0000107 (Pheochromocytoma, Clear cell renal cell carcinoma, Renal cyst)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2 and S3

      Variant: p.H115Y (c.343C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA16621930, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.343C%3ET

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: H115Y (c.343C>T)

      MultipleGeneVariants: N/A

    4. PatientID: 260

      KindredID: 260

      Case: Sex Unknown, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666; HP:0000107 (Pheochromocytoma, Renal cyst)

      CaseHPOFreeText: Renal cystic lesion and pheochromocytoma.

      CaseNotHPOs: HP:0006770; HP:0001732; HP:0009711; HP:0010797 (Clear cell renal cell carcinoma, Abnormality of the pancreas, Retinal capillary hemangioma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2 and S3

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    5. 232 31 c.500G>T p.Arg167Leu x x x Likely de novo Mother and sibling -

      PatientID: 232

      KindredID: 232

      Case: Sex Unknown, 31Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Variant noted as likely de novo (i.e. “parents were unaffected even if one or both parents were not available (n/a) for genetic testing”). Mother and sibling were analyzed but no details were provided. Based on likely de novo assertion, it’s assumed that mother and sibling were negative for this mutation.

      CasePresentingHPOs: HP:0002666; HP:0009711; HP:0010797 (Pheochromocytoma, Retinal capillary hemangioma, Hemangioblastoma)

      CaseHPOFreeText: Pheochromocytoma, retinal hemangioblastoma, CNS hemangioblastoma and pancreatic cyst or tumor.

      CaseNotHPOs: HP:0000107; HP:0006770; HP:0001732 (Renal cyst, Clear cell renal cell carcinoma, Abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2 and S3

      Variant: p.R167L (c.500G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 526685, https://www.ncbi.nlm.nih.gov/clinvar/variation/526685/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R167L (c.500G>T)

      MultipleGeneVariants: N/A

    6. 176 46 c.156G>T p.Glu52X x x Likely de novo n/a -

      PatientID: 176

      KindredID: 176

      Case: Sex Unknown, 46Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A. Described as likely de novo.

      CasePresentingHPOs: HP:0010797, HP:0001737 (hemangioblastoma, pancreatic cysts)

      CaseHPOFreeText: The patient had pancreatic cysts or tumours.

      CaseNotHPOs: HP:0009711, HP:0002666, HP:0006770, HP:0000107 (retinal capillary hemangioma, pheochromocytoma, clear cell renal cell carcinoma, renal cyst)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2, S3.

      Variant: p.E52 (c.156G>T) *Problem variant cDNA does not match protein position

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Problem variant cDNA does not match protein position.

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: The variant was found in the N-terminus and was predicted to reduce protein stability.

      MutationType: N/A

      CivicName: N/A

      MultipleGeneVariants: N/A

    7. PatientID: 108

      KindredID: 108

      Case: Sex Unknown, 35Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0006770; HP:0010797 (Clear cell renal cell carcinoma, Hemangioblastoma)

      CaseHPOFreeText: CNS hemangioblastoma and clear cell renal cell carcinoma.

      CaseNotHPOs: HP:0002666; HP:0000107; HP:0001732; HP:0009711 (Pheochromocytoma, Renal cyst, Abnormality of the pancreas, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished:N/A

      SupplementalData: Table S1, S2 and S3

      Variant: Complete Deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: deletion

      CivicName: Null (Complete deletion)

      MultipleGeneVariants: N/A

    Tags

    Annotators

    URL

    1. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 3624NCI

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the National Cancer Institute database, with an unknown number of members belonging to Family ID 3624NCI. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: 7728151

      SupplementalData: N/A

      Variant: p.R176Gfs*26 (c.526delA)

      LegacyVariant: FS (c.739delA)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625257 https://www.ncbi.nlm.nih.gov/clinvar/variation/625257/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by location between codons 157 and 189.

      MutationType: minus_1_frameshift_variant

      CivicName: R176fs (c.526delA)

      MultipleGeneVariants: N/A

    2. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 143CA

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Cambridge, Department of Pathology database, with an unknown number of members belonging to Family ID 143CA. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: (c.464-1G>T)

      LegacyVariant: Splice (c.677-1G>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223221 https://www.ncbi.nlm.nih.gov/clinvar/variation/223221/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by truncating the protein.

      MutationType: splice_site_variant

      CivicName: Splice Site (c.464-1G>T)

      MultipleGeneVariants: N/A

    3. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 81F

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Neuro Olcologie database in Paris, with an unknown number of members belonging to Family ID 81F. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170G (c.509T>G)

      LegacyVariant: p.V170G (c.722T>G)

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756196 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.509T>G

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by location between codons 157 and 189.

      MutationType: missense_variant; transversion

      CivicName: V170G (c.509T>G)

      MultipleGeneVariants: N/A

    4. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 44CE

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Munich, university of Freiburg and Institute of Pathology database, with an unknown number of members belonging to Family ID 44CE. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L129Wfs*30 (c.384delT)

      LegacyVariant: FS (c.597delT)

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA70049452 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.384delT

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by truncating the protein.

      MutationType: minus_1_frameshift_variant

      CivicName: L129fs (c.384delT)

      MultipleGeneVariants: N/A

    5. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 25YO

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Department of Uroglogy, Yokohama database, with an unknown number of members belonging to Family ID 25YO. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Q96_P97delinsH (c.288_290delGCC)

      LegacyVariant: FS (c.501delGCC)

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA2573106244 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.288_290delGCC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: inframe_deletion; delins

      CivicName: Q96_P97delinsH (c.288_290delGCC)

      MultipleGeneVariants: N/A

    6. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 4402NCI

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the National Cancer Institute database, with an unknown number of members belonging to Family ID 4402NCI. Table 4 lists all ID and mutations associated with individuals with pheochromocytoma.

      GroupPresentingHPOs: HP:0002666 (pheochromocytoma)

      GroupHPOFreeText: Described as a VHL family with pheochromocytoma. Other phenotypes are likely, including renal cell carcinoma, however not detailed here.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.T157I (c.470C>T)

      LegacyVariant: p.T157I (c.683C>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223223 https://www.ncbi.nlm.nih.gov/clinvar/variation/223223

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by location between codons 157 and 189.

      MutationType: missense_variant; transition

      CivicName: T157I (c.470C>T)

      MultipleGeneVariants: N/A

    7. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 107CA

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Cambridge, Department of Pathology database, with an unknown number of members belonging to Family ID 107CA. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.N141Mfs*18 (c.421delA)

      LegacyVariant: FS (c.634delA)

      CaseProblemVariantFreeText: NM_000551.3:c.421delA automapped to NM_000551.3:c.422delA

      ClinVarID: N/A

      CAID: CA432421876 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.421delA

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by truncating the protein.

      MutationType: minus_1_frameshift_variant

      CivicName: N141fs (c.422delA)

      MultipleGeneVariants: N/A

    8. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 54CA

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Cambridge, Department of Pathology database, with an unknown number of members belonging to Family ID 54CA. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R177Dfs*25 (c.528delG)

      LegacyVariant: FS (c.741delG)

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA432423454 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.528delG

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site either by truncating the protein or by location between codons 157 and 189.

      MutationType: minus_1_frameshift_variant

      CivicName: R177fs (c.528delG)

      MultipleGeneVariants: N/A

    9. Germline mutations were identified in 300/469 (63%) of the families tested; 137 distinct intragenic germline mutations were detected.

      GroupID/ KindredID: 3YO

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This germline familial VHL mutation was taken from the Department of Uroglogy, Yokohama database, with an unknown number of members belonging to Family ID 3YO. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without pheochromocytoma.

      GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)

      GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: (c.464-1G>T)

      LegacyVariant: Splice (c.677-1G>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223221 https://www.ncbi.nlm.nih.gov/clinvar/variation/223221/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by truncating the protein.

      MutationType: splice_site_variant

      CivicName: Splice Site (c.464-1G>T)

      MultipleGeneVariants: N/A

    1. VHL-case history Patient 12, a 35-year-old male, presented with a 12 month history of progressive loss of vision in the left eye. MR imaging revealed a suprasellar tumor compressing the left optic nerve and the optic chiasm. The patient was in good general health and reported no other complaints. The tumor was totally resected via a left sided pterional craniotomy and the origin was most likely the pituitary stalk. Histological examination revealed a capillary hemangioblastoma. According to our routines, he was then subjected to the standard VHL work-up. The family had no history of VHL disease. A significantly elevated level of normetanephrine was found in the blood test. Both abdominal CT and MR imaging revealed tumors in the adrenal glands and kidneys as well as small renal cysts. Biopsies were taken from the adrenal gland tumors, histological and endocrine evaluation confirmed pheochromocytoma. Spinal MR imaging showed a small spinal cord tumor at level Th6/7 (asymptomatic). The pheochromocytoma was treated, and according to protocol the patient is now undergoing regular image surveillance for his kidney and spinal cord lesions. Genetic analysis disclosed a base substitution in exon 2 of the VHL gene (c.453C>G) resulting in a substitution from isoleucine to methionine (p.Ile151Met). Both parents were negative for VHL mutations. Hence, our case most likely has a de novo mutation.

      PatientID: 12 (case)

      KindredID: 1

      Case: M, 35Y0M, Norwegian

      DiseaseAssertion: assumed VHL

      FamilyInfo: No family history of hemangioblastoma or any other component tumors of VHL disease. Both parents were negative for VHL mutations. Hence, our case most likely has a de novo mutation.

      CasePresentingHPOs: HP:0009711; HP:0002666; HP:0100561; HP:0000107; HP:0009726 (retinal capillary hemangioblastoma; pheochromocytoma; spinal cord lesion; renal cyst; renal neoplasm)

      CaseHPOFreeText: presented with a 12 month history of progressive loss of vision in the left eye. MRI revealed a suprasellar tumor compressing the left optic nerve and the optic chiasm - Histological examination revealed a capillary hemangioblastoma. CT and MR imaging revealed tumors in the adrenal glands and kidneys as well as small renal cysts. Biopsies were taken from the adrenal gland tumors, histological and endocrine evaluation confirmed pheochromocytoma. Spinal MR imaging showed a small spinal cord tumor at level Th6 ⁄ 7 (asymptomatic).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.I151M (c.453C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351754364 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.453C%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: I151M (c.453C>G)

      MultipleGeneVariants: N/A

    1. PatientID: 4

      KindredID: A (III-12)

      Case: M, 33Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient's mother (II:7) carried the VHL mutation and presented with hemangioblastoma, renal cell carcinoma, pheochromocytoma, and renal cysts. The patient had one brother (III:11) who had the mutation and presented with hemangioblastoma, renal cell carcinoma, renal cyst, and retinal capillary hemangioma, one asymptomatic sister (III:10) who did not undergo genetic testing and a sister (III:13) who had the mutation and renal cell carcinoma, retinal angioma, and hemangioblastoma. On the mother's side of the family there was extensive history of VHL disease. Refer to Figure 1 for family pedigree and information regarding extended family members.

      CohortInfo: 10 VHL patients with renal cell carcinoma and a definite VHL family history.

      CasePresentingHPOs: HP:0005584, HP:0000107 (renal cell carcinoma, renal cyst)

      CaseHPOFreeText: Diagnosed with renal cysts and renal cell carcinoma at age 28. Tumours were resected via nephron-sparing surgery. There were two RCC tumours both of which had invaded the pseudo-capsule. After the procedure he still had one solid tumour and five renal cysts.

      CaseNotHPOs: HP:001079, HP:0009711, HP:0002666 (hemangioblastoma, retinal capillary hemangioma, pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170D (c.509T>A)

      LegacyVariant:N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625256 https://www.ncbi.nlm.nih.gov/clinvar/variation/625256/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence:N/A

      MutationType: missense_variant;transversion

      CivicName: V170D (c.509T>A)

      MultipleGeneVariants: N/A

    1. GroupID/ KindredID: F7

      Case: Sex unknown, 43Y0M, Spanish

      DiseaseAssertion: assumed VHL

      FamilyInfo: Noted of familial antecedents of Clear Cell RCC

      CasePresentingHPOs: HP:0009713; HP:0006880; HP:0000107; HP:0009711 (spinal hemangioblastoma, cerebellar hemangioblastoma, renal cysts, retinal capillary hemangioma)

      CaseHPOFreeText: Age of onset is 43Y0M.

      CaseNotHPOs: HP:0006770; HP:0002666; HP:0001737 (clear cell renal cell carcinoma, pheochromocytoma, pancreatic cysts)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S111N (c.332G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223186 https://www.ncbi.nlm.nih.gov/clinvar/variation/223186/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: predicted that this variant may inhibit the ability of pVHL to interact with HIF1-a.

      MutationType: missense_variant; transition

      CivicName: S111N (c.332G>A)

      MultipleGeneVariants: N/A

    1. Methods: We report here one particular family carring a heterozygous R200W mutation associated, for the first time, with a typical von Hippel-Lindau disease (with pheochromocytoma, hemangioblastoma and renal cell carcinoma) (Olswang et al., 1998). We performed a comprehensive study with genotyping, phenotypic analysis, structural modeling, functional and transcriptomic studies of the R200W mutant in comparison to classical mutants involved in von Hippel-Lindau disease. For the first time, the use of inducible expression vectors encoding untagged VHL in the functional studies allowed the observation of very subtle effects.Results: We show that the R200W mutation alone is definitely not associated with the von Hippel Lindau disease because this particular family actually carries another pathogenic mutation, VHL-R161Q, on the same VHL allele, and the double mutated allele segregates with disease. Our genotyping showed that the doubled mutations lies on the Chuvash core haplotype transmitted with the R200W mutation. We can thus conclude that this haplotype does not contain any protective elements against cancer development and that the VHLmutations are, by themselves, predominantly responsible for manifestations of the von Hippel-Lindau disease. Functional studies demonstrate that the function of the R200W mutation is close to the wild type protein and the severity of disease manifestations observed in VHL syndrome is perfectly correlated with a gradient of pVHL dysfunction in hypoxia signaling pathways.Conclusion: We show that the R200W mutation associated with congenital erythrocytosis is at the bottom of an oncogenic gradient. These results validate for the first time in humans the recently proposed “continuum” model of tumor suppression, which differs from the classical Knudson’s two-hit model and implies that subtle gene dosage-sensitivity may underlie tumor predisposition. This model may be of major importance in our understanding of tumor risk in patients with erythrocytosis carrying germline mutations in other genes belonging the HIF pathway. Indeed, in rare cases, PHD2 and HIF2A pathogenic mutations also predispose patients to pheochromocytomas or paragangliomas development.

      PatientID: N/A

      KindredID: 1

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: A family carried a heterozygous R200W mutation. At least one member also carries the pathogenic mutation, R161Q, on the same VHL allele. The double mutated allele segregates with disease. The number of family members is unclear

      CasePresentingHPOs: HP:0002666; HP:0010797; HP:0005584 (pheochromocytoma; hemangioblastoma; renal cell carcinoma)

      CaseHPOFreeText: congenital erythrocytosis (Chuvash polycythemia) along with typical VHL disease including pheochromocytoma, hemangioblastoma, and renal cell carcinoma

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161Q (c.482G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182983 https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: the R200W mutation alone is not associated with the von Hippel Lindau disease because this particular family carries another pathogenic mutation, R161Q, on the same VHL allele, and the double mutated allele segregates with disease. 

      MutationType: missense_variant;transition

      CivicName: N/A

      MultipleGeneVariants: Germline, VHL, c.598C>T (p.Arg200Trp)

    1. 35 (45%) had missense variants,

      PatientID: 47

      KindredID: 47

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0006770 (hemangioblastoma; clear cell renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0100634; HP:0030405; HP:0009711; HP:0030421 (Neuroendocrine neoplasm, pancreatic neuroendocrine neoplasm, retinal capillary hemangioma, Epididymal neoplasm)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.P86L (c.257C>T)

      LegacyVariant: p.P157L (c.470C>T)

      CaseProblemVariantFreeText: converted from legacy notation c.470C>T; Pro157Leu; authors contacted and confirmed this error. [patient from supp table reported previously in Aronoff et al, 2018].

      ClinVarID: 182977 https://www.ncbi.nlm.nih.gov/clinvar/variation/182977/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: P86L (c.257C>T)

      MultipleGeneVariants: N/A

    2. missense variants

      PatientID: 77

      KindredID: 77

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL (asymptomatic)

      FamilyInfo: N/A

      CasePresentingHPOs: None

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0010797; HP:0009711; HP:0100634; HP:0030405; HP:0030421; HP:0006770 (hemangioblastoma; retinal capillary hemangioma, Neuroendocrine neoplasm, pancreatic neuroendocrine neoplasm, Epididymal neoplasm; clear cell renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867 (Family 10 - see here for more info)

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.R167W (c.499C>T)

      LegacyVariant: p.R167W (c.712C>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218 https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954 https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    3. 17 (22%) had frameshift variants

      PatientID: 72

      KindredID: 72 **

      Case: Sex, Age, Ethnicity unknown

      DiseaseAssertion: VHL (asymptomatic)

      FamilyInfo: ** Patients 46, 50, 71, and 72 were reported previously in Aronoff et al, 2018 (PMID: 29437867) as family 5

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0030421; HP:0009711; HP:0030405; HP:0006770; HP:0100634; HP:0010797 (epididymal tumour, retinal capillary hemangioma, pancreatic endocrine tumour, clear cell renal cell carcinoma, neuroendocrine neoplasm, hemangioblastoma)

      CaseNotHPOFreeText: patient was not recorded to have an epididymal tumor, a pancreatic endocrine tumour (pancreatic neuroendocrine neoplasm), CCRCC, a neuroendocrine neoplasm (pheochromocytoma/paraganglioma), nor a CNS hemangioblamstoma.

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.F136Lfs*23 (c.408delT)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 43601 https://www.ncbi.nlm.nih.gov/clinvar/variation/43601/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: F136Lfs*23 (c.408delT)

      MultipleGeneVariants: N/A

    4. 17 (22%) had frameshift variants

      PatientID: 50

      KindredID: 50 **

      Case: Sex, Age, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: ** Patients 46, 50, 71, and 72 were reported previously in Aronoff et al, 2018 (PMID: 29437867) as family 5

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: CNS hemangioblamstoma

      CaseNotHPOs: HP:0030421; HP:0009711; HP:0030405; HP:0006770; HP:0100634 (epididymal tumour, retinal capillary hemangioma, pancreatic endocrine tumour, clear cell renal cell carcinoma, neuroendocrine neoplasm)

      CaseNotHPOFreeText: patient was not recorded to have an epididymal tumor, a pancreatic endocrine tumour (pancreatic neuroendocrine neoplasm), CCRCC, nor a neuroendocrine neoplasm (pheochromocytoma/paraganglioma)

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.F136Lfs*23 (c.408delT)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 43601 https://www.ncbi.nlm.nih.gov/clinvar/variation/43601/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: F136Lfs*23 (c.408delT)

      MultipleGeneVariants: N/A

    5. frameshift variants

      PatientID: 55

      KindredID: 55

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL (asymptomatic)

      FamilyInfo: N/A

      CasePresentingHPOs: None

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0010797; HP:0009711; HP:0100634; HP:0030405; HP:0030421; HP:0006770 (hemangioblastoma; retinal capillary hemangioma, Neuroendocrine neoplasm, pancreatic neuroendocrine neoplasm, Epididymal neoplasm; clear cell renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867 (Family 2 - see here for more info)

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.R177fs (c.531_542delinsTC)

      LegacyVariant: p.R177Sfs*22 (c.531_544delinsTCCA)

      CaseProblemVariantFreeText: NM_000551.3:c.531_544delinsTCCA converts to c.531_542delinsTC

      ClinVarID: 545823 https://www.ncbi.nlm.nih.gov/clinvar/variation/545823/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: delins

      CivicName: R177fs (c.531_542delinsTC)

      MultipleGeneVariants: N/A

    6. c.496_506del11 (p.Val166Serfs*4) in seven individuals, belonging to two pedigrees.

      PatientID: 84

      KindredID: 84

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: asymptomatic

      FamilyInfo: N/A

      CasePresentingHPOs: None

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0010797; HP:0006770; HP:0100634; HP:0030405; HP:0009711; HP:0030421 (hemangioblastoma; clear cell renal cell carcinoma; Neuroendocrine neoplasm, pancreatic neuroendocrine neoplasm, retinal capillary hemangioma, Epididymal neoplasm)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 29437867 (likely family 17 - see here for more info)

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.V166Sfs*4 (c.496_506del11)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Paper (Suppl. table 1) records this as c.496_606del11. Authors contacted and c.496_506del11 was confirmed as the correct variant nomenclature resulting in the p.V166Sfs*4 protein change.

      ClinVarID: 223229 https://www.ncbi.nlm.nih.gov/clinvar/variation/223229/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_2_frameshift_variant

      CivicName: V166Sfs*4 (c.496_506del)

      MultipleGeneVariants: N/A

    7. 35 (45%) had missense variants,

      PatientID: 9

      KindredID: 9

      Case: Age, Sex, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0006770; HP:0100634; HP:0030405; HP:0009711 (hemangioblastoma, clear cell renal cell carcinoma, neuroendocrine neoplasm, pancreatic endocrine tumour, retinal capillary hemangioma)

      CaseHPOFreeText: patient was recorded with a CNS hemangioblastoma, CCRC, and a pheochromocytoma and/or paraganglioma (neuroendocrine neoplasm), pancreatic endocrine tumour (or pancreatic neuroendocrine neoplasm), and a retinal hemangioblastoma.

      CaseNotHPOs: HP:0030421 (epididymal tumour)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes; see table S1 for VHL subject genetic and manifestation information.

      Variant: p.R167Q (c.500G>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. We identified deletions ranging from 0.5 kb to 250 kb affecting part of or the entire VHL and flanking genes in 54 families.

      GroupID: 28

      DiseaseAssertion: VHL

      GroupSize: N/A GroupNumberMales: N/A GroupNumberFemales: N/A GroupEthnicity: N/A GroupAgeRange: N/A

      GroupInfo: 54 VHL deletion families from the Freiburg registry were selected in order to assist in the correlation of VHL deletions to clinical phenotypes.

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0001737 (Retinal capillary hemangioma, Hemangioblastoma, Pancreatic cysts)

      GroupHPOFreeText: # of affected individuals: Retinal capillary hemangioma (1), Hemangioblastoma/brain/cerebellum (1), Pancreatic cysts (1)

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplemental Table 2, Table 1, Table 3

      Variant: Exon 3 Deletion (c.464-?_642+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 3 Deletion

      MultipleGeneVariants: N/A

    1. PatientID: 1

      KindredID: 1

      Case: F, 17Y0M, Korean

      DiseaseAssertion: VHL

      FamilyInfo: Family history positive for VHL. No details provided.

      CohortInfo: 26 Korean patients with more than one HAB in the CNS or eye, a single HAB in the CNS or retina plus a visceral manifestation (multiple renal, pancreatic or hepatic cysts, pheochromocytoma and RCC) and positive family history plus any one of the above manifestations.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: CNS hemangioblastoma. Other phenotypes presented but not specified (one or more of: pancreatic cyst or tumor, renal or hepatic cyst). Diagnosed with VHL Type 1. Phenotypes revised from previous reports (see “PreviouslyPublished” section below for PMID).

      CaseNotHPOs: HP:0002666; HP:0009711; HP:0005584 (Pheochromocytoma, Retinal capillary hemangioma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 19270817

      SupplementalData: N/A

      Variant: p.P59Afs*73 (c.173_174insC)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA658795188, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA658795188

      gnomAD: N/A

      VariantEvidence: Authors noted variant as: c.173insC. Reported as a “novel mutation” by the current authors.

      MutationType: insertion; plus_1_frameshift_variant

      CivicName: P59fs (c.173_174insC)

      MultipleGeneVariants: N/A

    2. PatientID: 7

      KindredID: 7

      Case: F, 48Y0M, Korean

      DiseaseAssertion: VHL

      FamilyInfo: No family history of VHL.

      CohortInfo: 26 Korean patients with more than one HAB in the CNS or eye, a single HAB in the CNS or retina plus a visceral manifestation (multiple renal, pancreatic or hepatic cysts, pheochromocytoma and RCC) and positive family history plus any one of the above manifestations.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: CNS hemangioblastoma. Other phenotypes presented but not specified (one or more of: pancreatic cyst or tumor, renal or hepatic cyst). Diagnosed with VHL Type 1.

      CaseNotHPOs: HP:0002666; HP:0009711; HP:0005584 (Pheochromocytoma, Retinal capillary hemangioma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E70K (c.208G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 43598, https://www.ncbi.nlm.nih.gov/clinvar/variation/43598/

      CAID: N/A

      gnomAD: 0.000004365, https://gnomad.broadinstitute.org/variant/3-10183739-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: E70K (c.208G>A)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: 3748

      Case: Sex, Age, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: Familial VHL stated; although only 1 family member recorded.

      CasePresentingHPOs: HP:0009711; HP:0010797 (retinal capillary hemangioma, hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002666; HP:0005584 (Pheochromocytoma, renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 8956040

      SupplementalData: N/A

      Variant: p.Q164R (c.491A>G)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.Q235R (c.704A>G)

      ClinVarID: 2238 https://www.ncbi.nlm.nih.gov/clinvar/variation/2238/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: Q164R (c.491A>G)

      MultipleGeneVariants: N/A

    2. GroupID: 3101

      DiseaseAssertion: assumed VHL

      GroupSize: 3

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: Familial VHL stated; 3 family members recorded with this mutation.

      GroupPresentingHPOs: HP:0010797; HP:0009711 (hemangioblastoma, retinal capillary hemangioma)

      GroupHPOFreeText: 1/3 members had a retinal angioma (hemangioma), and 2/3 members had CNS hemangioblastoma

      GroupNotHPOs: HP:0002666; HP:0005584 (pheochromocytoma, renal cell carcinoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.N78T (c.233A>C)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.N149T (c.446A>C)

      ClinVarID: 223168 https://www.ncbi.nlm.nih.gov/clinvar/variation/223168/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: N78T (c.233A>C)

      MultipleGeneVariants: N/A

    3. PatientID: None

      KindredID: 3699

      Case: Sex, Age, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: Familial VHL stated; although only 1 family member recorded.

      CasePresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002666; HP:0010797; HP:0005584 (Pheochromocytoma, hemangioblastoma, renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 8956040

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.R238W (c.712C>T)

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. PatientID: III-1

      KindredID: 1

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: 13 affected individuals in this family were found. The p.Tyr112Asn (c.334T>A) mutation of the VHL gene cosegregated with the disease in all five tested affected individuals from the family (V-5, VI-1, VI-2, VI-3, and VII-1). 7/13 have had renal cell carcinoma. Other manifestations of the disease in this family include renal cysts, retinal angioma, and CNS hemangioblastoma. There was one case of pheochromocytoma (VII-1). No other pheochromocytomas or related neuroendocrine tumors of the pancreas or adrenal gland have been diagnosed or recognized retrospectively by review of medical records and recall of relatives. The mutation was also found in three asymptomatic relatives (VII-2, VII-3, and VII-4).

      CasePresentingHPOs: HP:0000107 (Renal cyst)

      CaseHPOFreeText: Age of onset not provided. Deceased.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y112N (c.334T>A)

      LegacyVariant: T547A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2228, https://www.ncbi.nlm.nih.gov/clinvar/variation/2228/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Variant is inferred in this patient from clinical findings and family history.

      MutationType: missense_variant;transversion

      CivicName: Y112N (c.334T>A)

      MultipleGeneVariants: N/A

    1. PatientID: 223

      KindredID: 83

      Case: F, 38Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband's brother had the same germline mutation. He presented with renal cell carcinoma at age 53. The proband's mother had a CNS hemangioblastoma at 52, but no genotyping information is available for her.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: The proband presented with pheochromocytoma at age 38.

      CaseNotHPOs: HP:0009711; HP:0001737; HP:0001732; HP:0010797; HP:0005584 (Retinal capillary hemangioma, Pancreatic cysts, Abnormality of the pancreas, Hemangioblastoma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    2. PatientID: 44

      KindredID: 15

      Case: M , Age Unknown, Chinese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Proband (patient 42) has four family members confirmed with the mutation, and two family members who passed away before diagnosis/ genetic confirmation of the mutation. Family members confirmed with the mutation include: the proband's daughter (patient 43) who had retinal angioma (age 17), renal cell carcinoma (21), multiple pancreatic cysts/tumors (18), and a pheochromocytoma (19). His son (patient 44) who was asymptomatic at the time of assessment. His niece 1 (patient 47) who had a retinal angioma and renal cell carcinoma (22). And his niece 2 (patient 28) who had a CNS hemangioblastoma (19) and a retinal angioma (18). Family members who passed away before diagnosis and were not genetically confirmed include: his sister (oatient 45) who had a CNS hemangioblastoma (22), and his brother (patient 46) who had a retinal angioma and renal cell carcinoma at 52.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: The proband's son (patient 44) was genetically confirmed with the mutation but was asymptomatic at the time of assessment.

      CaseNotHPOs: HP:0001737; HP:0001732; HP:0005584; HP:0002666; HP:0009711; HP:0010797 (Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma, Pheochromocytoma, Retinal capillary hemangioma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.S80Tfs*77 (c.239_245del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA913189246; https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.239_245del

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: S80fs (c.239_245del)

      MultipleGeneVariants: N/A

    3. PatientID: 241

      KindredID: 92

      Case: F, 39Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001737; HP:0001732; HP:0005584; HP:0010797 (Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma, Hemangioblastoma)

      CaseHPOFreeText: The proband presented with multiple pancreatic cysts/tumors at age 28.

      CaseNotHPOs: HP:0002666; HP:0009711 (Pheochromocytoma, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: Exon 1 Deletion (c.1-?_340+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1 Deletion

      MultipleGeneVariants: N/A

    4. PatientID: 85

      KindredID: 27

      Case: F, 50Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 81) had 3 family members confirmed with the mutation: his aunt 2 (patient 85) had pancreatic cysts and/or tumors at age 50, his cousin/ the son of Aunt 2 was asymptomatic at the time of assessment, and the granddaughter of aunt 2 was also asymptomatic at the time of assessment. The proband also had 3 family members who passed away before diagnosis/ before confirming the mutation: his mother (patient 82) had a CNS hemangioblastoma at 33, his Aunt 1 (patient 83) had a CNS hemangioblastoma at 32, and his cousin/ the son of Aunt 1 (patient 84) had a CNS hemangioblastoma at 30.

      CasePresentingHPOs: HP:0001732; HP:0001737 (Abnormality of the pancreas, Pancreatic cysts)

      CaseHPOFreeText: The proband's Aunt 2 presented with multiple pancreatic cysts and/or tumors at age 50.

      CaseNotHPOs: HP:0009711; HP:0010797; HP:0002666; HP:0005584 (Retinal capillary hemangioma, Hemangioblastoma, Pheochromocytoma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.N90I (c.269A>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223172; https://www.ncbi.nlm.nih.gov/clinvar/variation/223172/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: N90I (c.269A>T)

      MultipleGeneVariants: N/A

    5. PatientID: 20

      KindredID: 6

      Case: M, Age unknown, Chinese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Family #6 is large. The proband (patient 12) had 8 family members genetically confirmed with the mutation and two family members who passed away before diagnosis. The 8 genetically confirmed family members include patient 13/ her daughter (asymptomatic,) 14/ her mother (CNS hemangioblastoma at age 59,) 15/ her uncle 1 (CNS hemangioblastoma age 45, renal cell carcinoma at 59, multiple pancreatic cysts/tumors at 65), 18/ the son of her uncle 2 (CNS hemangioblastoma at age 22, renal cell carcinoma at 30, multiple pancreatic cysts/tumors at 31,) 19/ the granddaughter of her uncle 2 (asymptomatic), 20/ the second son of her uncle 2 (asymptomatic), 21/ her aunt (CNS hemangioblastoma and retinal angioma at 53,) and 22/ her uncle 3 (multiple pancreatic cysts/tumors at 29). The 2 family members who passed away before diagnosis are patients 16/ son of her uncle 1 (CNS hemangioblastoma at 22) and 17/ her uncle 2 (CNS hemangioblastoma, renal cell carcinoma, and multiple pancreatic cysts/tumors at age 51).

      CasePresentingHPOs: N/A

      CaseHPOFreeText: The proband's uncle's son (ie. the second son of uncle 2), patient 20, was asymptomatic at the time of the study.

      CaseNotHPOs: HP:0009711; HP:0002666; HP:0010797; HP:0001737; HP:0001732; HP:0005584 (Retinal capillary hemangioma, Pheochromocytoma, Hemangioblastoma, Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma )

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.S65L (c.194C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182975; https://www.ncbi.nlm.nih.gov/clinvar/variation/182975/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: S65L(c.194C>T)

      MultipleGeneVariants: N/A

    6. PatientID: 104

      KindredID: 35

      Case: F, 27Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 104, presented with multiple pancreatic cysts/tumors at age 27. Their sister, patient 105 presented with pancreatic cysts/tumors at age 28. Their mother presented with a CNS hemangioblastoma at 45 but passed away before diagnosis/genetic testing.

      CasePresentingHPOs: HP:0001737; HP:0001732 (Pancreatic cysts, Abnormality of the pancreas)

      CaseHPOFreeText: The proband presented with multiple pancreatic cysts/tumors at age 27.

      CaseNotHPOs: HP:0005584; HP:0002666; HP:0009711; HP:0010797 (Renal cell carcinoma, Pheochromocytoma, Retinal capillary hemangioma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.Y98S (c.293A>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 219160; https://www.ncbi.nlm.nih.gov/clinvar/variation/219160/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: Y98S (c.293A>C)

      MultipleGeneVariants: N/A

    Tags

    Annotators

    URL

    1. PatientID: 4

      KindredID: 1

      Case: M, 20Y0M, Japanese

      DiseaseAssertion: Assumed VHL

      FamilyInfo: Of sixteen analyzed family members, eight were found to carry the same mutation NM_000551.3:c.482G>A the patient carried. Of those family members, 3 were asymptomatic with ages 18Y, 18Y, and 20Y, 1 was 57Y and had bilateral adrenal pheochromocytoma, 1 was 23Y and had bilateral pheochromocytoma, 1 was 20Y and had unilateral pheochromocytoma with retinal angioma, 1 was 59Y and had unilateral pheochromocytoma with paraganglioma, and 1 was 49Y and had pancreatic neuroendocrine tumor.

      CasePresentingHPOs: HP:0002666; HP:0009711 (Pheochromocytoma, retinal capillary hemangioma)

      CaseHPOFreeText: The patient presented with grossly sized unilateral pheochromocytoma and retinal angioma (Fig. 2, patient 4).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161Q(c.482G>A)

      LegacyVariant: p.R161Q(c.695G>A)

      ClinVarID: 182983, https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R161Q(c.482G>A)

      MultipleGeneVariants: N/A

    2. PatientID: None

      KindredID: 1

      Case: F, 18Y0M, Japanese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Of sixteen analyzed family members, eight were found to carry the same mutation NM_000551.3:c.482G>A the patient carried. Of those family members, 3 were asymptomatic with ages 18Y, 18Y, and 20Y, 1 was 57Y and had bilateral adrenal pheochromocytoma, 1 was 23Y and had bilateral pheochromocytoma, 1 was 20Y and had unilateral pheochromocytoma with retinal angioma, 1 was 59Y and had unilateral pheochromocytoma with paraganglioma, and 1 was 49Y and had pancreatic neuroendocrine tumor.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161Q(c.482G>A)

      LegacyVariant: p.R161Q(c.695G>A)

      ClinVarID: 182983, https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R161Q(c.482G>A)

      MultipleGeneVariants: N/A

    3. PatientID: 3

      KindredID: 1

      Case: M, 52Y0M, Japanese

      DiseaseAssertion: Assumed VHL

      FamilyInfo: Of sixteen analyzed family members, eight were found to carry the same mutation NM_000551.3:c.482G>A the patient carried. Of those family members, 3 were asymptomatic with ages 18Y, 18Y, and 20Y, 1 was 57Y and had bilateral adrenal pheochromocytoma, 1 was 23Y and had bilateral pheochromocytoma, 1 was 20Y and had unilateral pheochromocytoma with retinal angioma, 1 was 59Y and had unilateral pheochromocytoma with paraganglioma, and 1 was 49Y and had pancreatic neuroendocrine tumor.

      CasePresentingHPOs: HP:0002666; HP:0002668 (Pheochromocytoma, paraganglioma)

      CaseHPOFreeText: The patient presented with unilateral pheochromocytoma and paraganglioma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161Q(c.482G>A)

      LegacyVariant: p.R161Q(c.695G>A)

      ClinVarID: 182983, https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R161Q(c.482G>A)

      MultipleGeneVariants: N/A

    1. VHL (n = 10)

      PatientID: N/A

      KindredID: 11

      Case: M, 23Y0M, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma and paraganglioma

      FamilyInfo: No family information provided.

      CasePresentingHPOs: HP:0002666; HP:0002668 (pheochromocytoma; paraganglioma)

      CaseHPOFreeText: Patient is a white 23Y0M female diagnosed with either pheochromocytoma and paraganglioma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: See table s3 for patient-related information.

      Variant: p.W117* (c.351G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351753679

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/3-10188208-G-A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: W117* (c.351G>A)

      MultipleGeneVariants: N/A

    1. PatientID: 9

      KindredID: 9

      Case: M, 24Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0009713 (Spinal hemangioblastoma)

      CaseHPOFreeText: Spinal cord (T4) hemangioblastoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L135* (c.404T>A)

      LegacyVariant: c.617T>A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351754021, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.404T%3EA

      gnomAD: N/A

      VariantEvidence: Preoperative hemoglobin: 17.2. Postoperative hemoglobin (<3 month postoperatively): 10.2.

      MutationType: missense_variant;transversion; stop_gained

      CivicName: L135* (c.404T>A)

      MultipleGeneVariants: N/A

    1. 3 M c.681T>G (Y156X) Unilateral Positive (CNS) Positive 

      PatientID: 3

      KindredID: 3

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0000107; HP:0005584; HP:0010797; HP:0001737 (Renal cyst, Renal cell carcinoma, Hemangioblastoma, Pancreatic cysts)

      CaseHPOFreeText: Unilateral RCC and renal cysts, CNS hemangioblastoma, positive for pancreatic cysts.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table 1

      Variant: p.Y156* (c.468T>G)

      LegacyVariant: c.681T>G (Y156X)

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756053, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.468T%3EG

      gnomAD: N/A

      VariantEvidence: Variant is declared as “c.681T>G (Y156X)” by the authors, this was treated as a legacy variant and mapped to c.468T>G, Y156*.This study found coexpression of Epo and EpoR in 11 RCCs and in 10 benign renal cysts in a spectrum of VHL renal disease suggesting that Epo/EpoR coexpression is present in both benign and malignant stages of renal neoplasia. Six benign cysts stained for Epo but not EpoR. The researchers detected loss of heterozygosity of a wild-type VHL allele in different RCCs with microsatellite markers, D3S1110 and D3S2452, flanking the VHL gene

      MutationType: stop_gained; missense_variant;transversion

      CivicName: Y156* (c.468T>G)

      MultipleGeneVariants: N/A

    2. 7 F Large deletion Bilateral Positive (CNS, retinal) Negative 

      PatientID: 7

      KindredID: 7

      Case: F, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0000107; HP:0005584; HP:0010797; HP:0009711 (Renal cyst, Renal cell carcinoma, Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: Bilateral RCC add renal cysts, CNS hemangioblastoma, retinal hemangioblastoma.

      CaseNotHPOs: HP:0001737 (Pancreatic cysts)

      CaseNotHPOFreeText: Negative for pancreatic cysts.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table 1

      Variant: Large deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: This study found coexpression of Epo and EpoR in 11 RCCs and in 10 benign renal cysts in a spectrum of VHL renal disease suggesting that Epo/EpoR coexpression is present in both benign and malignant stages of renal neoplasia. Six benign cysts stained for Epo but not EpoR. The researchers detected loss of heterozygosity of a wild-type VHL allele in different RCCs with microsatellite markers, D3S1110 and D3S2452, flanking the VHL gene

      MutationType: deletion

      CivicName: Null (Large Deletion)

      MultipleGeneVariants: N/A

    1. A 30-year-old woman was referred to Seoul National University Hospital diabetes clinic for glycemic control in July 2006. Her height was 159 cm and her body weight was 52 kg, physical examinations including vital signs were within normal limits, and her routine biochemical test results were normal except for the blood glucose level. She was diagnosed with GDM at gestational age 27 weeks of her first pregnancy (in January 2006). She used insulin for glycemic control during the pregnancy. The delivery occurred at full-term without any event, and the baby had no perinatal complications. After delivery, she did not take any antidiabetes medications. At 3 months postpartum, fasting plasma glucose level was 252 mg/dL, 2-hour postprandial glucose level was 572 mg/dL during a 75 g oral glucose tolerance test and her hemoglobin A1c level was 11.0%. Her antiglutamic acid decarboxylase antibody was negative and fasting C-peptide level was 0.2 ng/mL. She needed no more than 10 to 12 units of insulin a day to keep her blood glucose level under control, which was not maintained with oral antidiabetes drugs in the place of insulin. An abdominal computed tomography scan taken in October 2006 revealed that her pancreas and both kidneys were covered with numerous cysts (Fig. 1A); thereby, she was suspected to have VHL disease. Her family members had some features that appeared to be related to VHL disease. Her grandmother was troubled with severe headache during her lifetime, though the cause of death was unclear. Her father, who had diabetes mellitus requiring insulin therapy, underwent brain surgery twice and was diagnosed with brain hemangioblastoma, which was his cause of death. In addition, her younger brother underwent brain surgery in his teens due to brain hemangioblastoma. He had not been diagnosed with diabetes mellitus.Open in a separate windowFig. 1Radiologic studies revealing the clinical features of the patient. (A) Abdominal computed tomography (CT) scan shows multiple cysts in the pancreas and kidneys. (B) A hemangioblastoma is seen in the spinal cord (arrow). (C) Two hemangioblastomas are seen in the cerebellum (arrows). (D) A follow-up abdominal CT scan shows multiple renal cell carcinomas (arrow).In February 2007, she presented with paresthesia and weakness in both legs and voiding difficulty for 1 month prior to hospital admission. Magnetic resonance imaging (MRI) of the lumbosacral spine showed an intradural, brightly enhancing lesion at the approximated level of the L2 to L3 disc space (Fig. 1B). She underwent complete resection of the tumor. Histopathological examination demonstrated hemangioblastoma. To screen the intracranial lesion, we performed brain MRI. Multiple cerebellar hemangioblastomas were detected on MRI (Fig. 1C), and she underwent gamma knife surgery. Ophthalmologic exam revealed no retinal hemangioblastoma. Two years later (in March 2011), she was diagnosed with RCC and underwent partial nephrectomy on both kidneys (Fig. 1D). Pathology revealed clear cell type RCC.

      PatientID: III-2

      KindredID: 1

      Case: F, 35Y0M, Korean

      DiseaseAssertion: assumed VHL

      FamilyInfo: Her family members had features apparently related to VHL disease. Her grandmother was troubled with severe headache during her lifetime, though the cause of death was unclear. Her father and brother had brain hemangioblastomas: Her father, who had diabetes mellitus requiring insulin therapy, underwent brain surgery twice and was diagnosed with brain hemangioblastoma, which was his cause of death. In addition, her younger brother underwent brain surgery in his teens due to brain hemangioblastoma. He had not been diagnosed with diabetes mellitus. Her brother was tested with the same mutation, while whereas her clinically unaffected sister and second baby did not.

      CasePresentingHPOs: HP:0001737; HP:0005562; HP:0009713; HP:0006880; HP:0006770 (pancreatic cysts; multiple renal cysts; spinal hemangioblastoma; cerebellar hemangioblastomsa; clear cell renal cell carcinomas)

      CaseHPOFreeText: woman presented with gestational diabetes mellitus at 30Y. She showed multiple pancreatic and renal cysts. One year later (31Y), she presented with paresthesia and weakness in both legs, a lesion that was then removed and identified as a spinal cord (lumbosacral) hemangioblastoma. She later (33Y) was found to have cerebellar hemangioblastoma, and two years after (35Y), clear cell RCC as she underwent partial nephrectomy on both kidneys.

      CaseNotHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseNotHPOFreeText: Ophthalmologic exams revealed no retinal hemangioblastoma.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y98Tfs*61 (c.291delC)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA432420512 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.291delC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: Y98fs (c.291delC)

      MultipleGeneVariants: N/A

    1. 2

      PatientID: Unknown

      KindredID: 2

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: 5 members of this family were found to have the mutation and pheochromocytoma. Other declared diseases in this family are: paraganglioma, hemangioblastoma, lung metastases and spinal hemangioblastoma but the presenting patient is unclear.Relationship between these family members is unclear.

      CohortInfo: Patients with the diagnosis of familial or sporadic PHEO and their relatives.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Follow-up 18 years later but it is unclear if this pertained to all affected family members.

      CaseNotHPOs: HP:0005584 (Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table 1

      Variant: p.P138= (c.414A>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223206, https://www.ncbi.nlm.nih.gov/clinvar/variation/223206/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P138= (c.414A>G)

      MultipleGeneVariants: N/A

    2. Her paternal grandfather (I:1) had been diagnosed with an adrenal tumor and hypertension in his 40s.

      PatientID: I:1

      KindredID: 1

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Look to proband (III:3) for extensive family info.

      CohortInfo: Patients with the diagnosis of familial or sporadic PHEO and their relatives.

      CasePresentingHPOs: HP:0002666; HP:0000822 (Pheochromocytoma, Hypertension)

      CaseHPOFreeText: Diagnosed with hypertension and adrenal tumor in his 40’s.

      CaseNotHPOs: HP:0005584 (Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Figure 1

      Variant: p.P138= (c.414A>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223206, https://www.ncbi.nlm.nih.gov/clinvar/variation/223206/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: P138= (c.414A>G)

      MultipleGeneVariants: N/A

    1. PatientID: 102

      KindredID: 102

      Case: Sex Unknown, 12Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Single malignant PCC.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Patient information pulled from Supplemental Table 1a.

      Variant: p.P97L (c.290C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 1503290, https://www.ncbi.nlm.nih.gov/clinvar/variation/1503290/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Carbonic anhydrase 9 (CA9) mRNA level of 139.24 was detected. Membrane CA9 immunostaining was observed.

      MutationType: missense_variant;transition

      CivicName: P97L (c.290C>T) and L116P (347T>C)

      MultipleGeneVariants: Germline, VHL, L116P (347T>C)

    2. PatientID: 54

      KindredID: 54

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Patient information pulled from Supplemental Table 1b.

      Variant: p.A149Cfs*25 (c.444dup)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223211, https://www.ncbi.nlm.nih.gov/clinvar/variation/223211/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Membrane CA9 immunostaining was observed (supplemental table 1).

      MutationType: duplication; plus_1_frameshift_variant

      CivicName: A149fs (c.444dup)

      MultipleGeneVariants: N/A

    3. PatientID: 103

      KindredID: 103

      Case: Sex Unknown, 25Y0M, Ethnicity Unknown

      DiseaseAssertion: Pheochromocytoma

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: The patient had a single pheochromocytoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Patient information pulled from Supplemental Table 1. There is additional tumour specific information in Supplemental Table 2.

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: Carbonic anhydrase 9 (CA9) mRNA level of 184.56 was detected. Membrane CA9 immunostaining was observed (supplemental table 1).

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. GroupID: 73

      DiseaseAssertion: VHL

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 2 members of this family were found to harbor the c.417_418delTC germline variant of the VHL gene. Member 3246 presented with moderate renal disease (RCC). Member 3245 had unknown renal involvement. Families were recruited from the French VHL Registry. Enrolment in the study required identification of the germline VHL mutation (currently 85% of the families included in the French VHL Registry) and available data regarding renal phenotype. A total of 126 families fulfilled these criteria.

      GroupPresentingHPOs: HP:0005584 (Renal cell carcinoma)

      GroupHPOFreeText: Moderate renal disease (less than five solid lesions requiring surgical treatment, either unilateral or bilateral).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: Paper states that this family is previously reported in PMID 12202531 and/or 9829912, where 1 and 2 individuals respectively with this mutation are reported. It is unclear if one or both of these previously reported groups are the same as the current family. Alternatively, these individuals may also be associated with family 80.

      SupplementalData: Phenotype and genotype information can be found in Supplementary Table S1.

      Variant: p.L140Qfs*3 (c.419_420del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA357039, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.419_420del

      gnomAD: N/A

      VariantEvidence: Variant was reported as c.417_418delTC and mapped to c.419_420del.

      MutationType: deletion; minus_2_frameshift_variant

      CivicName: L140Qfs*3 (c.419_420del)

      MultipleGeneVariants: N/A

    2. GroupID: 13

      DiseaseAssertion: VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 4 members of this family were found to harbor the c.351G>T germline variant of the VHL gene. Member 628 had unknown renal involvement. Members 1571 and 1578 presented with mild renal disease. Member 1488 presented with moderate renal disease (RCC). Member 625 presented with severe renal disease (RCC). Families were recruited from the French VHL Registry. Enrolment in the study required identification of the germline VHL mutation (currently 85% of the families included in the French VHL Registry) and available data regarding renal phenotype. A total of 126 families fulfilled these criteria.

      GroupPresentingHPOs: HP:0009726; HP:0005584 (Renal neoplasm, Renal cell carcinoma)

      GroupHPOFreeText: Mild renal disease (simple renal cyst, multicystic kidney[s], small lesion [less than 10 mm in size] of unknown significance, or small solid tumor without indication for surgical removal [less than 30 mm in size]). Moderate renal disease (less than five solid lesions requiring surgical treatment, either unilateral or bilateral). Severe renal disease (any solid lesion before 25 years of age, five or more solid lesions within one or two kidneys, or metastasis of renal cell carcinoma).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: Paper states that this family is previously reported in PMID 12202531 and/or 9829912, where 5 and 4 individuals respectively with this mutation are reported. It is unclear if one or both of these previously reported groups are the same as the current family.

      SupplementalData: Phenotype and genotype information can be found in Supplementary Table S1.

      Variant: p.W117C (c.351G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 167827, https://www.ncbi.nlm.nih.gov/clinvar/variation/167827/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: W117C (c.351G>T)

      MultipleGeneVariants: N/A

    3. GroupID: 64

      DiseaseAssertion: VHL

      GroupSize: 8

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 8 members of this family are reported as carrying the c.217C>T germline variant of the VHL gene. Members 2339, 2333 and 2338 presented with severe renal disease (RCC). Members 2331, 2329 and 1345 had unknown renal involvement. Member 2340 had mild renal disease. Member 2341 had no renal involvement. Families were recruited from the French VHL Registry. Enrolment in the study required identification of the germline VHL mutation (currently 85% of the families included in the French VHL Registry) and available data regarding renal phenotype. A total of 126 families fulfilled these criteria.

      GroupPresentingHPOs: HP:0009726; HP:0005584 (Renal neoplasm, Renal cell carcinoma)

      GroupHPOFreeText: Mild renal disease (simple renal cyst, multicystic kidney[s], small lesion [less than 10 mm in size] of unknown significance, or small solid tumor without indication for surgical removal [less than 30 mm in size]). Severe renal disease (any solid lesion before 25 years of age, five or more solid lesions within one or two kidneys, or metastasis of renal cell carcinoma).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: Paper states that this family is previously reported in PMID 12202531, where 4 patients with this mutation are reported but relation between patients is unknown.

      SupplementalData: Phenotype and genotype information can be found in Supplementary Table S1.

      Variant: p.Q73* (c.217C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223164, https://www.ncbi.nlm.nih.gov/clinvar/variation/223164/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition; stop_gained

      CivicName: Q73* (c.217C>T)

      MultipleGeneVariants: N/A

    4. GroupID: 69

      DiseaseAssertion: VHL

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 2 members of this family are reported as carrying the c.161dupT germline variant of the VHL gene. Both members (1466 and 24) presented with severe renal disease (RCC). Families were recruited from the French VHL Registry. Enrolment in the study required identification of the germline VHL mutation (currently 85% of the families included in the French VHL Registry) and available data regarding renal phenotype. A total of 126 families fulfilled these criteria.

      GroupPresentingHPOs: HP:0005584 (Renal cell carcinoma)

      GroupHPOFreeText: Severe renal disease (any solid lesion before 25 years of age, five or more solid lesions within one or two kidneys, or metastasis of renal cell carcinoma).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: 9829912

      SupplementalData: Phenotype and genotype information can be found in Supplementary Table S1.

      Variant: p.M54Ifs*78 (c.161dup)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA2497028723, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.161dup

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: duplication; plus_1_frameshift_variant

      CivicName: M54fs (c.161dup)

      MultipleGeneVariants: N/A

    1. VHL-4c.517G > Tp.Glu173X[22]yesA1+Bilateral––+–

      PatientID: VHL-4

      KindredID: 4

      Case: Sex Unknown, Age Unknown, Italian

      DiseaseAssertion: VHL

      FamilyInfo: Family history of VHL. No further details provided.

      CohortInfo: Forty-three index cases were referred to the Service of Medical Genetics, Genova, for germline mutation analysis in the VHL gene between 1995 and 2008.

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0009711 (Hemangioblastoma, Renal cell carcinoma, Retinal capillary hemangioma)

      CaseHPOFreeText: CNS hemangioblastoma and bilateral renal cell carcinoma. Clinical classification: A1.

      CaseNotHPOs: HP:0002666; HP:0001732 (Pheochromocytoma, Abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E173* (c.517G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 825515, https://www.ncbi.nlm.nih.gov/clinvar/variation/825515/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained; missense_variant;transversion

      CivicName: E173* (c.517G>T)

      MultipleGeneVariants: N/A

    2. VHL-8c.464 − 1G > ASplicing mutation[10]noA2Multiple+–––Epididymal

      PatientID: VHL-8

      KindredID: 8

      Case: Sex Unknown, Age Unknown, Italian

      DiseaseAssertion: VHL

      FamilyInfo: None.

      CohortInfo: Forty-three index cases were referred to the Service of Medical Genetics, Genova, for germline mutation analysis in the VHL gene between 1995 and 2008.

      CasePresentingHPOs: HP:0010797; HP:0005584, HP:0030424 (hemangioblastoma, renal cell carcinoma, epididymal cyst)

      CaseHPOFreeText: Multiple hemangioblastoma of the CNS and spinal cord.

      CaseNotHPOs: HP:0001737, HP:0002666, HP:0009711 (pancreatic cysts, pheochromocytoma, retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.464-1G>A

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVar: 43603 https://www.ncbi.nlm.nih.gov/clinvar/variation/43603/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: c.464-1G>A

      MultipleGeneVariants: N/A

    1. PMID: 7977367

      KindredID: 5

      DiseaseAssertion: VHL

      GroupSize: Unknown

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This is a family belonging to prefigure No. 5. They are described as ‘VHL-affected’.

      GroupPresentingHPOs: HP:0005584 (renal cell carcinoma)

      GroupHPOFreeText: RCC-affected; other manifestations are possible but not clear.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: p.R238Q (c.713G>A)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    2. PMID: 7977367

      KindredID: 2

      DiseaseAssertion: VHL

      GroupSize: Unknown

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This is a family belonging to prefigure No. 2. They are described as ‘VHL-affected’.

      GroupPresentingHPOs: HP:0005584 (renal cell carcinoma)

      GroupHPOFreeText: RCC-affected; other manifestations are possible but not clear.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L158P (c.473T>C)

      LegacyVariant: p.L229P (c.686T>C)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182980 https://www.ncbi.nlm.nih.gov/clinvar/variation/182980/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: L158P (c.473T>C)

      MultipleGeneVariants: N/A

    3. PMID: 7977367

      KindredID: 1

      DiseaseAssertion: VHL

      GroupSize: Unknown

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: This is a family belonging to prefigure No. 1. They are described as ‘VHL-affected’.

      GroupPresentingHPOs: HP:0005584 (renal cell carcinoma)

      GroupHPOFreeText: RCC-affected; other manifestations are possible but not clear.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L158P (c.473T>C)

      LegacyVariant: p.L229P (c.686T>C)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182980 https://www.ncbi.nlm.nih.gov/clinvar/variation/182980/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: L158P (c.473T>C)

      MultipleGeneVariants: N/A

    1. 3 (100)

      GroupID: 6

      DiseaseAssertion: VHL

      GroupSize: 3

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: a retrospective cohort study from an eye centre in Germany involved 148 VHL patients and their genetic data involved in retinal capillary hemangiomas.

      GroupPresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      GroupHPOFreeText: These 3 patients had retinal capillary hemangiomas. Other VHL manifestations were discussed but not per- variant.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes - Supplementary Table S1

      Variant: Exon 2 deletion

      LegacyVariant: N/A

      GroupProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: exon 2 deletion

      MultipleGeneVariants: N/A

    2. 3 (100)

      GroupID: 15

      DiseaseAssertion: VHL

      GroupSize: 3

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: a retrospective cohort study from an eye centre in Germany involved 148 VHL patients and their genetic data involved in retinal capillary hemangiomas.

      GroupPresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      GroupHPOFreeText: These 3 patients with a S183* (c.548C>A) mutation had retinal capillary hemangiomas. Other VHL manifestations were discussed but not per- variant.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S183* (c.548C>A)

      LegacyVariant: N/A

      GroupProblemVariantFreeText: N/A

      ClinVarID: 2215 https://www.ncbi.nlm.nih.gov/clinvar/variation/2215/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: S183* (c.548C>A)

      MultipleGeneVariants: N/A

    3. 1 (100)

      GroupID: 40

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      CohortInfo: a retrospective cohort study from an eye centre in Germany involved 148 VHL patients and their genetic data involved in retinal capillary hemangiomas.

      CasePresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: This individual patient was the only one discussed with this mutation. They had retinal hemangiomas; Other VHL manifestations were discussed but not per- variant.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes - Supplementary Table S1

      Variant: p.Q164L (c.491A>T)

      LegacyVariant: N/A

      GroupProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756149 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.491A>T

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: Q164L (c.491A>T)

      MultipleGeneVariants: N/A

    4. 1 (100)

      GroupID: 34

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      CohortInfo: a retrospective cohort study from an eye centre in Germany involved 148 VHL patients and their genetic data involved in retinal capillary hemangiomas.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: This individual patient did NOT have retinal capillary hemangiomas. Other VHL manifestations were discussed but not per- variant.

      CaseNotHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes - Supplementary Table S1

      Variant: p.Q132P (c.395A>C)

      LegacyVariant: N/A

      GroupProblemVariantFreeText: N/A

      ClinVarID: 496063 https://www.ncbi.nlm.nih.gov/clinvar/variation/496063

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: Q132P (c.395A>C)

      MultipleGeneVariants: N/A

    1. Family 3 had 2 individuals. Average age at presentation was 35 years and at last follow-up was 50 years (range, 48–52).

      GroupID: 3

      DiseaseAssertion: VHL

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: 48-52

      GroupInfo: Familial VHL stated; 2 family members recorded with this mutation. One individual had severe disease severity and one had mild severity. the members were 48Y and 52Y.

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0005554; HP:0006748; HP:0030405 (retinal capillary hemangioma; hemangioblastoma, renal cell carcinoma; adrenal pheochromocytoma, pancreatic endocrine tumor)

      GroupHPOFreeText: Both members presented with either cerebral or spinal hemangioblastomas, and renal cell carcinoma with nephrectomies. Only one member presented with an adrenal pheochromocytoma with an adrenalectomy, a pancreatic endocrine tumor, and one retinal capillary hemangioma, although it is unclear which patient matches with each phenotype (see table S1 and S2).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplemental Table 1 and Table 2.

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant, transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A  

    1. In our study, group 5 represented the c.262T > C p.Trp88Arg mutation that included 21 patients from 2 families (Figure 4 and Table 3). Variability was observed in the mean age at onset for CHB and RCC, which were 41.1 ± 9.1 (range = 29–62) and 37.4 ± 12.9 (range = 23–65), respectively.

      PatientID: 5

      KindredID: 1 (group ID 5)

      Case: F, 48Y0M (deceased), Chinese

      DiseaseAssertion: asymptomatic

      CohortInfo: Clinical characteristics of 258 patients from 80 unrelated Chinese families were reported in this study. Grouped by the 21 mutations found, 2 families with 21 members total were described, and phenotypic information was given for this group.

      FamilyInfo: In family 1, 17 members were described. The first generation describes 5 members with the VHL mutation, each passing on the gene to further generations. Patient 5 had a daughter and son with this mutation. See Fig 4 for family pedigree; Table 3 for details.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Phenotypes for this patient were not described

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.W88R (c.262T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496053 https://www.ncbi.nlm.nih.gov/clinvar/variation/496053/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: W88R (c.262T>C)

      MultipleGeneVariants: N/A

    2. In our study, group 5 represented the c.262T > C p.Trp88Arg mutation that included 21 patients from 2 families (Figure 4 and Table 3). Variability was observed in the mean age at onset for CHB and RCC, which were 41.1 ± 9.1 (range = 29–62) and 37.4 ± 12.9 (range = 23–65), respectively.

      PatientID: 1

      KindredID: 2 (group ID 5)

      Case: M, 58Y0M (deceased), Chinese

      DiseaseAssertion: assumed VHL

      CohortInfo: Clinical characteristics of 258 patients from 80 unrelated Chinese families were reported in this study. Grouped by the 21 mutations found, 2 families with 21 members total were described, and phenotypic information was given for this group.

      FamilyInfo: In family 2, 4 members were described in a 3 generation family. The patient’s daughter, son, and granddaughter were also present with the VHL mutation. See Fig 4 for family pedigree; Table 3 for details.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: He had an age of onset for CNS hemangioblastoma at 48Y.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.W88R (c.262T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496053 https://www.ncbi.nlm.nih.gov/clinvar/variation/496053/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: W88R (c.262T>C)

      MultipleGeneVariants: N/A

    3. c.481C > T p.Arg161stop (group 16)

      GroupID: 16

      DiseaseAssertion: assumed VHL

      GroupSize: 15

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: Chinese

      GroupAgeRange: 39.2Y +/- 10.4Y

      GroupInfo: Clinical characteristics of 258 patients from 80 unrelated Chinese families were reported in this study. Grouped by the 21 mutations found, 10 families with 15 members total were described, and phenotypic information was given for this group.

      GroupPresentingHPOs: HP:0010797; HP:0009711; HP:0005584; HP:0001737; HP:0002666; HP:0009715 (hemangioblastoma, retinal capillary hemangioma, renal cell carcinoma, pancreatic cysts, pheochromocytoma, papillary cystadenoma of the epididymis)

      GroupHPOFreeText: 12 of the 15 members presented with CNS hemangioblastoma (with a mean age of onset of 27.4Y), retinal capillary hemangioma in 1 member at the age of 28Y, renal cell carcinoma in 10 members (at the mean age of 36.6Y), pancreatic cysts in 9 members (at the mean age of 32.3Y), pheochromocytoma in an individual at the age of 41Y, and a papillary cystadenoma of the epididymis genital system tumor (epididymis or broad ligament) in 2 members at 30 and 36Y.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: see more information in 28388566 (7 families and 8 members described), and 29330336 (10 families and 15 members)

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2217, https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. PatientID: V-33

      KindredID: 2

      Case: F, Age Unknown, German

      DiseaseAssertion: VHL (Asymptomatic)

      FamilyInfo: Family 2 is comprised of 131 individuals over six generations including 65 members (50% of those at risk) with VHL type 2A (72% clinically affected, 12% obligate carriers, and 15% positive genetic analysis alone) and nearly equal gender distribution for affected status (54% male). An additional six members (II-3, II-4, II -5, III-1, III-2, and III-3) are suspected to have VHL without confirmation. Of note, the nuclear family (branch IV-13) contains 13 siblings, of whom 12 have been diagnosed with pheo. The presenting tumor types in Family 2 were pheo (70%), HB (17%), and RA (13%). No Family 2 member had RCC as the initial manifestation. Distribution of HB and RA are not described except for patient IV-8.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584; HP:0002666 (Renal cell carcinoma, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 7759077

      SupplementalData: N/A

      Variant: p.Y98H (c.292T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2223, https://www.ncbi.nlm.nih.gov/clinvar/variation/2223/

      CAID: N/A

      gnomAD: 0.00001343, https://gnomad.broadinstitute.org/variant/3-10183823-T-C

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y98H (c.292T>C)

      MultipleGeneVariants: N/A

    2. PatientID: IV-1

      KindredID: 2

      Case: F, Age Unknown, German

      DiseaseAssertion: VHL

      FamilyInfo: Family 2 is comprised of 131 individuals over six generations including 65 members (50% of those at risk) with VHL type 2A (72% clinically affected, 12% obligate carriers, and 15% positive genetic analysis alone) and nearly equal gender distribution for affected status (54% male). An additional six members (II-3, II-4, II -5, III-1, III-2, and III-3) are suspected to have VHL without confirmation. Of note, the nuclear family (branch IV-13) contains 13 siblings, of whom 12 have been diagnosed with pheo. The presenting tumor types in Family 2 were pheo (70%), HB (17%), and RA (13%). No Family 2 member had RCC as the initial manifestation. Distribution of HB and RA are not described except for patient IV-8.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584 (Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 7759077

      SupplementalData: N/A

      Variant: p.Y98H (c.292T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2223, https://www.ncbi.nlm.nih.gov/clinvar/variation/2223/

      CAID: N/A

      gnomAD: 0.00001343, https://gnomad.broadinstitute.org/variant/3-10183823-T-C

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y98H (c.292T>C)

      MultipleGeneVariants: N/A

    3. PatientID: V-19

      KindredID: 2

      Case: F, Age Unknown, German

      DiseaseAssertion: VHL

      FamilyInfo: Family 2 is comprised of 131 individuals over six generations including 65 members (50% of those at risk) with VHL type 2A (72% clinically affected, 12% obligate carriers, and 15% positive genetic analysis alone) and nearly equal gender distribution for affected status (54% male). An additional six members (II-3, II-4, II -5, III-1, III-2, and III-3) are suspected to have VHL without confirmation. Of note, the nuclear family (branch IV-13) contains 13 siblings, of whom 12 have been diagnosed with pheo. The presenting tumor types in Family 2 were pheo (70%), HB (17%), and RA (13%). No Family 2 member had RCC as the initial manifestation. Distribution of HB and RA are not described except for patient IV-8.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584 (Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 7759077

      SupplementalData: N/A

      Variant: p.Y98H (c.292T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2223, https://www.ncbi.nlm.nih.gov/clinvar/variation/2223/

      CAID: N/A

      gnomAD: 0.00001343, https://gnomad.broadinstitute.org/variant/3-10183823-T-C

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Y98H (c.292T>C)

      MultipleGeneVariants: N/A

    1. 3 MAU27/MPheochromocytoma (Bilateral surrenal—metastatic lymph nodes)UnknownVHL{"type":"entrez-nucleotide","attrs":{"text":"NM_000551.4","term_id":"1779521775"}}NM_000551.4:c.277G>Ap.(Gly93Ser)rs5030808

      PatientID: 3 MAU

      KindredID: 3

      Case: M, 27Y0M, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: N/A - unknown

      CasePresentingHPOs: HP:0002666; HP:0002733 (Pheochromocytoma, abnormality of the lymph nodes)

      CaseHPOFreeText: Patient had bilateral surreal pheochromocytoma, with metastatic lymph nodes (metastatic bilateral surrenal adenomas).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET, SDHB, SDHD, TMEM127

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G93S (c.277G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2237 https://www.ncbi.nlm.nih.gov/clinvar/variation/2237/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Described as a VHL pathogenic/likely pathogenic variant.

      MutationType: missense_variant; transition

      CivicName: G93S (c.277G>A)

      MultipleGeneVariants: N/A

    1. von Hippel-Lindau disease in two unrelated cases with mutations of the VHL gene

      PatientID: 9

      KindredID: VI

      Case: Sex Unknown, 34Y0M, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0006748; HP:0005584; HP:0002894 (adrenal pheochromocytoma, renal cell carcinoma, neoplasm of the pancreas)

      CaseHPOFreeText: adrenal mass indicated as a diagnosis of pheochromocytoma, was also found with renal cell carcinoma and pancreas carcinoma manifestations

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S80I (c.239G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625229 https://www.ncbi.nlm.nih.gov/clinvar/variation/625229/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: S80I (c.239G>T)

      MultipleGeneVariants: N/A

    1. Large deletionsb

      GroupID: 30A

      DiseaseAssertion: VHL

      GroupSize: 6

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 6 VHL patients with a large deletion of 1, 2, or 3 exons of the VHL gene and ICTs were grouped in this study.

      GroupPresentingHPOs: HP:0030405 (pancreatic endocrine tumor)

      GroupHPOFreeText: Patients have islet cell tumors (ICTs), or listed as pancreatic endocrine tumor. Other clinical manifestations outside of a pancreatic neuroendocrine tumor are possible, but were not discussed.

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: large deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: deletion

      CivicName: Null (Large deletion)

      MultipleGeneVariants: N/A

    2. c.461 C>Tap.P154L

      GroupID: 17A

      Case: Sex, Age, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: None. The patient with the given mutation in this study was a VHL patient with pancreatic ICTs.

      CasePresentingHPOs: HP:0030405 (pancreatic endocrine tumor)

      CaseHPOFreeText: Patient has islet cell tumors (ICTs), or listed as pancreatic endocrine tumor.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P154L (c.461C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 649525 https://www.ncbi.nlm.nih.gov/clinvar/variation/649525/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: P154L (c.461C>T)

      MultipleGeneVariants: N/A

    3. c.221 T/Gap.V74G

      GroupID: 2A

      Case: Sex, Age, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: None. The patient with the given mutation in this study was a VHL patient with pancreatic ICTs.

      CasePresentingHPOs: HP:0030405 (pancreatic endocrine tumor)

      CaseHPOFreeText: Patient has islet cell tumors (ICTs), or listed as pancreatic endocrine tumor.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V74G (c.221T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA70042528 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.221T%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: V74G (c.221T>G)

      MultipleGeneVariants: N/A

    4. c.478_479delGAp.E160AfsX12

      GroupID: 21B

      DiseaseAssertion: Unknown. Patients were pulled from either the VHL-Registry or NET-Registry and recorded with the given mutation. Symptoms or manifestations are not clear.

      GroupSize: 3

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 3 patients with the given mutation were grouped as group 21(B) in this study. These patients were asymptomatic or unclear of symptoms.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: N/A

      GroupNotHPOs: HP:0030405 (pancreatic endocrine tumor)

      GroupNotHPOFreeText: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E160Afs*13 (c.478_479del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: c.478_479del automaps to NM_000551.3:c.479_480delAG

      ClinVarID: N/A

      CAID: CA16621940 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.478_479del

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_2_frameshift_variant

      CivicName: E160FS (c.479_480delAG)

      MultipleGeneVariants: N/A

    1. p.E134X*

      PatientID: None

      KindredID: 23

      Case: Sex and Ethnicity unknown; Age >18Y0M

      DiseaseAssertion: asymptomatic

      FamilyInfo: Total of 3 family members belonging to Family 23 (see Table 2; or follow KindredID 23)

      CasePresentingHPOs: None

      CaseHPOFreeText: At initial screening (and same by final 5 year follow up) patient was found to be asymptomatic

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E134* (c.400G>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 1069709 https://www.ncbi.nlm.nih.gov/clinvar/variation/1069709/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: E134* (c.400G>T)

      MultipleGeneVariants: N/A

    2. p.E134X*

      PatientID: None

      KindredID: 23

      Case: Sex and Ethnicity unknown; Age >18Y0M

      DiseaseAssertion: asymptomatic

      FamilyInfo: Total of 3 family members belonging to Family 23 (see Table 2; or follow KindredID 23)

      CasePresentingHPOs: None

      CaseHPOFreeText: At initial screening (and same by final 5 year follow up) patient was found to be asymptomatic

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E134* (c.400G>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 1069709 https://www.ncbi.nlm.nih.gov/clinvar/variation/1069709/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: E134* (c.400G>T)

      MultipleGeneVariants: N/A

    3. c.99_100InsA*

      PatientID: None (IV)

      KindredID: 6

      Case: Sex and Ethnicity unknown; Age >18Y0M

      DiseaseAssertion: assumed VHL

      FamilyInfo: Total of 6 family members belonging to Family 6 (see Table 2; or follow KindredID 6)

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: originally found to be aymspotmatic; by first screeing had found 1 HB and by 5 year follow up had developed +1 HB

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 16572651

      SupplementalData: N/A

      Variant: p.G34Rfs*98 (c.99_100insA)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: CA2018007671 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA2018007671

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: plus_1_frameshift_variant

      CivicName: G34Rfs (c.99_100insA)

      MultipleGeneVariants: N/A

    1. Results: A three base pair (bp) deletion in exon 1 of the VHL gene was found in the father and both sons. This in-frame deletion results in the loss of a phenylalanine residue from the von Hippel-Lindau protein product, at amino acid position 76.

      PatientID: III:2 (brother)

      KindredID: 1

      Case: M, 14Y0M, Ethnicity Unknown

      DiseaseAssertion: cerebellar hemangioblastoma

      FamilyInfo: The proband’s father and brother were found to have the same mutation as his. With spinal cord tumors in the father, and retinal capillary hemangioma in the 10Y brother. His mother and paternal grandparents did not harbor this change. (see Fig 2). The ocular and medical histories of these other members of this family were also noncontributory. One note is that the paternal grandfather had occupational history remarkable for significant radiation exposure at the Bikini atoll nuclear testing facility.

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: MRI found small tumors in the cerebellum

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.F76del (c.227_229delTCT)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA357012, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.224_226del

      gnomAD: N/A

      VariantEvidence: An Mbo II restriction digest of polymerase chain reaction products from exon 1 of the von Hippel–Lindau gene. The 3-bp deletion abolishes an Mbo II restriction site in the mutated allele and results in an abnormal 262-bp product observed. This abnormal band is not observed in similarly treated samples from unaffected family members.

      MutationType: inframe_deletion

      CivicName: F76del (c.227_229delTCT)

      MultipleGeneVariants: N/A

    2. Results: A three base pair (bp) deletion in exon 1 of the VHL gene was found in the father and both sons. This in-frame deletion results in the loss of a phenylalanine residue from the von Hippel-Lindau protein product, at amino acid position 76.

      PatientID: II:1 (father)

      KindredID: 1

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: spinal cord tumors

      FamilyInfo: Both of his sons were found to have the same mutation as his. With retinal capillary hemangioma and cerebellar tumors associated. His wife and parents all tested negative for harboring this change. (see Fig 2). The ocular and medical histories of these other members of this family were also noncontributory. One note is that the paternal grandfather (his father) had occupational history remarkable for significant radiation exposure at the Bikini atoll nuclear testing facility.

      CasePresentingHPOs: HP:0002143; HP:0010302 (abnormality of the spinal cord, spinal cord tumor)

      CaseHPOFreeText: disclosed a history of spinal surgery for disease of unclear evolution and etiology, on account of incomplete medical records. This study’s records showed small tumors in the spinal cord.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.F76del (c.227_229delTCT)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA357012, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.224_226del

      gnomAD: N/A

      VariantEvidence: An Mbo II restriction digest of polymerase chain reaction products from exon 1 of the von Hippel–Lindau gene. The 3-bp deletion abolishes an Mbo II restriction site in the mutated allele and results in an abnormal 262-bp product observed. This abnormal band is not observed in similarly treated samples from unaffected family members.

      MutationType: inframe_deletion

      CivicName: F76del (c.227_229delTCT)

      MultipleGeneVariants: N/A

    1. Table 1

      PatientID: N/A

      KindredID: 22

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Family history not mentioned. Patient’s variant reported as germline.

      CasePresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: Patient had VHL disease: R-HB (see table 1).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 17024664

      SupplementalData: N/A

      Variant: p.I151T (c.452T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 428803, www.ncbi.nlm.nih.gov/clinvar/variation/428803/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: I151T (c.452T>C)

      MultipleGeneVariants: N/A

    1. During an ophthalmology consult in 2015 (age 7), Twin 1 was noted to have a retinal HGB in both eyes: the left eye HGB was surrounded by sub-retinal fluid (Fig. ​(Fig.1d),1d), and a small intra-retinal HGB of the right eye was located in close proximity to the optic nerve and therefore not operated on (Fig. ​(Fig.1e).1e). Her left eye was treated with laser photocoagulation to dry the fluid and stabilize the fundus. Two months later, evaluation of the left eye revealed a residual retinal HGB (2.5 mm), which was treated with laser again. The blood flow to the tumor persisted and was treated two more times with laser on an outpatient basis to completely resolve the left eye HGB. Right eye HGB has remained unchanged. Twin 1 receives ophthalmologic exams three times a year to monitor the eye tumors along with brain, spine and abdominal MRI screenings. No other tumors have been found.

      PatientID: V-2 (Twin 1)

      KindredID: 1

      Case: F, 11Y0M, Caucasian

      DiseaseAssertion: retinal capillary hemangioma

      FamilyInfo: Positive family history of pheochromocytoma and the VHL mutation c.414A >G (p.Pro138Pro). Her father and mother underwent genetic testing where the father was positive for the VHL mutation. He and the aunt both had variousVHL related tumors throughout their body. Her twin sister also had retinal hemnagioblastomas at age 7Y. See Fig 1 for pedigree.

      CasePresentingHPOs:HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: At 7Y of age, retinal HGB in both eyes: her left eye was treated on twice, while the right eye was located in close proximity to the optic nerve so not operated on. Two additional laser treatments were needed.

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: p.P138P (c.414A>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223206 https://www.ncbi.nlm.nih.gov/clinvar/variation/223206/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Despite being synonymous, the mutation is not functionally silent because it causes aberrant splicing by skipping exon 2. The reduced VHL protein in LOH genetic backdrop may underlie the etiology of VHL disease.

      MutationType: synonymous_variant; missense_variant;transition

      CivicName: P138= (c.414A>G)

      MultipleGeneVariants: N/A

    1. FNiece3c.499C > Tp.Arg167Trp11426, B32–26, M32, B4

      PatientID: Niece

      KindredID: 9

      Case: F, 32Y0M, Korean

      DiseaseAssertion: VHL

      FamilyInfo: Uncle presented with CNS hemangioblastoma at 47Y, RCC at 47Y, multiple pancreatic lesions (pancreatic cyst or tumor, unspecified) at 47Y, renal cyst at 48Y and pheochromocytoma at 47Y. Father had a history of CNS hemangioblastoma but was not genetically confirmed.

      CohortInfo: Thirteen unrelated patients with germline VHL mutations who were diagnosed with VHL disease were evaluated.

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0001732; HP:0000107; HP:0009711 (Hemangioblastoma, Renal cell carcinoma, Abnormality of the pancreas, Renal cyst, Retinal capillary hemangioma)

      CaseHPOFreeText: CNS hemangioblastoma at 14Y, bilateral retinal hemangioblastoma at 26Y, RCC at 32Y, multiple pancreatic lesions (pancreatic cyst or tumor, unspecified) at 26Y and bilateral renal cysts at 32Y. Diagnosed with VHL Type 1.

      CaseNotHPOs: HP:0002666 (Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1.  Son2c.349T > G, p.Trp117Gly12–––––

      PatientID: None

      KindredID: 6

      Case: M, 12Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Positive. Patient's parent was the proband and had the mutation c.349T>G presenting with renal cell carcinoma, retinal angioma, hemangioblastoma, abnormality of the pancreas, and epididymal or ovarian cystadenoma. The patient's grandmother, great aunt, great grandmother, uncles 1 and 2, and aunt 3 all passed before they could undergo genetic testing but had a variety of VHL presentations. The patient's first aunt and the father's third nephew were confirmed to have this genetic mutation. The aunt presented with abnormality of the pancreas at age 53. The nephew had hemangioblastoma and retinal angioma at age 13. Additional familial phenotypes can be found in Table 1.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: The patient presented with hemangioblastoma at age 12.

      CaseNotHPOs: HP:0002666, , HP:0005584, HP:0001732, HP:0009711 (pheochromocytoma, renal cell carcinoma, abnormality of the pancreas, retinal capillary hemangioma)

      CaseNotHPOFreeText: The patient did not have a cystadenoma of the epididymis.

      CasePreviousTesting: N/A

      PreviouslyPublished: 29330336

      Variant: p.W117G (c.349T>G)

      LegacyVariant:N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 862346 https://www.ncbi.nlm.nih.gov/clinvar/variation/862346/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName:W117G (c.349T>G)

      MultipleGeneVariants: N/A

    2. Family 19−Intron 1IVSI + 3insCGdelACGGGCCCYes2B35–––38–

      PatientID: None

      KindredID: 19

      Case: Sex Unknown, 38Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0010797, HP:0002666 (hemangioblastoma, pheochromocytoma)

      CaseHPOFreeText: The patient presented with hemangioblastoma at age 35 and pheochromocytoma at age 38.

      CaseNotHPOs: HP:0009711, HP:0005584, HP:0001732 (retinal capillary hemangioma, renal cell carcinoma, abnormality of the pancreas)

      CaseNotHPOFreeText: The patient did not have an epididymal or ovarian cystadenoma.

      CasePreviousTesting: N/A

      PreviouslyPublished: 29330336

      Variant: 340+3insCGdelACGGGCCC

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: intron_variant

      CivicName:N/A

      MultipleGeneVariants: N/A

    1. GroupID: 2338

      DiseaseAssertion: VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: Each group represents a family.

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0002666; HP:0005584; HP:0030405 (Retinal capillary hemangioma, Hemangioblastoma, Pheochromocytoma, Renal cell carcinoma, Pancreatic endocrine tumor)

      GroupHPOFreeText: 3/4 members with pheochromocytoma, 3/4 members with CNS hemangioblastoma, 4/4 members with retinal angioma, 2/4 members with cysts and ¼ members with renal cell carcinoma. Diagnosed as a VHL Type 2B family. Localized pancreatic neuroendocrine tumor is also associated with this family but the number of family members affected is not specified.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: 7728151

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: c.712C>T

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: Variant reported as 712, C to T (Arg to Trp), assumed to be reported in legacy nomenclature (AF010238.1) and mapped to c.499C>T, p.Arg167Trp (NM_000551.3).

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    2. PatientID: None

      KindredID: 4589

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Two members of this family were diagnosed with VHL Type 2B. Both members presented with pheochromocytoma and one of these also presented with retinal angioma.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Diagnosed with VHL Type 2B.

      CaseNotHPOs: HP:0010797; HP:0005584; HP:0009711 (Hemangioblastoma, Renal cell carcinoma, Retinal capillary hemangioma)

      CaseNotHPOFreeText: No CNS hemangioblastoma, retinal angioma or RCC presentations.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.C162F (c.485G>T)

      LegacyVariant: c.698G>T

      CaseProblemVariantFreeText: N/A

      ClinVarID: 43604, https://www.ncbi.nlm.nih.gov/clinvar/variation/43604/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191492-G-T?dataset=gnomad_r2_1

      VariantEvidence: Variant reported as 689, G to T (Cys to Phe), assumed to be reported in legacy nomenclature (AF010238.1) and mapped to c.485G>T, p.Cys162Phe (NM_000551.3).

      MutationType: missense_variant;transversion

      CivicName: C162F (c.485G>T)

      MultipleGeneVariants: N/A

    1. PatientID: 22

      KindredID: 19

      Case: M, 27Y0M, Ethnicity Unknown

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Positive. This patient is the proband's (1) first cousin once removed. The proband's mother (2) and uncle (7) carried the mutation and presented with symptoms. The proband's cousin (9) was also found to have the mutation but was asymptomatic.

      CohortInfo: 20 unrelated VHL families from an ethnically diverse cohort containing both affected and unaffected individuals.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0009711, HP:0005584, HP:0002666, HP:0001732, HP:0000077, HP:0010797 (retinal capillary hemangioma, renal cell carcinoma, pheochromocytoma, abnormality of the pancreas, abnormality of the kidney, hemangioblastoma)

      CaseNotHPOFreeText: The patient did not have epididymal or ovarian cysts.

      CasePreviousTesting: N/A

      PreviouslyPublished: 31368132

      SupplementalData: Supplementary file 1.

      Variant: p.W88* (c.263G>A)

      LegacyVariant: p.W88* (c.476G>A)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182978 https://www.ncbi.nlm.nih.gov/clinvar/variation/182978/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: W88* (c.263G>A)

      MultipleGeneVariants: N/A

    2. PatientID: 85 (First cousin once removed)

      KindredID: 18

      Case: F, 67Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: 11 members of this family tested positive for the c.712C>T/c.499C>T germline variant of the VHL gene. 14 members of this family were assumed to carry this variant due to family history/personal medical history. Members of this family range from asymptomatic to multi-organ involvement (pheochromocytoma, pancreatic and renal cysts/tumors and hemangioblastomas). The family was previously reported in PMID 3942913.

      CasePresentingHPOs: HP:0009711; HP:0002666; HP:0005584 (Retinal capillary hemangioma, Pheochromocytoma, Renal cell carcinoma)

      CaseHPOFreeText: This patient presented with retinal angioma (29Y) and pheochromocytoma (17Y). Age of diagnosis of renal cell carcinoma is unknown.

      CaseNotHPOs: HP:0000077; HP:0001732; HP:0010797 (Abnormality of the kidney, Abnormality of the pancreas, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 3942913 (some members of this family are previously reported (phenotypes only) but unable to match patients across papers with confidence)

      SupplementalData: Supplementary Table 1.

      Variant: p.R167W (c.499C>T)

      LegacyVariant: c.712C>T

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: A point mutation (c.712C>T) was found. Being that this variant is out of bound with respect to the NM_000551.3 reference sequence, it was concluded that this variant is noted in the Latif et al. (1993) reference and was translated to c.499C>T (NM_000551.3).

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. GroupID/ KindredID: VHL 60

      DiseaseAssertion: assumed VHL

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: German

      GroupAgeRange: N/A

      GroupInfo: 2 patients with the given mutation belonging to VHL family 60

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0005584; HP:0000107; HP:0001737; HP:0009715; HP:0031207 (retinal capillary hemangioma, hemangioblastoma, renal cell carcinoma, renal cyst, pancreatic cysts, papillary cystadenoma of the epididymis, hepatic hemangioma)

      GroupHPOFreeText: both patients were found with hemangioblastomas, renal cysts, pancreatic cysts, and papillary cystadenoma of the epididymis. Retinal capillary hemangioma, renal cell carcinoma and a liver angioma were only found in 1/2 patients.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.H115R (c.344A>G)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.H115R (c.557A>G)

      ClinVarID: 664415 https://www.ncbi.nlm.nih.gov/clinvar/variation/664415/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: H115R (c.344A>G)

      MultipleGeneVariants: N/A

    2. GroupID/ KindredID: VHL 53

      DiseaseAssertion: assumed VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: German

      GroupAgeRange: N/A

      GroupInfo: 4 patients with the given mutation belonging to VHL family 53

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0000107; HP:0030065 (retinal capillary hemangioma, hemangioblastoma, renal cyst, primitive neuroectodermal tumor)

      GroupHPOFreeText: retinal capillary hemangioma was found in 2 members, hemangioblastomas in 4, renal cyst in 1, and a primitive neuroectodermal tumor also found in 1 member

      GroupNotHPOs: GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V74G (c.221T>G)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.V74G (c.434T>G)

      ClinVarID: N/A

      CAID: CA70042528 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.221T%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V74G (c.221T>G)

      MultipleGeneVariants: N/A

    1. II 9 20 1 pheo (15 years) M c.278G > A (p.Gly93Asp)

      PatientID: II

      KindredID: 3

      Case: Sex Unknown, 20Y0M, Danish

      DiseaseAssertion: VHL

      FamilyInfo: 3 other family members presented with his VHL mutation. Patient 3-I was asymptomatic. Patient 3-III presented with pheochromocytoma at 15Y. Patient 3-IV presented with 2 pehochromocytoma (12Y) and retinal hemangioblastoma (10Y).

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Diagnosed with VHL at age 9Y. Presented with pheochromocytoma at 15Y. Age at the end of study: 20Y.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G93D (c.278G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496054, https://www.ncbi.nlm.nih.gov/clinvar/variation/496054/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: G93D (c.278G>A)

      MultipleGeneVariants: N/A

    2. 14 I 10 46 2 EC (10 years) M nt481 C > T Arg161X

      PatientID: I

      KindredID: 14

      Case: Sex Unknown, 46Y0M, Danish

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0009715 (Papillary cystadenoma of the epididymis)

      CaseHPOFreeText: The patient had two epididymal cyst-adenomas at age 10.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 19863552, 25834951, 27966541, 27539272

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    3. III 9 13 3 retinal hb (8 + 16 years) M c.500G > A (p.Arg167Gln)

      PatientID: III

      KindredID: 1

      Case: Sex Unknown, 16Y0M, Danish

      DiseaseAssertion: VHL

      FamilyInfo: In the same family two other patients had this mutation and had VHL related phenotypes. Patient I was asymptomatic and patient II had retinal hemangioblastoma, pheochromocytoma, and kidney disease.

      CasePresentingHPOs: HP:0009711 (Retinal capillary hemangioma)

      CaseHPOFreeText: The patient presented with three retinal hemangiomas at age 8 and again at age 16.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 19863552, 25834951, 27966541, 27539272

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: 39

      Case: F, 19Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: A total of 190 patients recruited by the COMETE network over 15 years were included in the study.

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: The patient had one benign pheochromocytoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET, SDHB, SDHC, SDHD

      PreviouslyPublished: N/A

      SupplementalData: Patient information was extracted from Table 1 of Supplementary.

      Variant: p.Y98H (c.292T>C)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2223 https://www.ncbi.nlm.nih.gov/clinvar/variation/2223/

      CAID: N/A

      gnomAD: 0.00001343 https://gnomad.broadinstitute.org/variant/3-10183823-T-C

      VariantEvidence: The patient had LOH found in the BAC array CGH data.

      MutationType: missense_variant; transition

      CivicName: Y98H (c.292T>C)

      MultipleGeneVariants: N/A

    2. PatientID: None

      KindredID: VHL14

      Case: M, 27Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: A total of 190 patients recruited by the COMETE network over 15 years were included in the study.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: The patient had one benign pheochromocytoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET/SDHB/SDHC/SDHD

      PreviouslyPublished: N/A

      SupplementalData: Table 1 of Supplementary

      Variant: p.V166F (c.496G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2224, https://www.ncbi.nlm.nih.gov/clinvar/variation/2224/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: The patient had LOH found in the BAC array CGH data.

      MutationType: missense_variant;transversion

      CivicName: V166F (c.496G>T)

      MultipleGeneVariants: N/A

    1. Von Hippel-Lindau (VHL) is a tumor suppressor that negatively regulates the production of angiogenic factors. Mutations in the VHL gene cause VHL syndrome, which is characterized by highly vascularized tumors. Here we report a c.464T>A mutation of the VHL gene in three patients with hemangioblastoma from a Chinese family. This mutation was not reported previously and was absent in the unaffected family members. The mutation is predicted to cause Val to Glu substitution at VHL protein residue 155 in a conserved region. Previous biochemical studies demonstrated that residue Val-155 was critical for VHL protein binding to chaperonin TRiC/CCT, an essential step for proper VHL protein folding. Our finding of naturally occurring VHL V155E mutation in patients with VHL syndrome supports the functional importance of Val-155 residue in VHL protein and illustrates the diversity of VHL gene defects underlying VHL syndrome.

      PatientID: I-1

      KindredID: 1

      Case: F, 79Y0M, Chinese

      DiseaseAssertion: hemangioblastoma

      FamilyInfo: 10 members of this Chinese family were tested, and 3 were found with the same genetic mutation (c.464T>A). The patient’s son (II-1, 53Y) had hemangioblastomas, and grand-daughter (III-1, 26Y) had cerebellar hemangioblastoma, pheochromocytoma and, and tested positive for the mutation. This mutation was not found in the other unaffected members in the family.

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: At 74Y, suffered frequent headache, dizziness, vomiting and numbness in lower extremities. She was admitted to the hospital. CT and MRI exams identified two occupying cystic nodes in her cerebellar vermis and brain stem space, which later were removed surgically. Histological exam indicated the tumors to be hemangioblastoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V155E (c.464T>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756032 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.464T%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V155E (c.464T>A)

      MultipleGeneVariants: N/A

    2. Von Hippel-Lindau (VHL) is a tumor suppressor that negatively regulates the production of angiogenic factors. Mutations in the VHL gene cause VHL syndrome, which is characterized by highly vascularized tumors. Here we report a c.464T>A mutation of the VHL gene in three patients with hemangioblastoma from a Chinese family. This mutation was not reported previously and was absent in the unaffected family members. The mutation is predicted to cause Val to Glu substitution at VHL protein residue 155 in a conserved region. Previous biochemical studies demonstrated that residue Val-155 was critical for VHL protein binding to chaperonin TRiC/CCT, an essential step for proper VHL protein folding. Our finding of naturally occurring VHL V155E mutation in patients with VHL syndrome supports the functional importance of Val-155 residue in VHL protein and illustrates the diversity of VHL gene defects underlying VHL syndrome.

      PatientID: II-1

      KindredID: 1

      Case: M, 53Y0M, Chinese

      DiseaseAssertion: hemangioblastoma

      FamilyInfo: 10 members of this Chinese family were tested, and 3 were found with the same genetic mutation (c.464T>A). The patient’s mother (I-1, 79Y) had hemangioblastomas, and his daughter (III-1, 26Y) had cerebellar hemangioblastoma, pheochromocytoma and, and tested positive for the mutation. This mutation was not found in the other unaffected members in the family.

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: Head CT scan at 39Y revealed cystic lesions with bleeding at left cerebellopontine angle. The tumors were removed surgically and identified as hemangioblastoma in histological examinations. He was operated on two more times. Babinski’s sign test showed mild reduction to movements - disability.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V155E (c.464T>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756032 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.464T%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V155E (c.464T>A)

      MultipleGeneVariants: N/A

    1. 29 c.473dupT p.Leu158fs p.L158fs Familial VHL

      GroupID/ KindredID: 29

      DiseaseAssertion: VHL

      GroupSize: 8

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 8 registrants belonging to the same family (29) have the germline VHL mutation.

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0005584; HP:0000107; HP:0001737 (retinal capillary hemangioma, hemangioblastoma, renal cell carcinoma, renal cyst, pancreatic cysts)

      GroupHPOFreeText: 6/8 members had retinal capillary hemangioma, 2 had hemangioblastoma,7 had renal cell carcinoma with 6 with renal cyst, 4 had pancreatic cysts, and 1 had pancreatic carcinoma

      GroupNotHPOs: HP:0002666 (pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: Previously reported, HGMD (Human Gene Mutation Database: http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/120488.html)

      SupplementalData: N/A

      Variant: p.K159Efs*15(c.473dupT)

      CaseProblemVariantFreeText: written as: p.Leu158fs; c.473dupT, correctly maps to NM_000551.3: K159Efs*15 (c.473dupT)

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: CA432423097 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.473dupT

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: duplication

      CivicName: K159fs (c.473dup)

      MultipleGeneVariants: N/A

    2. 5 c.208G>A p.Glu70Lys p.E70K Bilateral rHAB

      PatientID: None

      KindredID: 5

      Case: Age, Sex, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Reported as sporadic VHL - patient was adopted and parents were not available for DNA analysis.

      CasePresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: Said to be non-classic VHL disease (i.e. with limited VHL manifestations or single-organ involvement but complying with current diagnostic VHL criteria). Patient had bilateral rHAB.

      CaseNotHPOs: HP:0002666; HP:0010797; HP:0001737; HP:0005584; HP:0000107 (pheochromocytoma, hemangioblastoma, pancreatic cysts, renal cell carcinoma, renal cyst)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 9829912

      SupplementalData: N/A

      Variant: p.E70K (c.208G>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 43598 https://www.ncbi.nlm.nih.gov/clinvar/variation/43598/

      CAID: N/A

      gnomAD: 0.000004365, https://gnomad.broadinstitute.org/variant/3-10183739-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: E70K (c.208G>A)

      MultipleGeneVariants: N/A

    3. 1 c.191G>C p.Arg64Pro p.R64P Familial VHL

      PatientID: III-1

      KindredID: 1

      Case: 40Y0M, Sex and Ethnicity Unknown

      DiseaseAssertion: asymptomatic

      FamilyInfo: Family suggesting incomplete penetrance of a VHL gene germline mutation. Mutation (p.R64P) was found in a family with 6 patients total with three generations. The earliest patient described (I-1) presented with renal cell carcinoma (age at diagnosis 48 years), 1 of their 6 children (II-1) at age 59 had no typical VHL manifestations after annual clinical monitoring and suggest non-penetrance in the patient; the second of 6 children (II-3), then aged 51, had bilateral pheochromocytoma diagnosed age 14. Their only child (III-5) had a paraganglioma with an age of diagnosis of 29 years, and a renal cyst. Patient II-1 had 4 children - one (III-1; aged 40) who presented as a carrier with no typical VHL manifestations after annual clinical monitoring; and another 32 years old presenting with pheochromocytoma. (See Figure 2 for pedigree)

      CasePresentingHPOs: N/A

      CaseHPOFreeText: no typical VHL manifestations after annual clinical monitoring and suggests non-penetrance

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: Previously reported, HGMD (Human Gene Mutation Database: http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/120488.html)

      SupplementalData: N/A

      Variant: p.R64P (c.191G>C)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2226 https://www.ncbi.nlm.nih.gov/clinvar/variation/2226/

      CAID: CA020089 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.191G%3EC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R64P (c.191G>C)

      MultipleGeneVariants: N/A

    4. 34 c.1-?_340+? Genomic deletion of exon 1 Familial VHL

      GroupID/ KindredID: 34

      DiseaseAssertion: VHL

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 2 registrants belonging to the same family (34) have the germline VHL deletion.

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0005584; HP:0002666; HP:0030424 (retinal capillary hemangioma, hemangioblastoma, renal cell carcinoma, pheochromocytoma, epididymal cyst)

      GroupHPOFreeText: both members had hemangioblastomas, but only 1 of the two had retinal capillary hemangioma, renal cell carcinoma, pheochromocytoma, and an epididymal cyst

      GroupNotHPOs: HP:0000107; HP:0001737 (renal cyst, pancreatic cysts)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 1 deletion (c.1-?_340+?)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1 deletion

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: 306

      Case: Age, Sex, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: Familial VHL mutation

      CasePresentingHPOs: HP:0009711; HP:0001737 (retinal capillary hemangioma, pancreatic cysts)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: p.R161* (c.481C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    2. PatientID: N/A

      KindredID: 24907

      Case: Age unknown, Sex unknown, Ethnicity unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: Paper states: germline mutation, inconclusive origin

      CasePresentingHPOs: unknown

      CaseHPOFreeText: Patient had VHL, but no specific phenotypes were described

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes (Specifically Supp. Table S2)

      Variant: p.C162W (c.486C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223227 https://www.ncbi.nlm.nih.gov/clinvar/variation/223227/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: C162W (c.486C>G)

      MultipleGeneVariants: N/A

    3. PatientID: N/A

      KindredID: 182

      Case: Age unknown, Sex unknown, Ethnicity unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: Paper states familial VHL; no obvious relation (family surnames, location) but could be distantly related

      CasePresentingHPOs: HP:0002666; HP:0005584; HP:0009711 (pheochromocytoma; renal cell carcinoma; retinal capillary hemangioma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes (Specifically Supp. Table S2)

      Variant: p.P86S (c.256C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 178692, https://www.ncbi.nlm.nih.gov/clinvar/variation/178692/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType:missense_variant;transition

      CivicName: P86S (c.256C>T)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: 1

      Case: M, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: His daughter and grandchildren had the same mutation. His daughter presented with pancreatic cysts, pheochromocytoma, endolymphatic sac tumor, and spinal hemangioblastoma.

      CohortInfo:Three patients with endolymphatic sac tumors were studied.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.464-1G>A

      LegacyVariant: N/A

      CaseProblemVariantFreeText: The paper describes the mutation as "C-to-A transversion at position −1 on the exon 3 splice acceptor sequence in the VHL gene"

      ClinVar: 43603 https://www.ncbi.nlm.nih.gov/clinvar/variation/43603/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: Splice Site (c.464-1G>A)

      MultipleGeneVariants: N/A

    1. c.236G>C, p.R79P

      PatientID: II-3

      KindredID: Family B

      Case: F, 18Y0M, Ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: Family positive pedigree showing patient’s father with RCC and CNS hemangioblastoma; as well as 2 siblings: brother and sister with CNS/spinal and retinal hemangioblastomas

      CasePresentingHPOs: HP:0010797; HP:0009711; HP:0000107; HP:0001737 (hemangioblastoma; retinal capillary hemangioblastoma; renal cyst, pancreatic cysts)

      CaseHPOFreeText: has three small, asymptomatic CNS hemangioblastomas, as well as pancreatic and renal cell cysts. Retinal angioma at the age of 10.

      CaseNotHPOs: HP:0005584; HP:0002666 (renal cell carcinoma, pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R79P (c.236G>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351749311 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.236G%3EC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: R79P (c.236G>C)

      MultipleGeneVariants: N/A

    1. A 23-yr-old female was initially diagnosed with hypertension and elevated platelets. Because of the young age and hypertension, 24-h urine catecholamines were measured and found to be elevated. Abdominal CT scan disclosed bilateral adrenal pheochromocytomas, confirmed by [123I]metaiodobenzylguanidine scintigraphy (MIBG). The MIBG scan, however, showed uptake not only in the adrenal glands but also in the right neck area. Subsequently, an MRI of the neck disclosed a 2.5-cm carotid body tumor. The tumor was resected and histologically confirmed. The family history was negative for tumors of the VHL spectrum. Genetic testing revealed a germline mutation of the VHL gene p.Phe119Leu.

      PatientID: 3

      KindredID: 3

      Case: F, 23Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: None. The family history was negative for tumors of the VHL spectrum.

      CohortInfo: An international consortium registered patients with head and neck paragangliomas with VHL or RET gene mutations.

      CasePresentingHPOs: HP:0006748, HP:0002864, HP:0000822, HP:0001894 (Adrenal pheochromocytoma, Paraganglioma of head and neck, hypertension, thrombocytosis)

      CaseHPOFreeText: At age 24 the patient was found to have hypertension, elevated platelets, and elevated urine catecholamines. She was found to have a bilateral adrenal pheochromocytoma and a paraganglioma on the right neck area measuring 2.5 cm. The tumour was resected.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.F119L(c.355T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496059 https://www.ncbi.nlm.nih.gov/clinvar/variation/496059/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:F119L(c.355T>C)

      MultipleGeneVariants: N/A

    1. Eighteen VHL patients who underwent pancreatectomy for one or several endocrine tumors at Beaujon hospital from 1997 to 2008 were retrieved from the file of VHL patients (Table 1).

      PatientID: 17

      KindredID: 17

      Case: F, 33Y0M, Ethnicity unknown

      DiseaseAssertion: pancreatic endocrine tumor

      FamilyInfo: None

      CasePresentingHPOs: HP:0030405 (pancreatic endocrine tumor)

      CaseHPOFreeText: See Table 1 for more information

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Null (Complete deletion)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: deletion

      CivicName: DELETION

      MultipleGeneVariants: N/A

    1. The 70-yr-old mother of the index patient proved to be not only a gene carrier for the Ser80Ile mutation, but she also had the CCT25CTT (Pro25Leu) c.74C>T, p.Pro25Leu variant (identification number: rs35460768 (dbSNP127)), both in heterozygous forms. However, the mother showed no clinical, biochemical or radiological evidence of VHL-associated tumors.

      PatientID: II-1

      KindredID: 1

      Case: F, 70Y0M, Hungarian

      DiseaseAssertion: Asymptomatic

      FamilyInfo: The patient's daughter (III-1), the index patient, had the Ser80Asn mutation and presented with renal cell carcinoma, hemangioblastoma, pheochromocytoma. The patient's sister (II-5) died due to bilateral renal cell carcinoma at age 63. Family member (III-6) carried the Pro25Leu mutation but was asymptomatic. Family members (III-7, III-8, IV-13, IV-14, IV-16) all carried the Ser80Asn mutation. III-7 presented with hemangioblastoma and retina hemangioblastoma. III-8 presented with brain hemangioblastoma, pheochromocytoma, and retina hemangioblastoma. IV-13 had a brain hemangioblastoma, renal cysts, and retina hemangioblastoma. IV-14 had a pheochromocytoma and retina hemangioblastoma. IV-16 was asymptomatic. Refer to figure 1 for pedigree.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: She showed no clinical, biochemical or radiological evidence of VHL-associated tumors.

      CaseNotHPOs: HP:0005584, HP:0002666, HP:0010797, HP:0009711 (renal cell carcinoma, pheochromocytoma, hemangioblastoma, retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S80I (c.239G>A)

      LegacyVariant: p.S80I (c.239G>A) *author mistake

      CaseProblemVariantFreeText: N/A

      ClinVarID:N/A

      CAID: CA70046108 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.239G%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:S80N (c.239G>A) and P25L (c.74C>T)

      MultipleGeneVariants: Germline, VHL , c.74C>T (p.Pro25Leu)

    1. PatientID: III-50

      KindredID: 1

      Case: Sex unknown, Age unknown, Ethnicity Unknown

      DiseaseAssertion: asymptomatic

      FamilyInfo: Large multigenerational family with a history of both VHL and spinocerebellar ataxia type 2 (SCA2). Screening for clinical and genetic diagnostics were gathered as well as thorough information on non-living members. This patient's brother, mom and grandmother appeared to have the VHL mutation. See family pedigree (Fig. 1).

      CasePresentingHPOs: None

      CaseHPOFreeText: VHL found by genetic testing not clinical findings.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.E160Sfs*10 (c.477delA)

      LegacyVariant: c.688delA

      CaseProblemVariantFreeText: c.477del, p.Glu160Serfs10 should be used. Details: 477del same as 475delA bc that codon is AAA so doesn't matter which A gets deleted: there is an A at 475 476 477 so for HGVS we say that 477 (the latter) is deleted since that follows HGVS nomenclature. Thus use c.477del: p.Glu160Serfs10

      ClinVarID: 182959 https://www.ncbi.nlm.nih.gov/clinvar/variation/182959/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: E160fs (c.477del)

      MultipleGeneVariants: SCA2 (an abnormal increase in CAG repeats in one allele of her ataxin-2 gene. This abnormal trinucleotide expansion is consistent with the diagnosis of spinocerebellar ataxia type 2)

    1. 162Yes42––c–3500G>A3Arg167GlnMissense 12

      GroupID: None

      KindredID: 16

      DiseaseAssertion: VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: American Admixed /Latino

      GroupAgeRange: N/A

      GroupInfo: Four members of a South American family expressed this c.500G>A mutation.

      GroupPresentingHPOs: HP:0010797, HP:0002666 (hemangioblastoma,pheochromocytoma)

      GroupHPOFreeText:Two family members had hemangioblastoma of the central nervous system. Three had pheochromocytoma.

      GroupNotHPOs: HP:0002894, HP:0009711, HP:0005584 (neoplasm of the pancreas, retinal capillary hemangioma, renal cell carcinoma )

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q(c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q(c.500G>A) and c.464-94T>A

      MultipleGeneVariants: Germline, VHL, 464-94T>A

    1. GroupID: 69

      Case: 31Y0M, Sex Unknown, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: 1 of the 573 patients discussed in this paper were found to have this variant. This mutation (c.392A>C) was found in 1 VHL family with a single patient.

      CasePresentingHPOs: HP:0005584; HP:0009711; HP:0006880 (renal cell carcinoma; retinal capillary hemangioma; cerebellar hemangioblastoma)

      CaseHPOFreeText: patient had cerebellar hemangioblastoma diagnosed at 21Y, a retinal angioma at 28Y, and RCC at 31Y

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1.

      Variant: p.N131T (c.392A>C)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: CA351753944 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.392A%3EC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: N131T (c.392A>C)

      MultipleGeneVariants: N/A

    2. GroupID: 76

      DiseaseAssertion: assumed VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 4 of the 573 patients discussed in this paper were found to have identical variants. This mutation (c.482G>A) was found in 2 VHL families with 4 patients.

      GroupPresentingHPOs: HP:0002666 (pheochromocytoma)

      GroupHPOFreeText: all 4 patients had pheos, with a mean age of diagnosis of 16Y

      GroupNotHPOs: HP:0005584; HP:0009711; HP:0006880 (renal cell carcinoma; retinal capillary hemangioma; cerebellar hemangioblastoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1.

      Variant: p.R161Q (c.482G>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 182983 https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R161Q (c.482G>A)

      MultipleGeneVariants: N/A

    1. 94VHLE3c.500G>Ap.R167QPP7987306M141431NoPCCNo

      PatientID: 94

      KindredID: 94

      Case: M, 45Y0M, Chinese (East Asian)

      DiseaseAssertion: Pheochromocytoma

      FamilyInfo: No family history.

      CasePresentingHPOs: Pheochromocytoma (HP:0002666)

      CaseHPOFreeText: Pheochromocytoma wth an age of onset at 14Y and diagnosis at 14Y. 31 years later they were confirmed with a genetic mutation

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MAX, NF1, RET, SDHA, SDHB, SDHC, SDHD, SDHAF2, TMEM127

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: Described as a pathogenic variant, according to the ACMG guidelines at the time of publication.

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. 2M27PCC + sPGL + PNETProgressive, metastasis (metachronous)LiverS3102125.5 (IV)+−VHL (Exon:1)/ p.(Tyr98Ser)

      PatientID: 2

      KindredID: 2

      Case: M, 27Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: No family information reported.

      CasePresentingHPOs: HP:0002666; HP:0030405; HP:0002668 (pheochromocytoma; pancreatic endocrine tumor, paraganglioma)

      CaseHPOFreeText: Patient was diagnosed with pheochromocytoma, paraganglioma, and pancreatic endocrine tumor.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y98S (c.293A>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 219160, https://www.ncbi.nlm.nih.gov/clinvar/variation/219160/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense variant, transversion

      CivicName: Y98S (c.293A>C)

      MultipleGeneVariants: N/A

    1. In four families, partial deletions of one or more exons were detected by Southern blot analysis.

      PatientID: None (i)

      KindredID: E

      Case: Sex and Age unknown, Dutch

      DiseaseAssertion: assumed VHL

      FamilyInfo: 2 family members are grouped with this deletion (ages 31 and 60Y). VHL was clinically diagnosed in, at minimum, the proband. The other family member was found with this deletion and rHAB and neurofibromatosis

      CasePresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584; HP:0010797; HP:0002666 (renal cell carcinoma, hemangioblastoma, pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Deletion of exon 1

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: restriction with EcoRI, HindIII, and StuI did not result in abnormalities on Southern blots. Further analysis revealed a deletion of exon 1.

      MutationType: exon_loss_variant

      CivicName: exon 1 deletion

      MultipleGeneVariants: N/A

    1. 4 XX 27 Missense, A→G, 446 CNS, kidney, pancreas, adrenal

      PatientID: 4

      KindredID: 4

      Case: F, 27Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: Six unrelated VHL patients with known germline VHL mutations underwent surgery for uni- or bilateral renal lesions.

      CasePresentingHPOs: HP:0010797, HP:0005584, HP:0000107, HP:0001732, HP:0006748 (hemangioblastoma, renal cell carcinoma, renal cyst, abnormality of the pancreas, adrenal pheochromocytoma)

      CaseHPOFreeText: The patient had a renal lesion. The VHL disease affected this patient's CNS, kindey, pancreas, and adrenal (not specified).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.N78S (c.233A>G)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.N78S (c.446A>G)

      ClinVarID: 93326 https://www.ncbi.nlm.nih.gov/clinvar/variation/93326/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Patient 4 had a cell culture from a clear cell cyst with a dic(9;9)(p10;p10) in 10% of metaphase cells, as well as +1 in 30%, and +2, +13, and −21 in 50%.

      MutationType: missense_variant; transition

      CivicName: N78S (c.233A>G)

      MultipleGeneVariants: N/A

    2. 5 XX 38 Missense, C→T, 712 CNS, kidney, pancreas, adrenal

      PatientID: 5

      KindredID: 5

      Case: F, 38Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: Six unrelated VHL patients with known germline VHL mutations underwent surgery for uni- or bilateral renal lesions.

      CasePresentingHPOs: HP:0010797, HP:0005584, HP:0000107, HP:0001732, HP:0006748 (hemangioblastoma, renal cell carcinoma, renal cyst, abnormality of the pancreas, adrenal pheochromocytoma)

      CaseHPOFreeText: The patient had a solid low-grade renal lesion. The VHL disease affected this patient's CNS, kindey, pancreas, and adrenal (not specified).

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: p.R167W (c.712C>T)

      ClinVarID: 2218 https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954 https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: Patient 5 had a low-grade solid lesion at passage 10, which revealed i(9q)(q10) in 6 of 12 (50%) cells. Each of the 12 cells evaluated was different karyotypically.

      MutationType: missense_variant; transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. family A, a c.490G>T/ p.Gly93Cys

      PatientID: AIII3

      KindredID: A

      Case: M, 24Y0M, Serbian

      DiseaseAssertion: VHL

      FamilyInfo: Families were selected based on their clinical data and family history. Patient’s grandmother had CNS hemangioblastoma (AI1). Patient's mother (AII2) was diagnosed with pheochromocytoma at 33Y0M. The patient’s maternal aunt (AII5) has pheochromocytoma and CNS hemangioblastoma. Genetic testing was performed on nine family members and two carried the heterozygous missense variant - current patient and his mother. The patient’s grandmother and aunt with VHL were not genetically tested. See pedigree in figure 1.

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: The patient had severe arterial hypertension since 12Y0M and left pheochromocytoma was found and removed at 24Y0M.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G93C (c.277G>T)

      LegacyVariant: p.G93C (c.490G>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223175, https://www.ncbi.nlm.nih.gov/clinvar/variation/223175/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense variant; transversion

      CivicName: G93C (c.277G>T)

      MultipleGeneVariants: N/A

    1. #3PCC(38)7c.340+578C>Trs1396223560.05NoNoNegNormalIncreaseVUS

      PatientID: 3

      KindredID: 3

      Case: Sex Unknown, 45Y0M, Ethnicity Unknown

      DiseaseAssertion: Pheochromocytoma

      FamilyInfo: N/A - not stated

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: A pheochromocytoma (PCC) diagnosed first at 38Y was found, with follow up of a 7 year duration.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: c.340+578C>T

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 849869 https://www.ncbi.nlm.nih.gov/clinvar/variation/849869/

      CAID: N/A

      gnomAD: 0.0005097 https://gnomad.broadinstitute.org/variant/3-10184449-C-T

      VariantEvidence: Tumor analysis was performed since a frozen sample was available, and no other mutations of the VHL gene were identified. Immunostaining was negative for detection of CA9 expression. CA9 is a protein reported to influence regulation cell proliferation and tumor progression and is known to be expressed at the membrane of tumour cells in the case of VHL inactivation.

      MutationType: splice_site_variant; intron_variant

      CivicName: Splice Site (c.340+578C>T)

      MultipleGeneVariants: N/A

    1. PatientID: 18

      KindredID: 18

      Case: M, 45Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0009726; HP:0010797 (Renal neoplasm, Hemangioblastoma)

      CaseHPOFreeText: Patient 18 had a medical history of synchonous bilateral solid renal tumor. They underwent a left enucleation and a right nephrectomy. They also presented with central nervous system hemangioblastomas.

      CaseNotHPOs:None

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S111N (c.332G>A)

      LegacyVariant: c.545G>A

      CaseProblemVariantFreeText: N/A

      ClinVar: 223186, https://www.ncbi.nlm.nih.gov/clinvar/variation/223186/?new_evidence=true

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: S111N (c.332G>A)

      MultipleGeneVariants: N/A

    1. in seven of the asymptomatic family members.

      PatientID: IV-12

      KindredID: 1

      Case: M, Age Unknown, Turkish

      DiseaseAssertion: asymptomatic

      FamilyInfo: 17 family members from three generations were examined with the c.445G>T mutation and diagnosed with VHL type 2B. 11 individuals had clinical manifestations and 6 were asymptomatic carriers. One additional member (II-9) had passed before testing however were likely a carrier of the mutation. This patient’s father had passed down the mutation. See Fig. 1 for full family pedigree.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: None - described as a carrier of the p.A149S mutation, with no clinical manifestations. Their asymptomatic work up could have been due to the individual's young age

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.A149S (c.445G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 127829 https://www.ncbi.nlm.nih.gov/clinvar/variation/127829/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: A149S (c.445G>T)

      MultipleGeneVariants: N/A

    1. WM04 VHL VHL 0.62 

      PatientID: WM04

      KindredID: 10

      Case: Sex Unknown, 13Y0M, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MAX, RET, SDHA, SDHB, SDHC, SDHD, TMEM127

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: p.P103H (c.308C>A)

      LegacyVariant: Given as ENSP00000256474.2:p.Pro103His

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351751075 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.308C%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: P103H (c.308C>A)

      MultipleGeneVariants: N/A

    1. detected point germline vhl mutations in 14 patients

      PatientID: 3

      KindredID: 3

      Case: 35Y0M, sex unknown, ethnicity unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0009711 (hemangioblastoma; retinal capillary hemangioma)

      CaseHPOFreeText: See Table 1&2 for retinal capillary hemangioma information

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. Case reportA 5-year-old male, known to be a carrier of a VHL variant leading to a p.V170G substitution, presented to the Urology clinic in 2009 for pheohchromocytoma screening. His previous medical history was unremarkable.The boy’s mother was the index case in this VHL family. She was diagnosed incidentally with bilateral pheochromocytoma at the age of 23 years and underwent bilateral adrenalectomy. Following this, the mother had genetic screening for VHL. This also prompted screening of her kindred. Over time, DNA sequencing from blood of consenting family members condirmed the presence of a VHL variant in seven family members (three generations, all from maternal side) (Fig. 1). The seven members were found to carry the variant p.V170G (c.509.T>G), a mutation of exon 3 of the VHL tumor suppressor gene that leads to substitution of a surface amino acid valine with glycine at the 170 position in the resulting VHL protein. The c.509.T>G mutation in VHL is pathogenic (see acknowledgements) and has been previously associated with pheochromcytomas, ccRCC, retinal hemangioblastomas, paragangliomas and pancreatic neuroendocrine tumors [3,4,5].Fig. 1Pedigree of a family severely affected by a missense mutation of the VHL gene (p.V170G). The members with the variant identified are presented in color. The first brother (our patient) described in this case report is indicated by an arrowFull size imageUpon commencing follow-up, our patient was clinically asymptomatic. His blood pressure was within normal limits. The baseline neurologic evaluation was normal, as well his ophthalmology and audiology evaluations. His baseline abdominal ultrasound (US) did not reveal any abnormal masses and his baseline urinary and plasma catecholamine levels were normal. As per suggested protocols he underwent annual screening with US and plasma or urinary catecholamines (Table 1).Nine months after his last annual visit, at the age of 7 years, the patient presented with a 3-month history of flushing, night sweats, heat intolerance and intermittent headaches. His systolic blood pressure was elevated at 160 mmHg. His baseline plasma norepinephrine level was increased to 27,233 pmol/L (normal range: 1180–3550 pmol/L), a 15-fold increase compared to the level measured 9 months prior. An abdominal US followed by magnetic resonance imaging (MRI) showed a left suprarenal mass measuring 4.8 cm in its greater dimension. The metaiodobenzylguanidine (MIBG) scan was negative, probably due to the fact that the boy had already started treatment with alpha-adrenergic blockers to control his hypertension. As a definitive treatment, the patient underwent total adrenalectomy (the mass was too large for partial resection) using a retroperitoneoscopic approach [6]. Pathology revealed a pheochromocytoma that measured 4.2 cm in its greater dimension and weighed 35 g.Thereafter, a first accelerated protocol was developed, which consisted of visits every 6 months, with annual US alternating with annual plasma catecholamines. At the age of 10 years, a new solid mass was observed on routine US in the right adrenal gland measuring 2 cm. MRI and MIBG confirmed the finding. His plasma catecholamines level increased to 20,947 pmol/L, a sevenfold increase compared to the level measured 1 year prior. During that period of time he complained of fatigue but denied any other symptoms associated with pheochromocytoma. Mild hypertension was observed. Right retroperitoneoscopic adrenalectomy was delayed 3 months due to family reasons. Due to its central location next to the adrenal vein, a partial adrenalectomy was not feasible. Pathological evaluation confirmed a pheochromocytoma measuring 4 cm in its greater dimension. Six years after his second surgery he remains asymptomatic with normal blood pressure and no clinical evidence for recurrence of pheochromocytoma. He remains on fludrocortisone and hydrocortisone as hormone replacement therapy.

      PatientID: N/A (case report - older son of index case)

      KindredID: 1

      Case: M, 16Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient's mother was the index case in this VHL family, as she was diagnosed with bilateral pheochromocytoma at age 23 and underwent bilateral adrenalectomy. Genetic screening revealed the VHL variant, which prompted screening of family members. DNA sequencing from blood of consenting family members confirmed the presence of the VHL variant in seven family members (three generations) (see figure 1 for familial pedigree). This included the mother (index case), the patient, his brother, maternal grandmother, uncle and two cousins. The brother, who was 3 years younger, presented with an adrenal mass, which required total adrenalectomy and remains well 2.5 years later. The uncle developed hemangioblastoma, multiple bilateral renal cell carcinomas, bilateral pheochromocytomas, and succumbed to his disease at age 45. The uncle's two daughters both had the mutation. One of which was found to have pheochromocytoma at age 15 due to routine screening. The other 8 year old daughter has not had any manifestations. No phenotype was noted for the grandmother.

      CasePresentingHPOs: HP:0006748 (adrenal pheochromocytoma)

      CaseHPOFreeText: The 5Y0M patient presented to a urology clinic in 2009 for pheohchromocytoma screening due to a known VHL heterozygous V170G(c.509.T>G) missense variant in the VHL gene, despite unremarkable medical history. The patient remained asymptomaticuntil nine months after his annual visit at age 7, where he was admitted to the hospital due to 3-months of flushing, night sweats, heat intolerance and headaches. An abdominal ultrasound and MRI showed a left suprarenal mass. A total adrenalectomy was performed since the mass was too big for partial adrenalectomy. Pathology confirmed a left pheochromocytoma. At age 10, routine ultrasound revealed a new mass in the right adrenal gland measuring 2 cm, confirmed by MRI. Right adrenalectomy was delayed 3 months, but pathology confirmed a pheochromocytoma. Six years after his second surgery he is asymptomatic with no clinical evidence for recurrence. He remains on fludrocortisone and hydrocortisone as hormone replacement therapy.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170G (c.509T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756196, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.509T%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; tranversion

      CivicName: V170G (c.509T>G)

      MultipleGeneVariants: N/A

    1. c.292T>A p.Tyr99Asn

      PatientID: None (proband 14)

      KindredID: 14

      Case: M, 41Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Patient’s mother, sister and brother all died before diagnosis; thus no DNA sample available. The mother was last observed at 62Y with multiple pancreatic cysts or tumors, as well as had CNS hemangioblastomas at 50Y. The sister had CNS hemangioblastomas at 40Y and RCC at 49Y. Lastly, the brother had retinal angiomas at 20Y and CNS hemangioblastomas at 27Y.

      CasePresentingHPOs: HP:0002666; HP:0010797; HP:0005584; HP:0001737 (pheochromocytoma, hemangioblastoma, renal cell carcinoma, pancreatic cysts)

      CaseHPOFreeText: patient had pheochromocytoma and hemangioblastoma diagnosed at 40Y, and renal cell carcinoma and multiple pancreatic cysts or tumors at 41Y.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y98N (c.292T>A)

      CaseProblemVariantFreeText: Stated in paper as c.292T>A p.Tyr99Asn. Likely p.Y98N rather.

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: CA351750883 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.292T%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: Y98N (c.292T>A)

      MultipleGeneVariants: N/A

    2. 1Deletion

      PatientID: III:2

      KindredID: 8

      Case: M, 23Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: a 3 generational family found with 5 phenotypically affected members, two of which were confirmed with the exon 1 deletion. This proband and his mother were tested to be found with the deletion of exon 1. His mother was found with retinal hemangioblastomas at 35Y and hemangioblastomas at 43Y. His two aunts and grandfather father all had hemangioblastomas; and grandfather also had RCC, however the he and one aunt were deceased; and the other aunt was not available to provide a DNA sample.

      CasePresentingHPOs: HP:0009711; HP:0010797; HP:0009715; HP:0001737 (retinal capillary hemangioma, hemangioblastoma, Papillary cystadenoma of the epididymis, pancreatic cysts)

      CaseHPOFreeText: patient was found with retinal angiomas at 17Y, pancreatic cysts and epididymal/ovarian cystadenoma at 19Y, and hemangioblastomas at 23Y.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: exon 1 deletion

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: exon 1 deletion

      MultipleGeneVariants: N/A

    3. c.263G>A p.Trp88Stop

      PatientID: None (mother)

      KindredID: 11

      Case: F, 36Y0M (last known), Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Patient had a son (last known age 38Y) with RCC and multiple pancreatic cysts or tumors diagnosed at age 34 and 38Y.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: patient had CNS hemangioblastomas diagnosed at 36Y

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 22357542

      SupplementalData: N/A

      Variant: p.W88* (c.263G>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 182978 https://www.ncbi.nlm.nih.gov/clinvar/variation/182978/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: W88* (c.263G>A)

      MultipleGeneVariants: N/A

    4. c.500G>A p.Arg167Gln

      PatientID: None (proband 16)

      KindredID: 16

      Case: M, 46Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Daughter, sister, and nephew all stated with manifestations although no DNA sample was available. Sister and nephew had died before diagnosis. Daughter was diagnosed with retinal angiomas at the age of 14, and then CNS hemangioblastomas at the age of 24. The late sister had CNS hemangioblastoma at 50, and the late nephew at CNS hemangioblastoma at 15, and renal cell carcinoma at 26.

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0002666 (hemangioblastoma, renal cell carcinoma, pheochromocytoma)

      CaseHPOFreeText: Patient presented with hemangioblastoma at age 29 and pheochromocytoma and renal cell carcinoma at age 46.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    Tags

    Annotators

    URL

    1. 312FPHEOBilateraln.d.NoNoVHL: c.602T>C, p.Leu201Pro

      PatientID: 3

      KindredID: 3

      Case: F, 12Y0M, Ethnicity Unknown

      DiseaseAssertion: pheochromocytoma

      FamilyInfo: No details on family information provided.

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: Patient had bilateral pheochromocytoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L201P (c.602T>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 1326283, https://www.ncbi.nlm.nih.gov/clinvar/variation/1326283/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: L201P (c.602T>C)

      MultipleGeneVariants: N/A

    1. A male patient in his 20s initially presented to the UOB at the NCI with several clinical phenotypic manifestations consistent with a diagnosis of VHL. At an outside institution, the patient had previously had multiple resections of CNS haemangioblastomas, a left robotic partial nephrectomy for multifocal ccRCC (five tumours ranging from 1.3 cm to 4.6 cm in largest dimension) and a right ablation of a central renal tumour. Previous germline mutation testing had been negative for VHL mutation and the patient reported no family history of kidney cancer or any other clinical manifestations consistent with VHL.Further evaluation and imaging at the UOB revealed that the patient had bilateral epididymal cysts, numerous pancreatic cysts and numerous bilateral renal cysts with two solid lesions in the left kidney (2.3 cm and 1.7 cm) and one solid lesion in the right kidney (2.1 cm) (figure 1A). Currently, the adrenal glands appear unaffected. These clinical manifestations were consistent with a diagnosis of VHL. Germline genetic analysis was repeated using DNA derived from peripheral blood leucocytes to evaluate for point mutations, insertions, deletions or duplications in VHL and was negative. To assess the possibility of mosaicism, germline genetic testing was additionally performed on DNA derived from saliva containing buccal epithelial cells and from fibroblasts acquired via a skin punch biopsy. No alterations of the VHL gene were detected.<img class="highwire-fragment fragment-image" alt="Figure 1" src="https://jmg.bmj.com/content/jmedgenet/59/1/18/F1.medium.gif" width="440" height="202"/>Download figure Open in new tab Download powerpoint Figure 1 Imaging and karyotype analysis of patient with von Hippel-Lindau (VHL) disease. (A) Coronal (upper) and axial (lower) MRI images of the abdomen of the patient with VHL showing multiple bilateral renal cysts (green arrows), one of the left-sided solid lesions (red arrows) and multiple pancreatic cysts (blue arrow). (B) Karyotype analysis of the germline DNA of the patient with VHL demonstrating a translocation between chromosomes 1 and 3.Germline translocations involving chromosome 3 have been reported and shown to result in an increased risk of kidney cancer, but to date no other VHL-associated clinical manifestations have been seen.13–16 To investigate whether a translocation could cause these clinical features, a karyotype analysis was performed. The patient was shown to have a germline translocation between chromosomes 1 and 3, 46, XY, t(1;3)(p36.3;p25). The predicted breakpoint at chromosome 3p25 was in the same region as the VHL gene, potentially directly disrupting the VHL gene (figure 1B).Paired-end WGS was performed on the DNA derived from peripheral blood leucocytes and several paired reads were found with one pair mate on chromosome 1 and the other within intron 2 of the VHL gene on chromosome 3. To confirm the breakpoints, primers were designed to amplify and Sanger sequence the breakpoint regions in both derivative chromosomes. The breakpoint on the derivative chromosome 3 had a 2 bp sequence present in both the wild-type sequences for chromosomes 1 and 3 with the last unique base of chromosome 1p at 716 702 bp (hg19) and the first unique base of chromosome 3p at 10 191 126 bp (hg19) (figure 2). The breakpoint on the derivative chromosome 1 had an insertion of 10 bp which was a duplication of an upstream region of chromosome 3, with the last unique base of chromosome 3p at 10,191,119 bp (hg19) and the first unique base of chromosome 1p at 716 698 bp (hg19) (figure 2). This results in a few base pairs being lost from wild-type sequence of chromosome 3 but no loss of sequence compared with wild-type chromosome 1. The break on chromosome 3p was confirmed to be within the second intron of the VHL gene creating a germline alteration that would result in either a truncated VHL protein or no protein being produced by this allele. However, the break on chromosome 1p did not occur within a gene, and the nearest telomeric gene, LOC100288069, was ~2.6 kb away and the nearest centromeric gene, FAM87B, was ~36 kb away. Neither of these genes were mutated in any of the 426 sporadic ccRCCs analysed by the Cancer Genome Atlas suggesting that alterations in either of these genes is unlikely to influence the risk of kidney cancer in this patient.

      PatientID: N/A (case)

      KindredID: 1

      Case: M, 20Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient reported no family history of kidney cancer or any other clinical manifestations related to VHL disease. Sincehe patient had no family history of VHL, the authors suggest that the germline translocation was a de novo event.

      CasePresentingHPOs: HP:0006880; HP:0030424; HP:0001737; HP:0000107; HP:0009726 (Cerebellar hemangioblastomas; Epididymal cysts; Pancreatic Cysts; Renal cysts; Renal Tumors)

      CaseHPOFreeText: The patient presented to the Urologic Oncology Branch at the National Cancer Institute with clinical manifestations consistent with VHL in his 20s (exact age of patient was not indicated). He had multiple cerebellar haemangioblastomas, bilateral epididymal cysts, pancreatic cysts, and bilateral renal tumours and cysts. Standard genetic testing for VHL did not detect a mutation. Karyotype analysis however revealed a translocation between chromosomes 1 and 3. This balanced translocation with a breakpoint within the second intro of the VHL gene was confirmed by whole genome sequencing.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: t(1;3)(p36.3;p25)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: balanced_translocation

      CivicName: t(1;3)(p36.3;p25)

      MultipleGeneVariants: N/A

    1. 13 Yes Yes No Yes* Yes Epid cyst

      PatientID: 13

      KindredID: 7

      Case: M, 37Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Three total family members presented with this germline variant in VHL. No phenotypes were reported for patients 6 and 7 of this family.

      CohortInfo: A retrospective analysis of case notes of 17 patients was performed for this study. Initially, 23 consecutive patients with VHL disease followed by the Department of Endocrinology at St Bartholomew's Hospital since 1988 were reviewed.

      CasePresentingHPOs: HP:0001732; HP:0000077; HP:0002668; HP:0009711; HP:0030424 (Abnormality of the pancreas, Abnormality of the kidney, Paraganglioma, Retinal capillary hemangioma, Epididymal cyst)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0002666; HP:0010797 (Pheochromocytoma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y185* (c.555C>G)

      LegacyVariant: c.768C>G

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223233, https://www.ncbi.nlm.nih.gov/clinvar/variation/223233/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Reported as: C768G, assumed to be in Legacy reference sequence (AF010238.1) and mapped to c.555C>G according to NM_000551.3 reference sequence.

      MutationType: missense_variant;transversion; stop_gained

      CivicName: Y185* (c.555C>G)

      MultipleGeneVariants: N/A

    1. A 23-year-old man

      PatientID: None

      KindredID: 1

      Case: M, 23Y0M, Caucasian

      DiseaseAssertion: Retinal hemangioma

      FamilyInfo: Parental testing did not detect this Exon 2 mutation in either parent, suggesting a de novo mutation.

      CasePresentingHPOs: HP:0009711 (Retinal hemangioma)

      CaseHPOFreeText: The 23Y male patient presented with blurry vision and metamorphopsia, and was diagnosed with bilateral retinal hemangioblastoma. The patient underwent FPAL (fluorescein potentiated argon laser) treatment after diagnosis, and the retinal hemangiomas were found to be inactive throughout the seven month followup.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 2 Deletion

      LegacyVariant: N/A

      ClinVarID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 2 Deletion

      MultipleGeneVariants: N/A

    1. PatientID: 8

      KindredID: 3

      Case: M, 38Y0M, Indian

      DiseaseAssertion: VHL

      FamilyInfo: Another member of this family (Gen 2) presented with the same variant and bilateral pheochromocytoma and sympathetic paraganglioma, pancreatic cysts, neural hemangioblastomas and pancreatic neuroendocrine tumors and died due to an adrenal crisis.

      CohortInfo: This retrospective study was conducted at Department of Endocrinology of a tertiary care health centre in Western India. Patients presented to our institute between 2008 and 2016 were included in the study. During the study period a total of 33 patients were suspected to have VHL syndrome based on clinical features among whom 31 patients were found to have mutation in VHL gene. All patients are of Asian Indian descent.

      CasePresentingHPOs: HP:0002666; HP:0010797; HP:0002668; HP:0001737; HP:0005584 (Pheochromocytoma, Hemangioblastoma, Paraganglioma, Pancreatic cysts, Renal cell carcinoma)

      CaseHPOFreeText: Bilateral pheochromocytoma.

      CaseNotHPOs: HP:0009711; HP:0030405 (Retinal capillary hemangioma, Pancreatic endocrine tumor)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    2. PatientID: 31

      KindredID: 21

      Case: M, 50Y0M, Indian

      DiseaseAssertion: VHL

      FamilyInfo: Relevant family history but details are not made available.

      CohortInfo: This retrospective study was conducted at Department of Endocrinology of a tertiary care health centre in Western India. Patients presented to our institute between 2008 and 2016 were included in the study. During the study period a total of 33 patients were suspected to have VHL syndrome based on clinical features among whom 31 patients were found to have mutation in VHL gene. All patients are of Asian Indian descent.

      CasePresentingHPOs: HP:0002666; HP:0010797 (Pheochromocytoma, Hemangioblastoma)

      CaseHPOFreeText: Unilateral pheochromocytoma. Cause of death: neural hemangioblastomas.

      CaseNotHPOs: HP:0002668; HP:0005584; HP:0009711; HP:0001737; HP:0030405 (Paraganglioma, Retinal capillary hemangioma, Renal cell carcinoma, Pancreatic cysts, Pancreatic endocrine tumor)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 1 Deletion (c.1-?_340+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1 Deletion

      MultipleGeneVariants: N/A

    1. Her daughter presented with a spinal tumor at the age of 18, which was surgically resected and confirmed to be a CNS hemangioblastoma, with subsequent recurrence and additional surgery at 36 years of age. No other VHL-associated symptoms were observed in this patient, and she died 1 year after the second surgery.

      PatientID: N/A

      KindredID: 1

      Case: F, 37Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Her brother had a normal phenotype and was not found to carry the VHL mutation. Her mother (the proband) harboured the mutation and presented with renal cell carcinoma, multiple renal cysts, pancreatic cysts, and nephropathy. She passed away at age 66 due to renal cell carcinoma.

      CasePresentingHPOs: HP:0009713 (spinal hemangioblastoma)

      CaseHPOFreeText: The patient presented with a spinal tumor at the age of 18, which was surgically resected and confirmed to be a CNS hemangioblastoma, with subsequent recurrence and additional surgery at 36  years of age. She died at age 37.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S65W(c.194C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 43597 https://www.ncbi.nlm.nih.gov/clinvar/variation/43597/

      CAID: CA020099 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.194C%3EG

      gnomAD: N/A

      VariantEvidence: Harboured a heterozygous c.194C>G (p.Ser65Trp) VHL mutation.

      MutationType: missense_variant;transversion

      CivicName:S65W(c.194C>G)

      MultipleGeneVariants: N/A

    1. We report the case of a 43 years old female patient with gross hematuria and renal colic who was evaluated by a community urologist. An abdominal non-contrast CT showed small kidney stones without obstruction and a left 14mm renal mass. She underwent abdominal magnetic resonance imaging (MRI), which revealed two right hyper-intense masses (9×7mm and 6×5mm) and one left mass (16×9mm), which was associated with one unspecific left pulmonary node (Figures 1a and ​and1b).1b). These findings were evaluated at the uro-oncology clinic in March 2013. Initially, surgery was not recommended considering the young age of the patient and the small size of the tumors (less than 3cm). Furthermore, since this was a case of bilateral renal cell carcinoma (RCC), preserving renal function was important for future treatments. An active surveillance protocol with strict follow-up instructions was established according to the recommendations set by the National Cancer Institute. In September 2013, the MRI revealed that the left mass had grown to a volume of 21x15mm, but other tumors did not grow according to the imaging results.Open in a separate windowFigure 1Abdominal Magnetic resonance.a) Right renal mass. b. Left renal mass. A genetic test was performed in June 2013. This test specifically genotyped single nucleotide polymorphisms (SNPs) that were relevant to: (a) pharmaceutical drug response (b) genetic diseases and (c) complex diseases. In the latter group, colorectal, lung and breast cancer were included. Results from this genotyping test are presented in Table-1.Table 1SNP genotyping results associated with some cancer types. Gen/LocusMarkerGenotypeColorectal CancerBMP4rs4444235T/CCDH1rs9929218G/GCRAC1rs4779584T/CEIF3Hrs16892766A/AIntergenic_10p14rs10795668G/GIntergenic_20p12rs961253C/CIntergenic_8q24 region3rs6983267G/GLOC120376rs3802842A/CRHPN2rs10411210C/CSMAD7rs4939827T/TLung CancerBAT3rs3117582A/ACHRNA3rs1051730T/CTERTrs2736100C/CBreast CancerAKAP9rs6964587T/GCASP8rs1045485G/GCHEK2 1100delC C/CESR1rs2046210G/GFGFR2rs1219648A/AIntergenic_2q35rs13387042G/GIntergenic_8q24rs13281615A/GLSP1rs3817198T/TMAP3K1rs889312A/AMRPS30rs10941679A/GPALB2 1592delT T/TTNRC9rs3803662C/COpen in a separate window In January 2014, we asked for a genetic sequence specific for renal cancer. We carried out a very extensive genomic sequencing study to identify polymorphisms associated with renal cancer and Birt-Hogg-Dubé (BHD) syndrome. This study sequenced a panel of five genes: the VHL gene, which has been associated with von Hippel-Lindau disease (3, 4), the MET gene, which is associated with papillary carcinoma of kidney cells (5, 6), genes SDHB and SDHD, which are associated with hereditary paraganglioma-pheochromocytoma (7, 6), and the FLCN gene, which is associated with BHD syndrome (8, 9). Predictive studies in silico of variants with unknown significance were performed using Alamut software V.2.11 (Interactive Biosoftware, http://www.interactive-biosoftware.com). Results from this sequencing are shown in Table-2.Table 2Sequence variants found in VHL, MET, FLCN, SDHB, and SDHD gene sequencing.GeneIDs.HGVSPatientFunctional consequenceClinical SignificanceSDHBrs10887990c.286+169A>G 1CIntron variantLikely benignSDHBrs732679c.73-302G>A 1AIntron variantLikely benignSDHBrs2746462c.18C>A 1ASynonymous codonBenignVHLrs779806c.340+384G>A 2AIntron variantLikely benignMETrs34822187c.1201-6898delA3CIntron variantLikely benignMETrs41736, COSM150377c.3912C>T 3 p.D1304DTSynonymous codonBenignMETrs2023748, COSM150378c.4071G>A3 p.A1357AASynonymous codonBenignMETrs41737, COSM150379c.4146G>A 3 p.P1382PASynonymous codonBenignFLCNrs8065832c.1062+6C>T 4TIntron variantUnknownFLCNrs2018781c.872-610C>G 4GIntron variantUnknownFLCNrs1736219c.397-14C>T 4TIntron variantBenignFLCNrs1736212c.-25+100C>G 4GIntron variantBenignOpen in a separate windowTranscript of reference BIOBASE:(1) {"type":"entrez-nucleotide","attrs":{"text":"NM_003000.2","term_id":"115387093","term_text":"NM_003000.2"}}NM_003000.2, (2) {"type":"entrez-nucleotide","attrs":{"text":"NM_000551.3","term_id":"319655736","term_text":"NM_000551.3"}}NM_000551.3, (3) {"type":"entrez-nucleotide","attrs":{"text":"NM_001127500.1","term_id":"188595715","term_text":"NM_001127500.1"}}NM_001127500.1, (4) {"type":"entrez-nucleotide","attrs":{"text":"NM_144997.5","term_id":"186928861","term_text":"NM_144997.5"}}NM_144997.5 As shown in Table-2, a total of twelve variants were found in the patient.

      PatientID: N/A (case)

      KindredID: 1

      Case: M, 47Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: No details on family information.

      CasePresentingHPOs: HP:0006770; HP:0006766; HP:0000787 (clear cell renal cell carcinoma, papillary renal cell carcinoma, nephrolithiasis)

      CaseHPOFreeText: At 43Y0M patient screened for germline mutations associated with renal cancer development due gross hematuria and renal colic. A CT showed small kidney stones and a left 14mm renal mass, along with bilateral renal cell carcinoma. A total of 12 variants were found in the patient. 2 years later, she underwent 3 right partial nephrectomies, revealing clear cell carcinoma in each tumor. Months later she also underwent 2 partial left nephrectomies revealling papillary-type renal carcinomas.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: SDHB, SDHD

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.340+384G>C

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA896160056, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.340%2B384G%3EC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: intron_variant

      CivicName: c.340+384G>C

      MultipleGeneVariants: Germline, SDHB, c.286+169A>G; Germline, SDHB, c.73-302G>A; Germline, SDHB, c.18C>A; Germline, MET, c.1201-6898delA; Germline, c.3912C>T (p.D1304D); Germline, MET, c.4071G>A (p.A1357A); Germline, MET, c.4146G>A (p.P1382=); Germline, FLCN, c.1062+6C>T; Germline, FLCN, c.872-610C>G; Germline, FLCN, c.397-14C>T; Germline, FLCN, c.-25+100C>G

    1. Aunt 1b45, Bilateral–––

      PatientID: None (Aunt)

      KindredID: G

      Case: F, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: Renal cell carcinoma

      FamilyInfo: Index patient was a 21-year-old man who had bilateral renal masses and renal cysts. Family history indicated a high suspicion for VHL disease, as his mother was operated for renal cell carcinoma, his uncle had spinal cord tumor, and his grandmother underwent operation for renal cell carcinoma. However, detailed clinical evaluation could not be performed in family members.

      CasePresentingHPOs: HP:0005584 (Renal cell carcinoma)

      CaseHPOFreeText: Presented with bilateral renal cell carcinoma. No VHL diagnosis noted but assumed to have VHL based on genetic, clinical and familial findings.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: N/A

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Was not genetically tested but is likely to carry the p.S80I (c.239G>T) germline variant of the VHL gene given phenotype presentation and family history.

      MutationType: N/A

      CivicName: N/A

      MultipleGeneVariants: N/A

    1. GroupID: XVII, XVIII (from Pheochromocytoma VHL-associated group)

      DiseaseAssertion: VHL

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: Patients were grouped based on having the same mutation.

      FamilyInfo: The patients were described as having familial pheochromocytomas and hemangioblastomas.

      GroupPresentingHPOs: HP:0002666 (pheochromocytoma)

      GroupHPOFreeText: N/A

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: MEN1 and SDHD

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L178Q (c.533T>A)

      LegacyVariant: p.L178Q (c.746T>A)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625260, https://www.ncbi.nlm.nih.gov/clinvar/variation/625260

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: L178Q (c.533T>A)

      MultipleGeneVariants: Patients had somatic copy number changes (table 1).

    1. 1.2001 40y/F/Caucasian/Slovenia Two tumors/ϕ 2 cm &4 cm each Intra/paraspinal*(extradural)/L1-L2 &L5-S2 nerve roots Radicular lumbar pain, lowerlimb paresthesia & weakness/CT, MRI: contrast enhancing masses & erosion of lumbar spine & sacrum Biopsy (L5-S2 T.)/E-HB +ve for ′brain tumors′/CB HBs;CCRCC; PHCC;cysts in K & P VHLD-associated E-HB Seq., LOHMSP Dead of VHLD(<17mos)

      PatientID: Case 1

      KindredID: 1

      Case: F, 40Y0M, Caucasian

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0010797, HP:0006880, HP:0006770, HP:0002666, HP:0000107, HP:0001737 (hemangioblastoma, cerebellar hemangioblastoma, clear cell renal cell carcinoma, pheochromocytoma, renal cyst, pancreatic cysts)

      CaseHPOFreeText: extraneuraxial hemangioblastoma

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.I151N (c.452T>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351754356 (http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.452T%3EA)

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_transversion

      CivicName: I151N (c.452T>A)

      MultipleGeneVariants: VHL p.R167Q (c.500G>A)

    1. PatientID: None

      KindredID: 22

      Case: Sex Unknown, Age Unknown, Japanese

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0009711; HP:0010797; HP:0005584 (Retinal capillary hemangioma, Hemangioblastoma, Renal cell carcinoma)

      CaseHPOFreeText: CNS hemangioblastoma, renal cell carcinoma and retinal angioma.

      CaseNotHPOs: HP:0001732 (Abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 8634692

      SupplementalData: N/A

      Variant: p.S80Ifs*79 (c.239del)

      LegacyVariant: c.452del

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA913189245, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.239del

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant; deletion

      CivicName: S80Ifs*79 (c.239del)

      MultipleGeneVariants: N/A

    2. GroupID: 61

      DiseaseAssertion: VHL

      GroupSize: 4

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: Japanese

      GroupAgeRange: N/A

      GroupInfo: 4 individuals from a single family (ID 61).

      GroupPresentingHPOs: HP:0009711; HP:0010797; HP:0001732; HP:0005584 (Retinal capillary hemangioma, Hemangioblastoma, Abnormality of the pancreas, Renal cell carcinoma)

      GroupHPOFreeText: CNS hemangioblastoma (4/4), retinal angioma (2/4), renal cell carcinoma (1/4) and pancreatic tumor or cyst (unspecified) (2/4).

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S111R (c.333C>A)

      LegacyVariant: c.546C>A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351751338, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.333C%3EA

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: S111R (c.333C>A)

      MultipleGeneVariants: N/A

    1. 30m4821.6n14.8n677-1G/C–0.2

      PatientID: 30

      KindredID: 30

      Case: M, 48Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: No details on family information.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.464-1G>C

      LegacyVariant: c.677-1G>C

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223220, https://www.ncbi.nlm.nih.gov/clinvar/variation/223220/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: Splice Site (c.464-1G>C)

      MultipleGeneVariants: N/A

    2. 3f4241↑11.9↓746 T/A–0.9

      PatientID: 3

      KindredID: 3

      Case: F, 42Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: No details on family information.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L178Q (c.533T>A)

      LegacyVariant: c.746T>A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625260, https://www.ncbi.nlm.nih.gov/clinvar/variation/625260/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: L178Q (c.533T>A)

      MultipleGeneVariants: N/A

    1. 179delG Fs Exon 1 60 CGG R Stop66

      GroupID: 4

      Case: Age unknown, Sex unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: None - one member documented here

      CasePresentingHPOs: N/A

      CaseHPOFreeText: other manifestations are not clearly stated.

      CaseNotHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: Possibly published in PMID:15300849

      SupplementalData: N/A

      Variant: p.V62Cfs*5 (c.179delG)

      CaseProblemVariantFreeText: c.179del automaps to NM_000551.3:c.180delG

      LegacyVariant: N/A

      ClinVarID: 182986 https://www.ncbi.nlm.nih.gov/clinvar/variation/182986/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift

      CivicName: V62fs (c.180delG)

      MultipleGeneVariants: N/A

    2. 161insG Fs Exon 1 54 ATG M Stop131/no initiation

      GroupID: 3

      DiseaseAssertion: VHL

      GroupSize: 3

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: French

      GroupAgeRange: N/A

      GroupInfo: 3 patients are listed with this mutation; any relation is unknown.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: other manifestations are not clearly stated.

      GroupNotHPOs: HP:0009711 (retinal capillary hemangioma)

      GroupNotHPOFreeText: All 3 members are said to not have retinal HBs

      GroupPreviousTesting: N/A

      PreviouslyPublished: Possibly published in PMID:15300849

      SupplementalData: N/A

      Variant: p.E55Gfs*77 (c.161_162insG)

      CaseProblemVariantFreeText: c.161_162insG automaps to NM_000551.3:c.163dupG

      LegacyVariant: N/A

      ClinVarID: 223159 https://www.ncbi.nlm.nih.gov/clinvar/variation/223159/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: duplication

      CivicName: E55fs (c.163dupG)

      MultipleGeneVariants: N/A

    3. 525C→A Tv Exon 3 175 TAC Y Y175X

      GroupID: 49

      Case: Age unknown, Sex unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: None - one member documented here

      CasePresentingHPOs: N/A

      CaseHPOFreeText: other manifestations are not clearly stated.

      CaseNotHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: Possibly published in PMID:15300849

      SupplementalData: N/A

      Variant: p.Y175* (c.525C>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 1298905 https://www.ncbi.nlm.nih.gov/clinvar/variation/1298905/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: Y175* (c.525C>A)

      MultipleGeneVariants: N/A

    1. 24F/20FSUnilateral PCCRenal and pancreatic cystsVHL1Heterozygous deletion of exon 1NA

      PatientID: 24

      KindredID: 24

      Case: F, 20Y0M, Asian Indian

      DiseaseAssertion: assumed VHL

      FamilyInfo: Positive family history

      CasePresentingHPOs: HP:0002666; HP:0000107; HP:0001737 (pheochromocytoma; Renal cyst; pancreatic cysts)

      CaseHPOFreeText: unilateral pheochromocytoma, renal and pancreatic cysts

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: RET/ SDHB/ SDHD/ NF1

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Heterozygous deletion of exon 1

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1 Deletion

      MultipleGeneVariants: N/A

    1. KindredID: 19

      GroupID: 24

      GroupSize: Unknown

      GroupNumberMales: Unknown

      GroupNumberFemales: Unknown

      GroupEthnicity: Unknown

      GroupAgeRange: Unknown

      DiseaseAssertion: VHL

      GroupInfo: Kindred no. 19 describes a family where at least one member (unspecified how many) had this mutation in the VHL gene. Pheochromocytoma was not observed in this kindred indicating VHL disease type 1.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: N/A

      GroupNotHPOs: HP:0002666 (Pheochromocytoma)

      GroupNotHPOFreeText: Pheochromocytoma was not observed in this kindred indicating VHL disease type 1.

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.L118P (c.353T>C)

      LegacyVariant: p.L189P (c.566T>C)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 428807, https://www.ncbi.nlm.nih.gov/clinvar/variation/428807/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: L118P (c.353T>C)

      MultipleGeneVariants: N/A

    2. KindredID: 137

      GroupID: 42

      GroupSize: Unknown

      GroupNumberMales: Unknown

      GroupNumberFemales: Unknown

      GroupEthnicity: Unknown

      GroupAgeRange: Unknown

      DiseaseAssertion: VHL

      GroupInfo: Kindred no. 91 describes a family where at least one member (unspecified how many) had this mutation in the VHL gene. No additional phenotypic information is listed for this kindred.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: N/A

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167G (c.499C>G)

      LegacyVariant: p.R238G (c.712C>G)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2219, https://www.ncbi.nlm.nih.gov/clinvar/variation/2219/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R167G (c.499C>G)

      MultipleGeneVariants: N/A

    3. KindredID: 82

      GroupID: 53

      GroupSize: Unknown

      GroupNumberMales: Unknown

      GroupNumberFemales: Unknown

      GroupEthnicity: Unknown

      GroupAgeRange: Unknown

      DiseaseAssertion: VHL

      GroupInfo: Kindred no. 82 describes a family where at least one member (unspecified how many) had this mutation in the VHL gene. Pheochromocytoma was not observed in this kindred indicating VHL disease type 1.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: N/A

      GroupNotHPOs: HP:0002666 (Pheochromocytoma)

      GroupNotHPOFreeText: Pheochromocytoma was not observed in this kindred indicating VHL disease type 1.

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y185* (c.555C>G)

      LegacyVariant: p.Y256* (c.768C>G)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223233, https://www.ncbi.nlm.nih.gov/clinvar/variation/223233/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: Y185* (c.555C>G)

      MultipleGeneVariants: N/A

    1. healthy

      PatientID: III-5

      KindredID: 1

      Case: M, Age Unknown, Chinese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: In the patient’s 12 member Chinese family, 7 members were found to carry the NM_000551.3:c.114delC mutation. Five had manifestations of CNS hemangioblastoma, and three of the five were deceased. The other member found to carry the mutation were asymptomatic, although the paper states that this is likely due to their young age.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: The paper states that the patient is young, but no specific age is given.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G39Afs*28(c.114delC)

      LegacyVariant: p.G39Afs*28(c.327delC)

      ClinVarID: N/A

      CAID: CA2573047816, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA2573047816

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: G39Afs(c.114delC)

      MultipleGeneVariants: N/A

    1. PatientID: V36

      KindredID: V36

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    2. PatientID: V67

      KindredID: V67

      Case: Sex Unknown, Age Unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Diagnosed with VHL Type 1.

      CaseNotHPOs: HP:0002666 (Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 32179488

      SupplementalData: N/A

      Variant: p.F76del (c.227_229del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA357012, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.227_229del

      gnomAD: N/A

      VariantEvidence: Variant reported as c.226_228del and was mapped to c.227_229del.

      MutationType: inframe_deletion; deletion

      CivicName: F76del (c.227_229del)

      MultipleGeneVariants: N/A

    1. Medical files and histopathology reports of patients who had been operated on before were also reviewed.

      PatientID: III-20

      KindredID: 1

      Case: M, 60Y0M, Iranian

      DiseaseAssertion: assumed VHL

      FamilyInfo: Familial history was positive. See Fig 1. A total of 43 members of the kindred, 24 males and 19 females, aged 2-77 years were reached for evaluation. It is stated in the paper that all affected subjects (13) were positive for the same mutation (c.500G>A). Additionally, gene sequencing revealed that 4 asymptomatic members of the kindred also harbored the pathogenic mutation. Phenotypes include pheochromocytoma, hemangioblastoma, and retinal HB.

      CasePresentingHPOs: HP:0006880; HP:0009711; HP:0002666 (cerebellar hemangioblastoma, retinal capillary hemangioma, pheochromocytoma)

      CaseHPOFreeText: Cerebellar tumor, unilateral PCC, and multiple metastases diagnosed at 55Y. Ophthalmologic evaluation at 60Y also revealed a retinal HB. Currently his status follows as slurred speech, gait disturbance - bedridden, and an intra-cranial shunt. Brain MRI revealed multiple heterogeneous enhancing masses with differing diameters (10-43mm), denoting multiple metastases.

      CaseNotHPOs: HP:0000077 (abnormality of the kidney)

      CaseNotHPOFreeText: There was no case of kidney tumors among the kindred.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: V1MO

      Case: Age unknown, sex unknown, Italian

      DiseaseAssertion: assumed VHL

      FamilyInfo: 2 patients belonging to family V1MO. Other member was recorded with a retinal and CNS hemangioblastoma. Specific familial relationship is unknown.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584; HP:0002666; HP:0009711 (renal cell carcinoma, pheochromocytoma, retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R113* (c.337C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: 550 (113) C>T (stop codon)

      ClinVarID: 220414 https://www.ncbi.nlm.nih.gov/clinvar/variation/220414/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R113* (c.337C>T)

      MultipleGeneVariants: N/A

    1. Case 1A 51-year-old woman was diagnosed with VHLD (C.500G > A, p.Arg167Gln) in 2007 with hemangioblastomas in the spinal cord (T6-T7) and the cerebellum, renal cell carcinoma, pancreatic neoplasm and left ovarian dermoid cyst. She had an episode of vision loss involving the left eye in early 1993 which evolved over a week and recovered over 4–5 months. MRI scan of the brain showed several white matter lesions. She was neurologically asymptomatic until 2010 when she developed left lower extremity weakness and paresthesia following a left partial nephrectomy which resolved over a few months except for subtle weakness of the left hip. She had a repeat episode accompanied by word finding difficulties and increased urinary frequency in 2011. MRI in 2010 and 2011 showed a small hemangioblastoma in the left cerebellum, a T2 hyperintensity in the left C6-C7 cervical cord with no contrast enhancement, and a 4-mm enhancing nodule in T6-T7 consistent with a hemangioblastoma with mild cord edema (Fig. 1, first row). She had mild residual weakness in the left hip and knee flexor muscles.Fig. 1Serial MRI performed in 2010 (row 1), 2016 (row 2), and 2021 (row 3) showing stable cerebellar hemangioblastoma (panel C) and increasing burden of T2 FLAIR hyperintense lesions disseminating in time and space. STIR-weighted image of the spinal cord showing an enhancing lesion in the cervical cord (panel D). Row 4 depicts contrast enhanced T1 sequence of 2021 MRIFull size imageIn 2012, the limb weakness worsened in a waxing and waning pattern with frequent falls and difficulty climbing stairs. She also had decreased vision from the left eye for 2 months, but eye evaluation and visual evoked potentials were normal. Somatosensory evoked potentials showed prolongation of the cortical potential following stimulation of the left posterior tibial nerve suggesting a lesion below C5. Her symptoms spontaneously improved. A diagnosis of MS was raised.MRI of the brain and spine in January 2016 showed multifocal areas of high signal intensity in the periventricular white matter of both hemispheres. Non-enhancing lesions were also present in the dorsal spinal cord at C2 and C6–7. The hemangioblastoma in the T6-T7 region remained unchanged (Fig. 1, second row). Evaluation showed worsening of left leg weakness with more frequent falls, increased blurry vision in the left eye and declining memory and concentration.In October 2018, the patient developed increased weakness and burning in both legs, fatigue, and worsened bowel and bladder function. Treatment with corticosteroids showed partial response of symptoms. In February 2020, a new non-enhancing lesion was found in the left frontal lobe on MR. In July, she had decreasing vision in her left eye with color desaturation and pain with eye movement suggestive of optic neuritis which improved after a course of high dose corticosteroids. By October 2020, the patient reported worsening urinary urgency, increased fatigue, and dragging of the left leg and foot. Copaxone was initiated for treating MS. Most recent MRI in February 2021 showed stability of known white matter lesions with no adverse events to date (Fig. 1, third row).

      PatientID: 1

      KindredID: 1

      Case: F, 51Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Patient’s 36Y0M daughter also carried the same VHL mutation and had relapsing-remitting multiple sclerosis (MS) in the background of VHL disease. She had retinal and cerebellar hemangioblastomas, pheochromocytoma, pancreatic neuroendocrine tumor, and recurrent renal cell carcinoma. She exhibited numbness in her limbs and developed vision loss. Their family history was significant for multiple cancers in prior generations. Her three grandsons were also affected by VHL disease, but no mention of genetic testing in these individuals. (see Fig.2 for Pedigree).

      CasePresentingHPOs: HP:0009713; HP:0006880; HP:0005584; HP:0025247; HP:0000572; HP:0001732 (Spinal hemangioblastoma; Cerebellar hemangioblastoma; Renal Cell Carcinoma; Dermoid cyst, vision loss; abnormality of the pancreas)

      CaseHPOFreeText: Patient was diagnosed with hemangioblastomas in the spinal cord and cerebellum, renal cell carcinoma, pancreatic neoplasm and a left ovarian dermoid cyst. She also exhibited vision loss in 1993 that recovered after 4-5 months. She was neurologically asymptomatic until 2010 but started developing left lower extremity muscle weak, which was partially resolved by a nephrectomy. The limb weakness worsened in 2012 and decreased vision for 2 months, which raised a diagnosis of MS. Since then, treatment with corticosteroids showed partial response of symptoms and Copaxone was then initiated for treating MS.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. 2. Case reportWe report the case of a 13-year-old boy known to be a carrier of the VHL mutation in exon3-codon 170 GTC->GGC with a p.Val170Gly substitution, part of type 2C VHL disease.The boy's father was the index case and had the same mutation with an exclusive expression of the disease in the adrenal gland. The father had been operated on for a bilateral pheochromocytoma at 12 years of age. Genetic screening of the patient at 7 years of age revealed the same mutation as his father without any expression of the disease at diagnosis.An annual endocrinological follow-up was organised after the diagnosis with clinical examination looking for clinical signs of pheochromocytoma such as sweating, headache, or palpitations; blood pressure was measured and an annual urinary metanephrine assay was performed using high-performance liquid chromatography (HPLC).All of these parameters were normal at each follow-up visit, including the last one at the age of 12 (blood pressure at 115/58 mmHg). At this time, urinary normetanephrine was measured with HPLC at 15 μmol/mol of creatinine (normal laboratory value for his age is between 1 and 171 μmol/mol of creatinine) and urinary metanephrine was measured at 11 μmol/mol of creatinine (normal laboratory value for his age is between 1 and 117 μmol/mol of creatinine).Four months after the last endocrinological follow-up visit, the patient was referred by his parents to the emergency department of a peripheral hospital for an alteration in his general condition, including polyuria, headache, flushes, and abnormal perspiration. These symptoms appeared 1 week before consultation. High blood pressure was recorded at the emergency department at 198/123 mmHg. In this context, a urinary metanephrine assay was performed and showed an elevation of normetanephrine at 4414 μmol/mol of creatinine. Abdominal ultrasonography (US) revealed a right-sided adrenal gland tumour with a diameter of 30 mm; the contralateral adrenal gland was normal. The patient was transferred to the pediatric intensive care unit at our tertiary centre after hemodynamic stabilisation for specialised medical and surgical management. Initial medical treatment was based on continuous monitoring of vital signs and medical treatment of high blood pressure with antihypertensive bitherapy combining an α- and β-blocker (labetalol) with a calcium antagonist (nicardipine).Magnetic resonance imaging (MRI) was performed and confirmed the diagnosis of right-sided adrenal gland tumour compatible with a pheochromocytoma (Fig. 1a and b) of 30-mm diameter, located in the suprarenal area, behind the inferior vena cava, in contact with the right diaphragmatic crus. The left adrenal gland was normal.Download : Download high-res image (110KB)Download : Download full-size imageFig. 1. Magnetic resonance imaging (MRI) transversal (a) and coronal sections (b) showing a right-sided adrenal gland tumour (yellow arrow).Right laparoscopic adrenalectomy under general anesthesia was performed after hemodynamic stabilisation by medical treatment. Dissection (Fig. 2) was made to isolate the adrenal mass from the right edge of the inferior vena cava. The mass was well limited, round, and essentially located behind the inferior vena cava. The main adrenal vein was clamped. The tumour could be resected in one piece and extracted through the umbilical incision. During surgery, there were variations in pressure, with hypertensive peaks during tumour mobilisation and hypotension requiring intravenous saline infusion and intravenous injection of noradrenaline after the control of the main adrenal vein.Download : Download high-res image (130KB)Download : Download full-size imageFig. 2. Laparoscopic view of the right adrenal tumour (red arrow) on the right side of the inferior vena cava (blue arrow).The tumour was 4 cm in diameter, adjacent to the macroscopically normal adrenal gland.Pathological study showed a classic pheochromocytoma with tumour cells presenting a characteristic pattern with well-defined nests “zellballen” bound by a delicate fibrovascular stroma (Fig. 3A and B), with healthy surgical margins and an adjacent normal adrenal gland. The tumour cells expressed synaptophysin and CD56 (Fig. 3C and D) and the sustentacular cells forming a peripheral coat around the “zellballen” were strongly reactive to S-100 protein (Fig. 3E).Download : Download high-res image (883KB)Download : Download full-size imageFig. 3. Pathological analysis of the tumour. A. H&E, ×10; B. H&E, ×20; C. Chromogranin, ×10; D. CD56, ×10; E. PS100, ×40.After surgery, the patient was hospitalised for 2 days in the intensive care unit and was gradually weaned off the amines before being transferred to the conventional pediatric surgery ward for an additional 4 days.Medium-term postoperative surveillance is based on clinical examination and bi-annual abdominal US with abdominal MRI and urinary metanephrine assay once a year for the next 3 years after surgery. Subsequent follow-up will be annual with clinical examination, determination of urinary methoxyl derivatives, and abdominal US or MRI. At the last follow-up 2 years after surgery, the patient's blood pressure was in the normal range at 95/65 mmHg and there was no clinical, laboratory, or radiological sign of recurrence or second localisation.

      PatientID: N/A (son)

      KindredID: 1

      Case: M, 15Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Father of the patient (index case) had the same mutation. Father had a bilateral pheochromocytoma, which was operated on at 12Y0M.

      CasePresentingHPOs: HP:0006748 (Adrenal Pheochromocytoma)

      CaseHPOFreeText: Following molecular diagnosis at 7Y0M, annual follow ups were performed on the patient, which appeared normal. At 13-years-old the patient was rushed to the hospital due to polyuria, headache, flushes, and abnormal perspiration. Abdominal ultrasonography revealed an adrenal gland tumor. His vitals were monitored and high blood pressure was treated with antihypertensive bitherapy combining an α- and β-blocker (labetalol) with a calcium antagonist (nicardipine). An MRI confirmed that the adrenal gland tumour was compatible with a pheochromocytoma. Adrenalectomy was performed, followed by slowly weaning the patient of the medications. At the last follow up 2 years after surgery, there has been no recurrence.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170G (c.509T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756196, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.509T%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: V170G (c.509T>G)

      MultipleGeneVariants: N/A

    1. inherited familial

      PatientID: N/A

      KindredID: 1

      Case: M, 55Y0M, Italian

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Genetic analysis was performed since his 45Y0M sister was found to carry a missense variant in VHL. This patient carries the same variant. CasePresentingHPOs: N/A

      CaseHPOFreeText: 55Y0M male is the brother of a patient with right adrenal pheochromocytoma and multiple pancreatic neuroendocrine tumors. He has the same mutation as his sister. CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.T157I (c.470C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223223, https://www.ncbi.nlm.nih.gov/clinvar/variation/223223/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense variant; transition

      CivicName: T157I (c.470C>T)

      MultipleGeneVariants: N/A

    1. PMID: 20567917

      PatientID: 4

      KindredID: 4

      Case: F, 24Y0M, Brazilian

      DiseaseAssertion: VHL

      FamilyInfo: familial VHL type 1 disease from the paternal germline. Proband and father show the splice-site mutation. No clinical assessment or genetic testing has been undertaken in other at-risk relatives and siblings yet.

      CasePresentingHPOs: HP:0010797; HP:0000107; HP:0001737 (hemangioblastoma; renal cysts; pancreatic cysts)

      CaseHPOFreeText: hemangioblastoma diagnosed at 23Y and renal and pancreatic cysts at 24Y

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: c.341-1G>A

      LegacyVariant: IVS1-1G>A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 823743 https://www.ncbi.nlm.nih.gov/clinvar/variation/823743/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: Splice_site_variant

      CivicName: Splice Site (c.341-1G>A)

      MultipleGeneVariants: N/A

    1. 26a5Mc.509T>G3Missensep.Val170 Gly29P, muSynchronous

      PatientID: 26

      KindredID: 5

      Case: M, 29Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: 2 members of this family, IDs #26 (29Y, M) and #27 (12Y, F) presented with the same variant and pheochromocytoma.

      CohortInfo: Thirty-one subjects were included in this study consisting of 16 SDHB mutation carriers and 15 subjects with VHL disease followed-up between 1975 and 2008. Subjects were included in the study if they had complete imaging from the base of the skull to the pelvis and measurements of urinary or plasma catecholamines. The case-notes and hospital databases were examined for the required data, which included: age at first symptom/diagnosis, family history, disease penetrance, site and size of tumor, symptoms, secretion of catecholamines, multifocal disease, metastatic disease, treatment and disease outcome.

      CasePresentingHPOs: HP:0002666 (Pheochromocytoma)

      CaseHPOFreeText: Synchronous multifocal pheochromocytoma. 29Y at VHL diagnosis.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170G (c.509T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756196, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA351756196

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V170G (c.509T>G)

      MultipleGeneVariants: N/A

    1. HGB-51 B Germline Exons 1–2 regions 1–2 4kb gene deletion Partial gene deletion Known NA NA  

      PatientID: HGB-51

      KindredID: 2

      Case: Sex Unknown, 19Y0M, Italian

      DiseaseAssertion: VHL

      FamilyInfo: Positive VHL family history.

      CohortInfo: The patient cohort consisted of 57 patients (26 male and 31 female) from Southern Italy, most of whom (55 of 57) presented with solitary HGB of the CNS: 6 were syndromic and 51 were apparently sporadic.

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: The patient had a single cerebellar hemangioblastoma at age 17.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Partial deletion of 4 Kb

      LegacyVariant: N/A

      CaseProblemVariantFreeText: The deletion was not specified. Was only mentioned to occur in the exon 1-2 region.

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: deletion

      CivicName: Partial deletion of 4 Kb

      MultipleGeneVariants: N/A

    1. VHL (p.Arg64Pro)

      GroupID: None

      DiseaseAssertion: VHL

      GroupSize: Unknown

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: Two retrospective series of 175 phaeochromocytomas and paragangliomas with known germline mutation status for phaeochromocytoma-susceptibility or paraganglioma-susceptibility genes were investigated. Additionally, a prospective series of 45 phaeochromocytomas and paragangliomas was investigated for SDHB immunostaining followed by SDHB, SDHC, and SDHD mutation testing.

      GroupPresentingHPOs: HP:0002666, HP:0002668 (pheochromocytoma, paraganglioma)

      GroupHPOFreeText: N/A

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: SDHB/SDHC/SDHD/RET

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R64P (c.191G>C)

      ClinVarID: 2226 https://www.ncbi.nlm.nih.gov/clinvar/variation/2226/

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R64P(c.191G>C)

      MultipleGeneVariants: N/A

    1. IV - 11

      PatientID: IV:11

      KindredID: 1

      Case: M, 24Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: A 5-generation family with VHL in 15 members. Both second generation children (presumed), 5 third generation, and 8 further generation individuals were affected and haplotyping was conducted using three polymorphic microsatellite markers. All of the 5th generation children (9 total at time of publication) had been sequenced and haplotyped as unaffected.

      CasePresentingHPOs: HP:0002666 (pheochromocytoma)

      CaseHPOFreeText: patient had bilateral pheochromocytoma. Age of onset was 24Y, and surgery (operation) was the same year

      CaseNotHPOs: HP:0006880; HP:0000107; HP:0030405; HP:0001737; HP:0002668 (cerebellar hemangioblastoma, renal cysts, pancreatic endocrine tumor, pancreatic cysts, paraganglioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T?dataset=gnomad_r2_1

      VariantEvidence: genotyped three polymorphic microsatellite markers that flanked VHL on chromosome 3p25 (D3S3691, D3S1597 and D3S1263). 

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. VHL kindreds for germline mutations and calculated the age related tumour risks for different classes of VHL gene mutations.

      PatientID: None

      KindredID: 139

      Case: Age, sex ethnicity unknown

      DiseaseAssertion: unknown; paper focused only on pheochromocytoma

      FamilyInfo: No specific family info was present; although this was recorded as a family germline mutation belonging to Family ID 139

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Unknown

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: No presence of phaeochromocytoma in family

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.340+5G>C

      CaseProblemVariantFreeText: N/A

      LegacyVariant: (c.553+5G>C)

      ClinVarID: 36901 https://www.ncbi.nlm.nih.gov/clinvar/variation/36901/

      CAID: N/A

      gnomAD: 0.01119 https://gnomad.broadinstitute.org/variant/3-10183876-G-C

      VariantEvidence: This large allele frequency means this is likely non disease causing (not deleterious)

      MutationType: splice_site_variant

      CivicName: Splice Region (c.340+5G>C)

      MultipleGeneVariants: N/A

    1. 34EP 1.0PPGL-glomus caroticum-VHL({"type":"entrez-nucleotide","attrs":{"text":"NM_000551.4","term_id":"1779521775","term_text":"NM_000551.4"}}NM_000551.4):c.123_137dupAGAGTCCGGCCCGGA (p.Ser43_Glu47dup) = {"type":"entrez-nucleotide","attrs":{"text":"NM_000551.3","term_id":"319655736","term_text":"NM_000551.3"}}NM_000551.3(VHL):c.123_137dup (p.38_42SGPEE [3])

      PatientID: 34

      KindredID: 2

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: PGL

      FamilyInfo: Genetic testing of the index patient’s parents showed the absence of this variant suggesting that it occurred de novo in this case.

      CasePresentingHPOs: HP:0100635 (Carotid paraganglioma)

      CaseHPOFreeText: patient with carotid body paraganglioma (PGL-glomus caroticum), which was stated that it would have been missed or delayed significantly if the routine protocol had been applied.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MAX, NF1, RET, SDHA, SDHB, SDHC, SDHD, TMEM127

      PreviouslyPublished: N/A

      SupplementalData: Yes

      Variant: p.S43_E47dup (c.123_137dup)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: c.123_137dupAGAGTCCGGCCCGGA (p.Ser43_Glu47dup). NM_000551.4(VHL):c.123_137dup (p.38SGPEE)

      ClinVarID: 456571 https://www.ncbi.nlm.nih.gov/clinvar/variation/456571

      CAID: N/A

      gnomAD: 0.00001998 https://gnomad.broadinstitute.org/variant/3-10183639-G-GGAGTCCGGCCCGGAA

      VariantEvidence: Described by authors as a variant of uncertain significance.

      MutationType: inframe_insertion; duplication

      CivicName: S43_E47dup (c.123_137dup)

      MultipleGeneVariants: N/A

    1. PatientID: H51

      KindredID: 2

      Case: F, 14Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: No definite family history of VHL disease or hemangioblastoma brain tumors.

      CohortInfo: Eleven patients with sporadic hemangioblastoma were enrolled and diagnosed with a neurological examination. Four of these were found to have a germline mutation of the VHL gene.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: Tumor location: 4th ventricle, lateral medulla. Patient underwent total excision of the tumor and fully recovered but had symptomatic recurrence after 1 year.

      CaseNotHPOs: HP:0009711; HP:0002012 (Retinal capillary hemangioma, Abnormality of the abdominal organs)

      CaseNotHPOFreeText: Negative ophthalmoscopic examinations for hemangioblastoma, and unremarkable abdominal ultrasounds and computed tomographic imaging.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table 1.

      Variant: p.R113* (c.337C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 220414, https://www.ncbi.nlm.nih.gov/clinvar/variation/220414/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained; missense_variant;transition

      CivicName: R113* (c.337C>T)

      MultipleGeneVariants: N/A

    1. nt 557 A/G 115 His→Arg H115R Missense 2

      GroupID: 19

      DiseaseAssertion: hemangioblastoma

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: 2 out of the 81 patients listed in this hemangioblastoma cohort were found with this c.344A>G mutation. Any relation is unknown.

      GroupPresentingHPOs: HP:0010797 (hemangioblastoma)

      GroupHPOFreeText: both patients had hemangioblastoma of the CNS; other phenotypes are unknown. One patent was said to be found with a primary asymptomatic tumor.

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: H115R (c.344A>G)

      LegacyVariant: H115R (c.557A>G)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 664415 https://www.ncbi.nlm.nih.gov/clinvar/variation/664415/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: H115R (c.344A>G)

      MultipleGeneVariants: N/A

    1. Patient 36, a 28 year old male, was referred to the local hospital due to hypertension, headache and multiple episodes of syncope. Urinary norepinephrine was elevated, 1752 nmol/24 h (<350), but epinephrine was within reference margins 37 nmol/24 h (<90). A computed tomography revealed an abdominal mass located in close proximity to the left renal artery and vein. The lesion was surgically resected and the pathology report showed a PGL, 20 mm in size with a Ki67 index of <1%. Genetic screening of RET as well as Succinate Dehydrogenase subunits B and D was normal. The proband remains free of recurrence 21 months following the initial diagnosis. There were no apparent signs or symptoms of von Hippel Lindau syndrome. Sanger sequencing revealed a single nucleotide polymorphism in VHL; c.548C>T, p.Ser183Leu. Multiplex ligation-dependent probe amplification of constitutional DNA did not show any pathological imbalances. In tumour tissue, loss of heterozogosity and copy number loss was observed on the whole arm of chromosome 3p by Omni-1-quad SNP array (Illumina, CA, USA).VHL; c.548C>T, p.Ser183Leu has been classified as pathogenic in a functional model but the individual contribution of the allele to patient phenotype is not fully described [37]. Screening of 190 healthy individuals revealed homozygous C allele in all cases. Codon 183 is conserved among mammalian orthologs and in silico analysis determined the variant as probably pathogenic: SIFT (0,18) and Polyphen2 (1,0).

      PatientID: 36

      KindredID: 3

      Case: M, 29Y0M, Ethnicity Unknown

      DiseaseAssertion: N/A

      FamilyInfo: noted as not hereditary but no family information is provided.

      CasePresentingHPOs: HP:0002668; HP:0000822; HP:0002315; HP:0001279 (Paraganglioma, Hypertension, Headache, Syncope)

      CaseHPOFreeText: Single thoracoabdominal paraganglioma (20mm) diagnosed at 28Y. Referred to the local hospital due to hypertension, headache and multiple episodes of syncope. The lesion was surgically resected and the pathology report showed a paraganglioma. The proband remains free of recurrence 21 months following the initial diagnosis. There were no apparent signs or symptoms of von Hippel Lindau syndrome.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: SDHB (NM_003000.2), SDHC (NM_003001.3), SDHD (NM_003002.2), SDHAF2 (NM_017841.2), RET (exons 10–11 and 13–16, NM_020975.4), TMEM127 (NM_017849.3), MAX (NM_002382.3).

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S183L (c.548C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 411985, https://www.ncbi.nlm.nih.gov/clinvar/variation/411985/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Multiplex ligation-dependent probe amplification of constitutional DNA did not show any pathological imbalances. In tumour tissue, loss of heterozogosity and copy number loss was observed on the whole arm of chromosome 3p.

      MutationType: missense_variant;transition

      CivicName: S183L (c.548C>T)

      MultipleGeneVariants: N/A

    1. Arg167Gln VHL mutation (data not shown)

      PatientID: None

      KindredID: 1

      Case: F, 32Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666, HP:0005584, HP:0030405, HP:0006748 (Pheochromocytoma, Renal cell carcinoma, Pancreatic endocrine tumour, Adrenal pheochromocytoma)

      CaseHPOFreeText: A CT study of the patient's abdomen and pelvis revealed a right adrenal mass, multiple bilateral kidney masses suspicious for renal cell carcinoma, a left adrenal nodule, and multiple pancreatic tumors.The patient underwent resection of a right adrenal pheochromocytoma and a lymph nodule with pheochromocytoma metastasis. A CT scan 5 days later revealed a metastatic pelvic pheochromocytoma. CT-guided biopsies also confirmed a well-differentiated pancreatic endocrine neoplasm. Kidney tumors were not biopsied. Taken together, the patient was diagnosed with VHL type 2B.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Nucleotide change is not specified in the paper, only protein coding change is. cDNA variant was inferred based on protein coding change, and reported based on VHL reference sequence NM_000551.3.

      ClinVarID: 2216, https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/3-10191507-G-A?dataset=gnomad_r2_1

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. AD 10 17 M ? - ? ? - - - c.340 ? 1 G[A, (340 ? 5 G[C) p.G114D b

      PatientID: 10

      KindredID: AD

      Case: M, 17Y0M, Indian

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0009711; HP:0010797 (Retinal capillary hemangioma, Hemangioblastoma)

      CaseHPOFreeText: CNS hemangioblastoma and retinal angioma.

      CaseNotHPOs: HP:0001737; HP:0005584; HP:0002666; HP:0030393 (Pancreatic cysts, Renal cell carcinoma, Pheochromocytoma, Endolymphatic sac tumor)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.340+5G>C

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 36901, https://www.ncbi.nlm.nih.gov/clinvar/variation/36901/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant; missense_variant;transversion

      CivicName: G114D (c.340+1G>A) and c.340+5G>C

      MultipleGeneVariants: Germline, VHL, p.G114D (c.340+1G>A)

    2. AD 14 50 F ? ? ? - ? - - c.340 ? 1 G[A, (340 ? 5 G[C) p.G114D b

      PatientID: 14

      KindredID: AD

      Case: F, 50Y0M, Indian

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0001737; HP:0005584 (Hemangioblastoma, Pancreatic cysts, Renal cell carcinoma)

      CaseHPOFreeText: Multi-cystic pancreatic lesions, RCC and CNS hemangioblastoma.

      CaseNotHPOs: HP:0009711; HP:0002666; HP:0030393 (Retinal capillary hemangioma, Pheochromocytoma, Endolymphatic sac tumor)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: c.340+5G>C

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 36901, https://www.ncbi.nlm.nih.gov/clinvar/variation/36901/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant; missense_variant;transversion

      CivicName: G114D (c.340+1G>A) and c.340+5G>C

      MultipleGeneVariants: Germline, VHL, p.G114D (c.340+1G>A)

    1. Because of the hemizygous deletion of the VHL gene at chromosome 3p25.3, the patient is at risk for von Hippel-Lindau (VHL) syndrome, predisposing to retinal, cerebellar, spinal haemangioblastomas, renal cell carcinoma, phaeochromocytoma and pancreatic tumors. Therefore, for early detection and treatment of VHL syndrome, we performed periodic screening beginning at age 5 years.

      PatientID: 1

      KindredID: 1

      Case: F, 9Y0M, Ethnicity Unknown

      DiseaseAssertion: asymptomatic (for VHL)

      FamilyInfo: familial rearrangement at t(3;8) (p25;q24) was observed in a three generation family: mother, maternal grandmother and brother (diagnosed prenatally). This was a balanced translocation. The uncle likely did too. 11 other individuals (niece, 2 nephews, and 7 miscarriages) likely had an unbalanced translocation - the three children born died within the first 6 months.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Presenting at 17 months old with severe motor and mental retardation, microcephaly, capillary hemangiomas of the forehead and perioral region, synophrys, ptosis, long philtrum, high arched palate, micrognathia, malformed ears, clinodactyly and hypotonia. The young girl began periodic screening beginning at age 5 years for early detection and treatment of VHL. No VHL-specific phenotypes were yet described.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Complete Deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: hemizygous VHL gene deletion at chromosome 3p25.3. Patient also had monosomy 3pter-p25 and trisomy 8q24-qter. At 8q24, located distal of TRPS1, was the breakpoint of the gene for trichorhinophalangeal syndrome. Note: the paper states that the deletion “possibly” removed the VHL gene - this is not fully confirmed though.

      MutationType: deletion

      CivicName: Deletion

      MultipleGeneVariants: N/A

    1. PatientID: 10

      KindredID: 10

      Case: F, 19Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient had a family member (patient 9) who had the same VHL mutation.

      CohortInfo: Thirteen patients with a supratentorial hemangioblastoma.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: The patient had a supratentorial hemangioblastoma (left perimesencephalic cistern) and tonicoclonic seizure at age 14. The patient had another supratentorial hemangioblastoma (left-frontal parasagittal region) at age 16.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161Q (c.482G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182983 https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R161Q (c.482G>A)

      MultipleGeneVariants: N/A

    1. PatientID: II-3

      KindredID: 1

      Case: M, Age Unknown (deceased), Middle Eastern

      DiseaseAssertion: VHL

      FamilyInfo: Multigenerational Kuwaiti family with Arabian and Persian genetic admixture. Thirteen members of the family had been clinically diagnosed as having VHL. Patient 1-I had 6 children, 5 of which were found with VHL and the p.W117C mutation. 7/20 of her grandchildren also found to have VHL and the same mutation.

      CasePresentingHPOs: HP:0010797; HP:0006770 (hemangioblastoma; clear cell renal cell carcinoma)

      CaseHPOFreeText: Member had clear cell renal carcinomas that were the main cause of mortality, in addition to hemangioblastomas

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: Lacked evidence of any pheos.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.W117C (c.351G>T)

      LegacyVariant: p.Trp117Cys (c.564G>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 167827 https://www.ncbi.nlm.nih.gov/clinvar/variation/167827/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: W117C (c.351G>T)

      MultipleGeneVariants: N/A

    1. 350FExon 3c.501 A > T1 juxtapapillaryExudation--No changesMuch less exudation

      PatientID: 3

      KindredID: 3

      Case: F, 50Y0M, Spanish

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: 7 VHL patients, from different regions of Spain, affected from juxtapapillary or peripheral haemangioblastomas were administered 120 mg propranolol daily.

      CasePresentingHPOs: HP:0009711 (Retinal capillary hemangioma)

      CaseHPOFreeText: The patient presented with a juxtapapillary retinal tumor with exudation in her left eye at the age of 50. She exited the trial 12 months later with no changes to the tumor size and with much less exudation after the administration of propranolol.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Information obtained from Table 2.

      Variant: c.501A>T

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Amino acid does not coincide with position, declared by the authors. Variant c.501A>T could be translated to c.501G>T or c.502A>T. Needs to be confirmed with the authors.

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant

      CivicName: N/A

      MultipleGeneVariants: N/A

    1. P17F10F18028nyOU20/250nn20/25nnn

      PatientID: 17

      KindredID: 10

      Case: F, 43Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: No family information was provided.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: Patient has VHL disease characterized by tumours, but specific types of tumours were not indicated.

      CaseNotHPOs: HP:0010797; HP:0009711 (hemangioblastoma; Retinal capillary hemangioma)

      CaseNotHPOFreeText: Patient did not have CNS hemangioblastoma or Retinal capillary hemangiomas.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y175C (c.524A>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 36905, https://www.ncbi.nlm.nih.gov/clinvar/variation/36905/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: Y175C (c.524A>G)

      MultipleGeneVariants: N/A

    1. PatientID: Carrier 9 (aunt to proband 6)

      KindredID: 2

      Case: F, Age Unknown, Chinese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: Mother, aunt and aunt’s cousin (all relative to proband 6) had this variant. Mother and proband presented with unilateral pheochromocytoma and aunt and aunt’s cousin were asymptomatic. Proband also presented with a renal cyst and hypertension.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.H125P (c.374A>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223201, https://www.ncbi.nlm.nih.gov/clinvar/variation/223201/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: H125P (c.374A>C)

      MultipleGeneVariants: N/A

    1. This English kindred (figure 1) was identified when family member IV:2 was referred for genetic counseling because of a single retinal hemangioma. A CT scan of her abdomen and pelvis identified a small cyst of <1cm on the right kidney.

      PatientID: IV:2

      KindredID: 1

      Case: F, 44, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: The patient had two siblings both of whom carried the P25L mutation but were asymptomatic (IV:4 and IV:6). Her cousin (IV:7) was diagnosed at the age of 47 years with renal cell carcinoma and subsequently died at the age of 48 years. Her great grandmother (I:2) had died of a brain tumor in her late 50s. Her grandfather (II:3) had a brain tumor at the age of 53 years and died aged 78 years. As well, her grandfather's sister (II,1) reportedly died of stomach cancer in her 80s. Of the 13 family members tested, V:2, IV:4, IV:6, III:2, III:3, and III:11 were all found to carry the P25L mutation in the VHL gene. Refer to Figure 1 for pedigree.

      CasePresentingHPOs: HP:0009711, HP:0000107 (retinal capillary hemangioma, renal cyst)

      CaseHPOFreeText: She was referred for a single retinal hemangioma. A CT scan of her abdomen and pelvis identified a small cyst of <1cm on the right kidney. This CT scan was repeated 2 years later, which revealed that the cyst was unchanged and the remainder of the scan was unremarkable.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.P25L (c.74C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 93330 https://www.ncbi.nlm.nih.gov/clinvar/variation/93330/

      CAID: N/A

      gnomAD: 0.002988 https://gnomad.broadinstitute.org/variant/3-10183605-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName:P25L (c.74C>T)

      MultipleGeneVariants: N/A

    1. three familial cases

      PatientID: 1

      KindredID: C

      Case: F, Age Unknown, Japanese

      DiseaseAssertion: Assumed VHL

      FamilyInfo: This mutation was found in a family of 10 individuals; six were found to carry the mutation NM_000551.3:c.464-1G>T the patient carried, and three presented with symptoms. They were identified with hemangioblastomas of the central nervous system and retinal angiomas.

      CasePresentingHPOs: HP:0010797; HP:0011513; HP:0005584 (CNS hemangioblastoma, retinal angioma, renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: (c.464-1G>T)

      LegacyVariant: (c.677-1G>T)

      ClinVarID: 223221, http://www.ncbi.nlm.nih.gov/clinvar/variation/223221

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: SpliceSite(c.464-1G>T)

      MultipleGeneVariants: N/A

    1. PatientID: 65

      KindredID: N/A

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: The authors evaluated 64 VHL patients (32 women and 32 men) with renal involvement of whom 54/64 had undergone renal surgery or a radiofrequency thermal ablation procedure for RCC. In 10/64 VHL patients, at least one or more RCC were diagnosed, however at the time of diagnosis an indication for treatment was not yet present. For all patients several CT/MRI scans existed for retrospective description of tumour growth kinetics.

      CasePresentingHPOs: HP:0005584 (Renal cell carcinoma)

      CaseHPOFreeText: This is a tumor resolution study (VHL patients were investigated based on the presence of renal tumors.) No other phenotypic information is available.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1 describes 19 patients with missense mutations, including this patient.

      Variant: p.S80I(c.239G>T)

      LegacyVariant: c.452G>T

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625229, https://www.ncbi.nlm.nih.gov/clinvar/variation/625229/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: S80I(c.239G>T)

      MultipleGeneVariants: N/A

    1. B4 CHB 36 c.811C → T, R200W No 3 y 1 m Nil No testing 

      PatientID: B4

      KindredID: 4

      Case: Sex Unknown, 36Y0M, Ethnicity Unknown

      DiseaseAssertion: cerebellar hemangioblastoma

      FamilyInfo: No testing was done for family history

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: no other clinical features were found after the cerebellar hemangioblastoma during 3 years and 1 month follow-up

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R200W (c.598C>T)

      LegacyVariant: p.R200W (c.811C>T)

      ClinVarID: 2232 (https://www.ncbi.nlm.nih.gov/clinvar/variation/2232/)

      CAID: N/A

      gnomAD: 0.0002016 (https://gnomad.broadinstitute.org/variant/3-10191605-C-T)

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R200W(c.598C>T)

      MultipleGeneVariants: N/A

    1. PatientID: None

      KindredID: 21

      Case: M, 35Y0M, Spanish

      DiseaseAssertion: VHL

      FamilyInfo: No familial antecedents and no known familial tumors.

      CohortInfo: Probands belonging to 18 unrelated Spanish VHL families carrying germline VHL deletions.

      CasePresentingHPOs: HP:0006880; HP:0010797; HP:0009711 (Cerebellar hemangioblastoma, Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 1-3 Deletion (c.1-?_642+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Germline HSPC300, ENST197804, FANCD2 (unclear if partial or complete deletion) and IRAK2 deletion (unclear if partial or complete). Study provides evidence to show that loss of HSPC300 highly correlates with the absence of ccRCC in VHL patients.

      MutationType: exon_loss_variant

      CivicName: Exon 1-3 Deletion

      MultipleGeneVariants: Germline, HSPC300, Deletion MultipleGeneVariants: Germline, ENST197804, Deletion MultipleGeneVariants: Germline, FANCD2, Deletion MultipleGeneVariants: Germline, IRAK2, Deletion

    1. Arg167Gln

      GroupID: 10

      DiseaseAssertion: Neuroendocrine neoplasm (pheochromocytoma or paraganglioma)

      GroupSize: 2

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: Ethnicity unknown

      GroupAgeRange: N/A

      GroupInfo: This mutation (p.R167Q (c.500G>A)) was found in 2 patients with a family history and/or a syndromic presentation.

      GroupPresentingHPOs: HP:0100634 (Neuroendocrine neoplasm)

      GroupHPOFreeText: Patients with a pheochromocytoma or a functional paraganglioma were recruited from several different French clinical centers participating in several clinical research networks (Cortico et Medullosurrènale: les Tumeurs Endocrines, Paragan-Glioma Network, Groupe des Tumeurs Endocrines)

      GroupNotHPOs: N/A

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: RET, NF1, SDHB/SDHC/SDHD

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. We studied six patients with VHL disease and their relatives. Loss of heterozygosity (LOH) was determined by five flanking microsatellite polymorphic markers in the VHL locus.

      PatientID: 37

      KindredID: F01

      Case: F, Age Unknown, Taiwanese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: A total of 10 members of this family (F01) had a complete deletion of the VHL gene. Four of these patients (16, 18, 21, 33) presented with clinical features of VHL.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 19288063

      SupplementalData: Figure 1

      Variant: Complete Deletion

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Deletion of 142.9kb resulted in deletion of the VHL gene.

      MutationType: deletion

      CivicName: Deletion

      MultipleGeneVariants: N/A

    1. A 53-year-old man of Puerto-Rican origin presented to the endocrinology clinic after undergoing bilateral adrenalectomy for multifocal pheochromocytomas. He had a prior history of morbid obesity, obstructive sleep apnea, diabetes, and hypertension. He was followed by his primary care physician for persistent hematuria ranging from 3 to 35 red blood cells per high power field on urinalysis, as well as urinary frequency, weak stream, and nocturia three times per night for the previous three years. He had been unable to tolerate an empiric trial of tamsulosin for benign prostate hypertrophy due to orthostatic dizziness. Negative symptoms pertinent to this case include flushing, headaches, sweating, palpitations, anxiety, blurry vision, or dizziness. His family history was notable for death from a myocardial infarction in his father at the age of 57 and an unknown genitourinary cancer in his sister. There was no family history of adrenal tumors, hyperparathyroidism, medullary thyroid cancer, renal cancer, or pituitary tumors. The patient was a smoker with several past attempts at quitting.Due to the persistent hematuria, smoking, and the family history of cancer, a CT urogram was performed to screen for bladder cancer. While no abnormalities were seen within the urogenital tract, bilateral, irregular, heterogeneous large adrenal masses (Figure 1) measuring 4.7 cm (R) and 1.6 cm (L) were noted. In addition, a prominent and suspicious lymph node was identified. Biochemical characterization of the adrenal masses revealed significantly elevated 24-hour urine normetanephrine (1090 micrograms/gram of creatinine; normal range, 0–400 micrograms/gram of creatinine), leading to the diagnosis of pheochromocytoma. Urine metanephrine level was within normal range. Cushing's syndrome was ruled out with an undetectable late-night salivary cortisol level. Electrolyte levels, kidney function, and complete blood count were within normal limits. In search for additional, extra-adrenal foci, a metaiodobenzylguanidine (MIBG) scan was performed but was nondiagnostic due to lack of cardiac activity. Nevertheless, given the available imaging and biochemical findings, there was concern for malignant pheochromocytoma, and the patient ultimately underwent an open bilateral adrenalectomy and paracaval lymph node excision. Intraoperatively, the patient required vasopressor support and a large amount of crystalloid resuscitation (13 liters) to maintain hemodynamic stability. Intraoperative ultrasound was used to identify one mesenteric lymph node of mildly suspicious appearance which was resected, in addition to a large retroperitoneal paracaval lymph node.Open in a separate windowFigure 1CT scan of the abdomen showing the right adrenal tumor ((a), arrow) and the left adrenal tumor ((b), arrow) prior to adrenalectomy.Surgical pathology confirmed pheochromocytomas in the bilateral adrenal glands (right, 5.0 x 3.5 x 2.5 cm, and left, 1.5 x 1.3 x 1.0 cm) which were both confined to the adrenal glands. The paracaval lymph node was described as paraganglioma versus metastatic pheochromocytoma measuring 1.6 cm in the greatest dimension with no lymphoid tissue identified. The immediate postoperative course was unremarkable. The patient was started on life-long glucocorticoid and mineralocorticoid replacement. His diabetes and hypertension resolved.

      PatientID: None

      KindredID: 1

      Case: M, 53Y0M, Puerto-Rican

      DiseaseAssertion: VHL

      FamilyInfo: His family history was notable for death from a myocardial infarction in his father at the age of 57 and an unknown genitourinary cancer in his sister. There was no family history of adrenal tumors, hyperparathyroidism, medullary thyroid cancer, renal cancer, or pituitary tumors.

      CasePresentingHPOs: HP:0002666; HP:0006748; HP:0002668; HP:0001513; HP:0002870; HP:0000819; HP:0000822; HP:0100293; HP:0000790; HP:0000079 (Pheochromocytoma, Adrenal pheochromocytoma, Paraganglioma, Obesity, Obstructive sleep apnea, Diabetes, Hypertension, Muscle fiber hypertrophy, Hematuria, Abnormality of the urinary system)

      CaseHPOFreeText: Prior history of morbid obesity, obstructive sleep apnea, diabetes, hypertension, benign prostate hypertrophy, persistent hematuria, urinary frequency, weak stream, and nocturia. He presented with multifocal pheochromocytomas. CT urogram showed bilateral, irregular, heterogeneous large adrenal masses diagnosed as pheochromocytomas and a prominent and suspicious lymph node. He underwent an open bilateral adrenalectomy and paracaval lymph node resection resulting in a paraganglioma diagnosis. Surgical pathology confirmed pheochromocytomas in the bilateral adrenal glands. Patient was identified as having type 2C VHL.

      CaseNotHPOs: HP:0000119; HP:0012211 (Abnormality of the genitourinary system, Abnormal renal physiology)

      CaseNotHPOFreeText: CT urogram showed no abnormalities within the urogenital tract. Cushing's syndrome was ruled out with an undetectable late-night salivary cortisol level. Electrolyte levels, kidney function, and complete blood count were within normal limits.

      CasePreviousTesting: Coding exons and adjacent intron nucleotides of the 12 targeted genes associated with hereditary pheochromocytoma syndromes were amplified and then sequenced using PCR and next-generation sequencing.

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Y175C (c.524A>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 36905, https://www.ncbi.nlm.nih.gov/clinvar/variation/36905/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: in vitro studies showed that under both normoxic and hypoxic conditions, Y175C VHL functions similarly to the WT with regard to HIFα degradation.

      MutationType: missense_variant;transition

      CivicName: Y175C (c.524A>G)

    1. PatientID: 1

      KindredID: K-V7/V6

      Case: F, 47Y0M, Korean

      DiseaseAssertion: VHL

      FamilyInfo: The proband (ID 1) was affected with retinal hemangioblastoma, bilateral pheochromocytoma, and pancreatic tumor. The daughter (ID 2) was affected with retinal hemangioblastoma and bilateral pheochromocytoma. The son (ID 3) was affected with retinal hemangioblastoma. All three were positive for the D121N (c.361G>A) germline variant of the VHL gene.

      CasePresentingHPOs: HP:0002666; HP:0009711; HP:0002894 (Pheochromocytoma, Retinal capillary hemangioma, Neoplasm of the pancreas)

      CaseHPOFreeText: Retinal hemangioblastomas, pancreatic tumor and bilateral pheochromocytoma. Diagnosed with VHL type 2.

      CaseNotHPOs: HP:0005584; HP:0010797 (Renal cell carcinoma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 25078357

      SupplementalData: N/A

      Variant: p.D121N (c.361G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351753750, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA351753750

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: D121N (c.361G>A)

      MultipleGeneVariants: N/A

    1. 3320Fnt 712 C to T, Arg to TrpP, 12301

      PatientID: 33

      KindredID: 2301

      Case: F, 20Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Another member of her family (patient 32) presented with two pathologic pancreatic neuroendocrine tumours and had the same VHL gene mutation.

      CasePresentingHPOs: HP:0030405 (pancreatic endocrine tumour)

      CaseHPOFreeText: She presented with one pathologic pancreatic endocrine tumour with metastases.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: p.R167W (c.712C>T)

      CaseProblemVariantFreeText: N/A

      ClinVar: 2218 https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: CA020450 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.499C%3ET

      gnomAD: 0.000007954 https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. Here, we report imaging findings in a VHL patient and in 3 consecutive family members undergoing clinical and radiological screening that included [111ln-DTPA0] octreotide scintigraphy in addition to the above-mentioned procedures.

      PatientID: 3

      KindredID: 1

      Case: F, 38Y0M, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: 4 patients from the same family (2 male 2 female; age range 27-35Y) carry this mutation (c.509T>G).

      CasePresentingHPOs: HP:0002666; HP:0030405 (pheochromocytoma, pancreatic endocrine tumour)

      CaseHPOFreeText: previously undergone right adrenalectomy for pheochromocytoma. Contrast-enhanced helical CT scan confirmed the presence of a solid hypervascular lesion at the level of the pancreatic tail, and of a hypervascular mass in the left adrenal gland, suggestive of an endocrine pancreatic tumor and of a pheochromocytoma, respectively.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170G (c.509T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351756196 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.509T%3EG

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: V170G (c.509T>G)

      MultipleGeneVariants: N/A

    1. 21 missense mutations, 5 nonsense mutations

      PatientID: 12

      KindredID: 240

      Case: Sex unknown, Age unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0030405; HP:0002666 (pancreatic endocrine tumour, pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0005584 (renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.T157I (c.470C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223223 https://www.ncbi.nlm.nih.gov/clinvar/variation/223223/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: T157I (c.470C>T)

      MultipleGeneVariants: N/A

    2. 21 missense mutations

      PatientID: 21

      KindredID: 99

      Case: Sex unknown, Age unknown, French

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs: HP:0030405; HP:0002666; HP:0005584 (pancreatic endocrine tumour, pheochromocytoma, renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161Q (c.482G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182983 https://www.ncbi.nlm.nih.gov/clinvar/variation/182983/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence:N/A

      MutationType: missense_variant;transition

      CivicName: R161Q (c.482G>A)

      MultipleGeneVariants: N/A

    1. 02234Grandmother VHL 2c.345C>Gp.His115Gln

      PatientID: 022

      KindredID: 1

      Case: M, 34Y0M, Ethnicity Unknown

      DiseaseAssertion: Clear Cell Renal Cell Carcinoma

      FamilyInfo: Grandmother had cancer, but no family history of clear cell renal cell carcinoma.

      CasePresentingHPOs: HP:0006770 (clear cell renal cell carcinoma)

      CaseHPOFreeText: At 34Y0M, patient 022 presented with clear cell renal cell carcinoma with metastasis.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MAX, NF1, RET, TMEM127, VHL, SDHA/SDHB/SDHC/SDHD/SDHAF2 (a few of the 618 genes in a panel of clear cell renal cell carcinoma relevant genes - see table S1 for list of genes).

      PreviouslyPublished: N/A

      SupplementalData: Gene panel list obtained from table S2.

      Variant: p.H115Q (c.345C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 496058, https://www.ncbi.nlm.nih.gov/clinvar/variation/496058/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant, transversion

      CivicName: H115Q (c.345C>G)

      MultipleGeneVariants: N/A

    1. PatientID: 1

      KindredID: Unknown

      Case: F, 57Y0M, Dutch

      DiseaseAssertion: VHL

      FamilyInfo: Unknown - study sampled 15 patients from 5 families

      CasePresentingHPOs: HP:0001737 (pancreatic cysts)

      CaseHPOFreeText: N/A

      CaseNotHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseNotHPOFreeText: No evidence of left or right eye angiomas

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.V170D (c.509T>A)

      LegacyVariant: p.V241D

      CaseProblemVariantFreeText: Variant determined through the assumption of the authors using Latif et al 1993 (AF010238.1) transcript and adding 71bp to the protein sequence.

      ClinVarID: 625256 https://www.ncbi.nlm.nih.gov/clinvar/variation/625256/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence:N/A

      MutationType: missense_variant;transversion

      CivicName: V170D (c.509T>A)

      MultipleGeneVariants: N/A

    1. oung VHL male patient

      PatientID: None

      KindredID: 1

      Case: M, 26Y0M, Ethnicity Unknown

      DiseaseAssertion: Pheochromocytoma

      FamilyInfo: The patient is an orphan and the family background of the parents and siblings history is unavailable.

      CasePresentingHPOs: HP:0006748 (Adrenal pheochromocytoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: None

      CaseNotHPOFreeText: Autopsy findings and histological study excluded any tumors or cystic lesions out of the spectrum of VHL disease in the brain, cerebellum, brain stem, spinal cord, petrous bones, both kidneys, pancreas, and both epididymides.Peripheral sympathetic and parasympathetic chains did not contain any lesions. An autopsy of the eyes was not performed.

      CasePreviousTesting: SDHB, SDHD, RET

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      ClinVar: 2218 https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: CA020450 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.499C%3ET

      gnomAD: 0.000007954 https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. 4PExon 1Missensec.245G>Tp. Arg82LeuPheo, HBA CNS, PanNET

      PatientID: 4

      KindredID: 3

      Case: Sex Unknown, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002666; HP:0010797; HP:0030405 (Pheochromocytoma; Hemangioblastoma; Pancreatic endocrine tumor)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: MEN1/ RET

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R82L (c.245G>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 526675 https://www.ncbi.nlm.nih.gov/clinvar/variation/526675/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: R82L (c.245G>T)

      MultipleGeneVariants: N/A